daga ina kuka sami alamun cutar?
da irin wannan ciwo na zuciya za a bi da shi kamar yadda yawancin shekarunku suke
da kuma masana'antu
dole ne a bincika yawan cholesterol a cikin jini
kuma kuna da kayan aiki na yanzu?
Ba ku da tabbaci a cikin zuciyarku?
kuma kana da matsala tare da numfashi
Shin za ka iya lissafa wasu alamun rashin lafiya da kake da su?
da kuma yadda za a yi wa'azin bishara
Ina da tambaya ma
ina da sanyi da sanyi
zuciyata tana shan wahala sosai yau
yana wakiltar zazzabin cizon sauro a ƙarshen rana
kuma zuciya tana da zafi
kamar ina da tushen shuka
Ina so ka nuna min yadda kake ji
kuma duk masana'antar suna da
da ciwon sukari mai tsanani
Kun san yadda nake baƙin ciki ƙwarai.
Ka san dukan abin da waɗannan mutane suka faɗa a kaina.
zuciyarku tana cike da baƙin ciki.
kuma kuna cewa akwai kamar yadda yake a cikinku
wani a cikinku yana da ciwon zuciya wanda ke haifar da yawan cholesterol a cikin jini
duk wata cuta ko wata matsala da kuka taɓa fuskanta a jikinku?
Shin akwai wasu mutane da ke da cutar kamar ku a gida tare da irin wannan alamun cutar?
Shin kuna da alamun cutar?
Za ku mutu kamar yadda kuka yi numfashi?
Yanzu zuciyarku tana cike da baƙin ciki da baƙin ciki.
saboda lokacin sanyi ne
amma kuma ta hanyar da suka bar mu a cikin wani yanayi saboda rashin lafiyar da muke da ita
amma babban kalubalen da muke fuskanta yanzu shine tunaninmu
amma ina da matsala da numfashi
amma na san mutane da yawa suna da'awar ni
mu kuma kawar da duk wani abin da zai sa mu yi fushi.
Amma yanzu kun yi nasara.
Saboda haka ina ta ɗokin shan wahala ƙwarai.
kamar dai wani yana kallon zuciyarka
har yanzu akwai kamar numfashi wanda za ku iya ɗauka
Shin suna da alamun da suka nuna cewa su ma suna da irin wannan ciwon?
kuna da wata cuta mai saurin kamuwa da cuta kamar zubar da jini da karfi ko wasu abubuwa kamar haka?
kuna da wata cuta mai saurin kamuwa da cutar sankara kamar su ciwon suga?
Ba ku da isashen ƙarfi, ba ku da isashen ƙarfi.
kuna da jini mai ƙarfi?
Shin kuna da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Shin kun san alamun cutar da yake da ita?
za ku iya ganin wannan hoton?
da yawa sha yau
amma dole ne in yi gwajin ciwon sukari
amma yana da alamun kamar nawa
yadda kuke barci
Yaya za ku iya jurewa?
idan har yanzu kuna da jikinku mai rauni
Idan jikinka ya yi zafi har sau biyu ko fiye
Idan kana tsammanin kana da wata cuta ko matsala da ke buƙatar bincike
jikina yana shan zafi kamar Kenya
Ina da ɗan zafin jiki
jikina yana jin kamar Kenya
ina da ciwon zuciya mai saurin tashi
Ina da matsala da numfashi kuma
zan aiko muku da hoto
ina da ciwon zuciya yau
Ina da ciwon daji da kuma jin zafi a jiki a yau
ina tsammanin cutar zazzabi ce
ina tsammanin wannan shine farkon cutar
Kamar yadda mutane da yawa suke zaune a kan dutsen da aka yi wa ado?
duk sun fara ne da ciwon jiki da kuma ciwon jiki a lokaci guda
yana tashi a tsakiyar zuciya
kamar ciwo na zuciya
ka ɓoye a cikin zuciyata
yana cikin zuciyata
yana cikin tsakiyar zuciya
Na sami baƙin ciki a zuciyata
baƙin ciki na sa ni in yi suwu
Ina so ku san yadda nake ji
kamar cutar sankarar jini ko ciwon sukari
kamar ƙaho a tsakiyar zuciya
yanzu zaka iya shan tachipirina saboda zazzabi
yanzu Mary daga ranar da kake da alamun cutar
yanzu ka ce kana da ciwon zuciya
Ina da baƙin ciki ƙwarai a zuciyata saboda ku,
kuma, kuna da wasu alamun rashin lafiya da ba su dace ba bayan wannan ciwo
Ko kuwa wani ya sa ka baƙin ciki?
kamar yadda za a yi da zafin jiki, da zafin rai, da zafin rai, da zafin rai,
wani abu a cikin zuciyata
nuna min wannan hoton kuma ka ji daɗin hakan
daga jikinku yana da zafi
Shin kuna tsammanin cewa wannan cutar zata iya faruwa idan wani yana da ciki?
Shin yaranku suna da wasu alamun cutar?
gaya mani game da ranar da kuka yi barci
jikin ya kara zafi da dare
jikina ya fara yin kuka tun kwana biyu da suka gabata
jikina ya daina kuka da dare
duba likita mai kula da kula da gaggawa
Za ku iya tambayar ni game da baƙin cikinku?
Ina da baƙin ciki marar ƙarewa a zuciyata.
Ina kuma cikin matsananciyar wahala.
Ina kuma da baƙin ciki a zuciyata.
me ya sa kuke baƙin ciki haka?
A ina ne baƙin cikinku ya fara?
Me ya sa kuke baƙin ciki?
NS
ku yi kamar yadda kuka yi niyya.
kun san cewa ina da ciwon sukari da sauran cututtuka
kun ce kuna da ciwo a wannan rana
Cutar cutar coronavirus (COVID-19) da aka yi a Tarayyar Turai/Hukumar Tsaro ta Turai da Majalisar Dinkin Duniya, 1 ga Janairu zuwa 15 ga Maris, 2020
Cutar coronavirus mai haɗuwa (COVID-19) tana haifar da rikice-rikice kamar yadda Tarayyar Turai/Taron Tsaro na Turai da Tarayyar Burtaniya suka yi, kuma a wani lokaci, ana gudanar da ayyukan COVID-19 a cikin gaggawa a duk faɗin duniya.
Dangane da abin da ya faru a Italiya, asibitoci, asibitoci da kungiyoyin kula da marasa lafiya dole ne su sake tsara shirye-shiryen su saboda yawan masu cutar COVID-19 da ke buƙatar kulawa ta musamman, da kuma ƙarin kulawa ta musamman.
A ranar 31 ga Disamba, 2019, wani taron ta'addanci wanda ba a san sunansa ba ya faru a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Hukumar Kula da Cututtuka ta kasar Sin ta bayyana cewa sabon kwayar cutar coronavirus da aka sani da cutar sankara ta coronavirus 2 (SARS-CoV-2) ba ta da wata illa.
Tun daga wannan lokacin, cutar da SARS-CoV ke haifarwa ana kiranta cutar (COVI-19).
Binciken da aka yi a baya ya nuna cewa kusan kashi 80% na mutane suna da cutar da ba ta da tsanani, wato cutar da ba ta shafi huhu, kuma ba ta da cutar.
A cikin kashi 14 cikin dari na cutar, COVID-19 ta haifar da rashin lafiya mai tsanani da kuma rayuwa a asibiti kuma kashi 6 cikin dari na marasa lafiya suna da matukar damuwa kuma suna buƙatar kulawa ta likita.
Mutuwar asibiti saboda COVID-19 ya kai kashi 4%.
A cikin wannan binciken, mun bincika yadda ake gudanar da aikin rigakafin COVID-19 a kowace ƙasa ta Tarayyar Turai/EEA da Tarayyar Burtaniya (UK) da kuma wanda ke Hubei, China.
Na kuma bincika adadin masu cutar COVID-19 a yanzu a cikin EU/EEA da UK da waɗanda ke Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Cutar COVID-19 a EU/EEA da UK
Bayan China, COVID-19 ya mamaye wasu yankuna kuma yaduwar cutar ta COVID-19 a sauran ƙasashe a duniya yanzu tana bin wannan matakin.
A ranar 11 ga Maris, 2020, Babban Jami'in Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba ta duniya.
A cikin rahoton Eurosurveillance na 5 ga Maris, 2020, Spiteri al. ya ba da rahoton farkon bayyanar da cutar COVID-19 a Turai bisa ga WHO.
A cikin EU/EEA, an fara sanar da cutar ta uku ta Faransa a ranar 24 ga Janairu 2020 a cikin mazauna birnin Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an gano sabbin cututtukan COVID-19 a cikin ƙasashe 30 na EU/EEA da Tarayyar Burtaniya, wanda a tsakanin 31 ga Disamba, 2019 da kuma wannan lokacin ya nuna cewa akwai masu kamuwa da cutar 39,768 da mutuwar 1,727, da kuma mutuwar 1,441 a cikin Italiya.
Gudanar da lissafin da kuma tattara adadin masu cutar COVID-19
A cewar Hukumar Kula da Cututtuka ta Turai (ECDC), adadin mutanen da suka kamu da cutar COVID-19 a kowace kasa a duniya, wanda aka ba da shawarar ga hukumomin da suka fi dacewa kamar su Ma'aikatar Lafiya ta Duniya, hukumomin cikin gida da na gari da WHO za a sake tantance su a ranar 8 na yamma.
An yi amfani da bayanan don yin gwajin COVID-19 a cikin EU/EEA da Burtaniya, tare da kwatanta rayuwa da na Italiya.
A matsayin kimantawa na yawan masu kamuwa da cutar ta COVID-19, mun lissafa haɗuwa da masu kamuwa da cutar ta COVID-19, ta hanyar kimanta yanayin COVID-19 a kowace ƙasar EU/EEA da Burtaniya daga 1 ga Janairu zuwa 15 ga Maris 2020.
Mun kuma gano jimillar adadin wadanda suka kamu da cutar a kowace kasa a ranar 15 ga Maris 2020 da karfe 8:00 na yamma, wanda ya shafi Italiya daga ranar 31 ga Janairu zuwa 15 ga Maris 2020.
Yanayin COVID-19 a cikin EU/EEA da UK.
Ci gaban da aka samu a cikin bayanan haɗin kai na COVID-19 a cikin EU/EEA na kwanaki 14 da Burtaniya ya biyo bayan lardin Hubei (Cin) (Hoto 1).
A duk fadin EU/EEA da kuma Burtaniya, adadin mutanen da suka kamu da cutar COVID-19 ya fara tashi ne daga ranar 21 ga Fabrairu ya kai ranar 28 ga Fabrairu, 2020 (Matsakaicin).
Babban dalilin wannan tashin hankali shine yawan adadin wadanda aka samu a Italiya, yayin da sauran kasashen EU/EEA da Burtaniya suka nuna irin wannan ci gaban a cikin adadin COVID-19 (Abubuwa).
Hoto na 2 ya nuna jimillar adadin mutanen da suka kamu da cutar COVID-19, a cikin EU/EEA da UK da kuma Italiya a ranar 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya ce, a ranar 15 ga watan Maris da karfe 8:00 na yamma, kasashe 15 na EU/EEA da wasu na Burtaniya sun sanar da adadin wadanda za a iya kamuwa da su da cutar a Italiya a cikin kwanaki uku kafin ko bayan karshen.
Wannan ya nuna cewa adadin mutanen da suka kamu da cutar COVID-19 ba su da yawa kamar yadda EU/EEA da Burtaniya suka yi.
Matsayin da muke tsammani na yaduwar COVID-19 yana nuna cewa cutar tana da daidaito da kuma yiwuwar a magance ta a duk ƙasashe.
Wannan ya faru ne saboda bambancin jihohi, canje-canje a cikin tsarin kula da lafiyar ƙasa, da kuma bambancin yanayin a cikin jihohi da kuma wasu matakai don zaɓin marasa lafiya waɗanda ke buƙatar sake gwadawa don COVID-19, da kuma sake gwadawa.
A farkon watan Maris na 2020, likitoci a yankunan da ke fama da cutar ta Italiya sun gano cewa kashi 10% na masu cutar COVID-19 sun buƙaci kulawa ta musamman kuma kafofin watsa labarai sun ce asibitoci da kungiyoyin kula da marasa lafiya a yankunan sun ci gaba da cimma hakan.
Bayanai game da asibitoci da/ko rukunin kula da marasa lafiya na COVID-19 suna cikin EU/EEA na kashi 6% da 1%, bi da bi (bayanai za a nuna).
Bayan haka, ana tattara su a cikin wani shafi don aika bayanan kulawa wanda ke nuna adadin marasa lafiya da mutuwar.
Wani bincike na 2010-2011 ya nuna bambancin da ke tattare da samun gadaje da umarnin kulawa a cikin marasa lafiya masu tsanani da marasa lafiya a Turai, daga gado 29.2 a Jamus zuwa 4.2 a cikin mutane 100,000 a Portugal.
A cewarsa, kasashe masu arziki za su iya zama masu arziki ko kuma marasa arziki kamar Italiya (12.5 na gadajen asibiti da kuma asibiti daya ga mutane 100,000 a 2010-11).
Shirya shirye-shiryen da suka shafi tsarin karbar bakuncin, tare da yiwuwar kowane EU/EEA da UK sun karɓi marasa lafiya na COVID-19 waɗanda ke buƙatar asibiti da kuma buƙatun gado waɗanda ke buƙatar samun umarnin kulawa na mutum aƙalla 90% a cikin jerin na shida na gwajin ECDC na gwajin cutar COVID-19.
Saboda yawan masu cutar da ke yaduwa a wasu sassan EU/EEA da sauran Burtaniya, da kuma asibitoci da kungiyoyin kula da marasa lafiya da ke aiki a wuraren kula da marasa lafiya, ana iya samun bayanai kan marasa lafiya da gadaje masu umarni a duk biranen da ke da ciwon daji na 2 (NUTS-2).
Abubuwan da suka faru a Italiya da kuma halin da ake ciki a wasu ƙasashe sun nuna cewa annobar COVID-19 ta ci gaba da yaduwa a cikin EU/EEA da Burtaniya.
Jihohi, asibitoci da kungiyoyin kula da marasa lafiya dole ne su tsara kansu kan yadda za su taimaka wa al'umma saboda cutar SARS-CoV-2 da karuwar adadin masu cutar COVID-19 da ke buƙatar kulawa ta musamman, kamar yadda ake samu a yankunan da ke fama da cutar a Italiya.
Kamar yadda aka lissafa a cikin binciken ECDC na cutar, akwai cikakkiyar hanyar da ba ta dace ba don hana yaduwar SARS-COV-2, da kuma hanyar da ta wuce daga magani zuwa raguwa, kamar yadda yawan adadin masu cutar ba zai ba da isasshen lokaci ga masu kula da lafiyar su fahimci, amsa da kuma daidaita tsarin amsawar su ba tare da lokaci ba.
Binciken rigakafin cutar ya kuma yi la'akari da matakan kiwon lafiya na gwamnati don rage tasirin cutar.
Akwai tsammanin yiwuwar ko ƙasashe a cikin gano hanyoyin da za su iya rage ƙarfin su wajen rage yaduwar SARS-CoV-2 da rage gaggawa a cikin kulawar lafiya.
Idan wannan ya ci gaba, zai yiwu cewa tsarin kiwon lafiya na wasu ƙasashen EU/EEA zai sami matsala saboda yawan marasa lafiya da ke buƙatar kulawa ta musamman a cikin kwanaki da makonni masu zuwa.
Cutar kwayar cutar coronavirus ta 2019 (COVID-19), wacce ke haifar da cutar sankara mai saurin yaduwa (SARS) coronavirus 2 (SARS-CoV-2), ta kuma kashe mutane sama da 3,000 tare da kamuwa da mutane sama da 80,000 a China da sauran kasashe a duniya, wanda ke zama babban abin damuwa ga mutane.
Kamar yadda yake a cikin SARS-CoV, wanda ya haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 na iya yaduwa daga tsuntsaye kuma yana haifar da alamun cutar ta hanyar kwayar cutar.
Koyaya, COVID-19 ya rage mutuwar mutane da cutar SARS kuma ya fi yaduwa kuma ya fi shafar tsofaffi fiye da mata da maza fiye da mata.
Don amsa tambayoyin da ke ci gaba da ƙaruwa game da cutar da ta taso, wannan labarin ya ba da shawarar bayar da cikakken bayani game da abubuwan da ke cikin binciken.
Za mu kuma tattauna game da nazarin cutar, yiwuwar cutar, nazarin kwayar cutar, ganewar asali, magani, tsinkaya, da kuma rigakafin cutar.
Duk da cewa akwai tambayoyi da dama da za a iya amsawa, muna tsammanin wannan labarin zai taimaka wajen fahimtar cutar.
Bikin bazara a ranar 25 ga Janairu, 2020 ya kasance abin tunawa ga duk jama'ar kasar Sin wadanda suka yi matukar damuwa da zama a gida a lokacin hutun ranar Asabar saboda barkewar sabon kwayar cutar.
Kwayar cutar ta yi kama da kwayar cutar coronavirus (CoV) da ta haifar da cutar sankara ta SARS a shekara ta 2003; saboda haka Hukumar Lafiya ta Duniya ta kira shi SARS-CoV-2, kuma ana kiran cutar CoV Disease 19 (COVID-19).
Cutar ta fara ne a Wuhan, China, daga baya ta bazu zuwa duk kasar sannan ta kai kusan kasashe 50 a duniya.
Tun daga ranar 2 ga watan Maris na shekarar 2020, cutar ta kamu da mutane 80,000 da suka kamu da cutar COVID-19, kuma an yi wa mutane 40,000 magani kuma sama da mutane 3,000 sun mutu.
WHO ta yi gargadin cewa COVID-19 "ta zama sanadin cutar dan adam" kuma tana iya zama mai saurin yaduwa.
Kamar yadda aka nuna a PubMed (https://www.ncbi.nlm.nih.gov/pubmed), kafin a yi rarrabuwa, sama da takardu 200 aka wallafa game da COVID-19 da kuma ilimin cutar, da yadda ake kamuwa da ita, da yadda ake kamuwa da ita, da kuma hanyoyin da ake bi da ita tun daga farkon fitowar ta a ranar 7 ga watan Janairun 2020 wanda ya nuna cewa cutar ta bambanta a cikin mutane da dama.
Wannan binciken yana haifar da ci gaba da ci gaba da bincike a cikin sabon binciken da kuma hanzari.
A wani bangare, za mu iya kwatanta cutar COVID-19 da SARS da wani annoba, wanda ake kira Middle East Respiratory Disease (MERS, annoba ta 2012).
Muna kuma fatan yin amfani da abubuwan da muka koya game da rigakafin cutar da kuma tsammanin cutar tare da shawarwarin da suka dace a halin yanzu.
CoVs sun kasance masu cutarwa ne da ba su kashe mutane ba a baya, wanda ke haifar da kamuwa da cuta a kashi 15% cikin 4 na kamuwa da cuta.
Amma, a cikin wannan yanayin, zamu iya kwatanta CoVs masu cutar mutum sau biyu, watau, SARS-CoV da MERS-CoV, waɗanda suka fara da barkewar cutar a China a 2003 da Saudi Arabia a 2012, kuma daga baya suka bazu zuwa wasu ƙasashe tare da adadi mai yawa da kuma yawan fitarwa.
Bugu da ƙari, cutar COVID-19 ta yanzu ita ce annoba ta uku ta CoV a tarihin ɗan adam.
Kamar yadda aka nuna a hoto, hoto na 1.1, an gano wani irin ciwon zuciya da ya faru a Wuhan a ranar 31 ga watan Disamba, 2019 a hukumar lafiya ta kasar Sin.
Bayan makonni biyu, an gano cutar CoV.
A ranar 15 ga Janairu, 2020, an sami mace ta farko a Wuhan.
A wannan lokacin, cutar ta fara yaduwa zuwa garuruwa, larduna, da wasu ƙasashe.
A ranar 20 ga watan Janairu, an sanar da cutar a cikin likitocin, wanda bai nuna cewa cutar za ta iya yaduwa daga mutum zuwa mutum ba.
A ranar 23 ga Janairu, 2020, an rufe birnin Wuhan kuma an dakatar da dukkan zirga-zirgar jiragen sama.
A ranar 24 ga watan Janairu, binciken farko na asibiti ya nuna cewa, daga cikin mutane 41 da suka kamu da cutar, 21 na iya haifar da cutar Wuhan, wanda aka ɗauka a matsayin asalin cutar da ta samo asali daga wani dabba da ba a sani ba.
Bayan 30 ga Janairu, WHO ta ayyana gaggawa ta duniya.
A lokacin rubuta wannan labarin, cutar ta ƙare a China kuma ta kai ƙasashe 50 a duniya (Hoto (Hoto 2).
Ko da yake cutar tana ci gaba sosai, ana iya samun tabbacin cewa cutar ta riga ta faru ko kuma wanda zai iya ganewa.
A ranar 11 ga Fabrairu, 2020, binciken da aka yi kan mutane 8,866 da suka kamu da cutar COVID-19 wanda ya kai ga mutane 4,021 a wasu dakunan gwaje-gwaje ya nuna cewa akwai wani sabon sakamako na cutar kamar haka (https://mp.weixin.qq.com/s/UIBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 na kamuwa da mutane na kowane zamani, amma mafi yawa daga cikin masu shekaru 30 zuwa 65.
Fiye da rabin (47.7%) na waɗanda suka kamu da cutar sun haura shekaru 50, waɗanda ba su kai shekaru 20 ba sun fi yawa, kuma kusan 14 daga cikinsu sun kai shekaru 10.
SARS-CoV-2 ya kamu da maza da yawa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya yadu a cikin gonaki da wuraren shuka a Hubei da kewayenta.
COVID-19 ya ɗauki kimanin kwanaki 5 (2 zuwa 9) daga farkon zuwa gwaji.
Lokacin bayyanar shine kimanin kwanaki 4.8 (3.0 zuwa 7.2).
Lokaci na tsawon lokaci daga farkon zuwa ƙarshe shine kimanin kwanaki 9.5 (4.8 zuwa 13).
Matsakaicin lambar haihuwa (R0) ya kasance 3.77 (95% CI:3.51-4.05), kuma R0 da aka kimanta ya kasance 2.23-4.82.
Yawan mutanen da suka kamu da cutar ba zai iya kaiwa matakin farko ba kafin 23 ga Janairu, 2020, wanda ya yi daidai da lokacin da aka dakatar da zirga-zirgar jiragen sama kafin bikin bazara a China.
Mutuwar da aka sani game da cutar ta kasance 1.44% (CI: 59%:1.10-1.86%), kuma yawan mutuwar da aka bincika ya kai 3.06% (CI: 2.02-4.59%).
Abubuwa uku da suka fi haifar da cutar COVID-19 sune haihuwa (mai tsufa), shekaru (≥60), da kuma ciwon zuciya mai tsanani.
CoVs suna kama da wasu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta.
Ana iya rarraba su ta hanyar inda ƙungiyoyi huɗu, wato, alpha, beta, gamma, delta, da alpha da beta ke da tasiri a cikin mutum.
Kwayar (S) glycoprotein tana da alaƙa da mai karɓar angiotensin da kuma mai hana kwayar cutar 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, bi da bi, kuma an yi amfani da su.
An tsara kwayar RNA ta kwayar cutar a cikin cytoplasm; bayan haihuwar kwayar halitta, kwayar RNA da kwayar glycoproteins da nucleocapsid suna samar da ƙananan gidajen da ke karɓar kwayar cutar, wanda ke shiga kuma ya haɗu da jini kuma ya haifar da kwayar cutar.
An fara ba da rahoton cutar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon beta-CoV wanda ya fi kashi 99.98% na kwayoyin halitta a cikin tashoshin 10 da aka gudanar a farkon wurin da cutar ta fara, Kasuwar Abinci na Huanan a Wuhan.
SARS-CoV-2 yana da kamanceceniya da SARS-CoV dangane da MERS-CoV.
Ta hanyar gano ƙananan lantarki, kwayar cutar SARS-CoV-2 ba ta iya zama a cikin ƙwayoyin ultrathin na epithelium na huhu na mutum.
An gano ACE2 na ɗan adam a matsayin mai haifar da maganin SARS-CoV-2 kamar SARS-CoV.
A cewarsa, kwayar S ta SARS-CoV-2 tana da tasiri sosai akan ACE2 na mutum fiye da SARS-CoV? wanda ya hada da SARS-CoV-2 wanda cutar ta cutar da SARS-CoV.
SARS-CoV-2 na iya kuma samar da wani karamin furotin wanda aka yiwa lamba ta hanyar orf3b da kuma wani furotin da aka yiwa lamba ta hanyar orf8.
SARS-CoV-2 orf3b na iya zama mai tasiri a cikin kwayar cutar kuma yana hana IFNβ; duk da haka, orf8 ba shi da wani tasiri ko alamun cutar.
A ranar 18 ga Fabrairu, 2020, Zhou, et al., sun ce kwayar halitta ta cryu-EM mai matsayi na iya zama na mutum ACE2 a 2.9 A tare da haɗuwa da BOAT1 mai ɗaukar hoto na amino acid.
Sun gano cewa wannan haɗin, wanda ke buɗewa da rufe kwayoyin, yana haɗuwa da hanyar ACE2-B0AT1 wanda zai iya haɗuwa da sunadarai S guda biyu, wanda ke ba da alamar ganowa da kamuwa da cutar CoV.
BOAT1 na iya zama wani magani na gwaji don maganin cutar SARS-CoV-2.
Gidan da ke tsakiyar
An gano cewa SARS-CoV da MERS-CoV sun samo asali ne daga tsuntsaye kuma an watsa su ga mutane ta hanyar dabbobi kamar su dabbobi masu shayarwa da raƙuma, da sauransu.
Ta hanyar nazarin kwayar cutar SARS-CoV-2 da kuma wasu nau'ikan CoV, tsuntsaye sune farkon wadanda suka kamu da cutar SARS-CoV-2 kamar yadda sabon kwayar cutar ya kasance kashi 96% daidai da nau'ikan SARS CoV da aka samar a cikin tsuntsaye wanda ake kira tsuntsaye-SL-CoVZX45 da tsuntsaye-SL-CoVZX21.
Amma, gidan wanka yana ba da damar kwayar cutar ta shiga cikin wani gini ba tare da sanin mutum ba, kuma dole ne a sake bincika abin da ya kama.
Ji et al., sun yi la'akari da cewa maciji na iya daukar kwayar cutar daga tsuntsaye zuwa mutum wanda ya hada da haɗin gwal a cikin furotin.
A sakamakon wani binciken, masu bincike a Guanzhou, China, sun gano cewa wani nau'in dabba mai suna pangolin mai tsayi, wanda ke da ƙwayoyin cuta, wanda ke aiki a matsayin magani ga wasu mutanen China, na iya zama cibiyar SARS-CoV-2 saboda kwayoyin halittarsa sun yi daidai da kashi 99% na CoV da aka samo a cikin pangolin da SARS-CoV-2.
Koyaya, bambancin 1% tsakanin waɗannan kwayoyin halitta na iya zama bambancin manga; kuma, muna da tabbacin sakamakon binciken (Hoto (Hoto 33).
Ba a san ainihin tsarin kwayar cutar SARS-CoV ba.
SARS-CoV-2 da MERS-CoV suna iya kamuwa da cutar ta hanyar rufewa na tsawon kwanaki 48 a kan takalmin da aka yi amfani da shi da kuma kwanaki 5 a cikin yanayin zafi na 20 °C da zafi na kashi 40 zuwa 50%.
SARS-CoV-2 na iya zama mai haɗari.
An ce SARS-CoV-2 yana fuskantar ultraviolet da zafin jiki sama da 56 °C na tsawon minti 30; ether, 75% ethanol, sinadarin da ke kashewa da chlorine, peracetic acid, chloroform, da kuma kayan aikin da ke da ƙanshi, ko kuma chlorhexidine, na iya kashe kwayar cutar da sauri.
Jama'a ba su da maganin cutar SARS-CoV-2 kuma haka lamarin yake ga wannan sabon kwayar cutar.
A halin yanzu, babu wani bincike da bincike da aka yi game da maganin SARS-CoV-2.
Hakanan, dole ne mu iya yin la'akari da nazarin wasu CoVs, musamman SARS-CoV da MERS-CoV (Hoto (Hoto 4).4).
Sau da yawa, idan kwayar cutar ta shiga jiki, kwayoyin cuta suna gano ta hanyar masu karɓar ƙwayar cuta (PRR) da masu karɓar lectin C, masu karɓar Toll (TLR), masu karɓar NOD (NLR), da masu karɓar RIG-I (RLR).
Ta hanyoyi daban-daban, kwayar cutar ta fara gano abin da zai iya cutarwa, ta hanyar hada kwayoyin dendritic, da kuma na'urorin interferon na I (IFNs) wadanda ke taimakawa wajen yaduwar kwayar cutar kuma suna taimakawa wajen kashe kwayoyin cutar.
Koyaya, furotin N na SARS-CoV na iya taimakawa kwayar cutar ta fitar da amsawar rigakafi.
A wannan yanayin, maganin rigakafi na jiki ya fara haɗuwa da kwayar cutar.
T lymphocytes da CD4+ da CD8+ T zasu iya zama masu tasiri a cikin rigakafi.
CD4+ T-cell suna motsa B-cell don kawar da kwayoyin cuta da ke da alaka da kwayar cutar, kuma CD8+ T-cell suna kashe kwayoyin da kwayar cutar ta shafa.
T mai karɓar kwayar halitta tana hana cytokine wanda ke taimakawa cutar ta hanyar kwayar halitta.
Koyaya, CoV na iya lalata ayyukan T-cell ta hanyar shigar da T-cell apostosis.
Abubuwan da jiki ke nunawa kamar C3a da C5a da kuma yadda suke aiki a cikin jini suna da mahimmanci wajen magance cutar ta kwayar cuta.
Misali, kwayar cutar da aka gano a cikin kwayar cutar da ta kamu da cutar ta kamu da cutar MERS-CoV.
A wasu lokuta, yawan ƙwayar cuta na jiki yana haifar da ƙananan ƙwayoyin cuta a wannan wuri wanda zai iya cutar da sauran kwayoyin, kuma idan ba haka ba zai iya shafar yawancin kwayoyin halitta ba.
Cutar SARS-CoV, wacce ke farawa a cikin yara, na iya kamuwa da tsofaffi da ke da cututtukan cututtukan jiki da mata masu juna biyu.
Hakazalika, mutanen da suka kamu da cutar ko kuma wadanda suke da ƙananan ƙwayoyin cuta suna iya kamuwa da wasu a cikin gidajensu.
Lokacin bayyanar cutar SARS-CoV-2 na yau da kullun shine kwanaki 1 zuwa 14, mafi ƙarancin kashi 3 zuwa 7 bisa ga nazarin 425 na Wuhan.
Koyaya, nazarin marasa lafiya 1,099 ya nuna cewa lokacin bayyanar cutar zai iya zama kusan kwanaki 3 kuma ya tashi daga kwanaki 0 zuwa 24.
Wani sabon bincike, kamar yadda aka lissafa a sama, ya nuna cewa tsawon bayyanar ya kai kwanaki 4.8 (3.0-7.2) a cikin adadin marasa lafiya 8,866.
Ya zama wajibi ga hukumomin kiwon lafiya su yi la'akari da lokacin da ake warewa da kuma lokacin da ake kamuwa da cutar a jiki, saboda cutar ba ta da kwayar cutar a cikin jini amma za ta iya haifar da alamun cutar ta hanyar yaduwa ga wasu mutane.
A wani bangare, mutanen da ke da damar kamuwa da cutar, ko kuma wadanda suka kamu da cutar sun kasance a cikin kwanaki 14 na rigakafin cutar.
Idan an tsawaita lokacin da ake ciki zuwa kwanaki 24?
Rashin jin daɗi na jiki shine farkon bayyanar cutar COVID-19, wanda zai iya haifar da wasu alamun bayyanar cututtuka kamar rashin jin daɗi, numfashi kamar tashin hankali, jin zafi, ciwon kai, ciwon hanci, jin zafi, jin zafi, rashin jin daɗi, kamar rashin jin daɗi, da kuma jin zafi.
Wasu marasa lafiya suna mutuwa kamar yadda suke numfashi da kuma/ko kuma rage yawan zafin jiki a cikin jini mako guda bayan fara cutar.
Lokacin da cutar ta ƙare, mai haƙuri yana da matsala mai tsanani tare da numfashi, ciwo a jiki, rashin jin daɗi, da kuma jini.
Masu cutar da suka kamu da cutar suna da zafi/ko kuma suna da alamun numfashi da kumburi da kumburi, ko da yake hoton numfashi zai nuna rashin lafiya, ya kamata a bincika kwayar cutar don bincike a kan lokaci.
Wani binciken da aka gudanar a watan Disamba na shekarar 2019 ya nuna cewa yawan alamun cutar sun kai kashi 98% na kumburi, kashi 76% na ciwon hanci, kashi 55% na numfashi, da kashi 3% na tari; kashi 8% na marasa lafiya suna bukatar taimakon iska.
An gano irin wannan sakamako a cikin wasu sabbin karatu kamar yadda aka gano cewa wasu kwayoyin halitta da sauran kwayoyin halitta sun samo asali ne daga kamuwa da cutar.
Bugu da ƙari, wani binciken jama'a na 2012 ya nuna cewa masu kamuwa da cutar MERS-CoV suna da ƙarancin zazzabi (98%), rashin jin daɗi (47%), da kuma rashin jin daɗi (55%) a matsayin farkon rahoton cutar.
Koyaya, kashi 80% daga cikinsu suna buƙatar taimako da iska, fiye da waɗanda ke fama da COVID-19 kuma suna ci gaba da samun ƙimar mutuwar MERS fiye da COVID-19.
Rashin jin daɗi (26%) da kumburi (26%) sun bayyana a cikin marasa lafiya na MERS.
A cikin marasa lafiya da cutar ta SARS, an gano cewa zazzabi (99%-100%), rashin jin daɗi (29%-75%), numfashi kamar ƙaiƙayi (40%-42%), tari (20%-25%), da kumburi (13%-25%) sune farkon alamun cutar kuma taimakon numfashi ya faru a cikin 14%-20% na marasa lafiya.
A ranar 14 ga Fabrairu, adadin COVID-19 ya kasance 2% yayin da adadin waɗanda aka tabbatar sun kai 66 576 a duniya.
A cewar wani kimantawa, mutuwar SARS a watan Nuwamba 2002 ya kai kashi 10 cikin 100 na kamuwa da cutar 8,096.
A cikin MERS, bisa ga binciken al'umma na Zwing 2012, yawan mutuwar ya kai kashi 37% na mutane 2,494.
Binciken farko ya nuna cewa R0 na SARS-CoV-2 zai kasance 6.47 tare da tabbacin 95% (CI) na 5.71-7.23, yayin da R0 na SARS-CoV ya kasance daga 2 zuwa 4.
An kwatanta da SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da alamun bayyanar, mutuwa, da R0 a cikin Table 1.1.
Ƙididdigar da ke ƙasa sun nuna cewa SARS-CoV yana da yiwuwar yaduwa fiye da MERS-CoV da SARS-CoV, kuma yana iya kashe mutane da yawa kamar yadda muka lissafa.
Bugu da ƙari, yana da wuya a iya sarrafa ci gaban cutar SARS-CoV-2 fiye da na MERS-CoV da SARS-CoV.
Ana iya yin amfani da kayan aiki na musamman a cikin wani wuri a cikin mota ko mota kamar jirgin sama.
Yawancin wadanda suka kamu da cutar sun yi tafiya ko kuma sun zauna a Wuhan ko kuma wuraren da cutar ta shafa ko kuma sun kasance tare da mutane masu kamuwa da cutar ko kuma wadanda suka kamu da cutar a cikin makonni biyu kafin farawar cutar.
Koyaya, an ce mutane na iya kamuwa da kwayar cutar ba tare da nuna alamun cutar ba har tsawon makonni biyu kuma marasa lafiya da suka warke daga asibiti na iya kamuwa da kwayar cutar, wanda ba zai iya haifar da wata cuta ba don tsawaita lokacin rayuwarsa.
Marasa lafiya suna da ƙwayoyin cuta masu yawa waɗanda ke da ƙananan jini ko raguwa (a maimakon lymphocytes) a farkon matakin.
Misali, an gano cutar lymphopenia tare da yawan kwayar cutar jini < 4×109/L da kuma yawan kwayar cutar lymphocyte < 1×109/L, tare da karuwar aspartate aminotransferase da viremia a tsakanin marasa lafiya COVID-19 1,099.
An sami karuwar matakan jini da myoglobin a cikin jinin wasu marasa lafiya, da kuma karuwar sinadarin C-reactive da kuma yawan ƙwayoyin erythrocytes.
A cikin marasa lafiya da ke fama da cutar, D-dimer, wanda shine babban sinadarin fibrin a cikin jini, yana ƙaruwa, kuma yawan ƙwayoyin lymphocyte yana raguwa a kan lokaci.
Radiation na zuciya yana nuna yanayin a yawancin masu cutar COVID-19 kuma yana nunawa a matsayin sauti na jiki ko kuma a matsayin gudu a cikin duhu a cikin iska.
Kusan dukkan marasa lafiya suna fama da cututtukan zuciya, ciwon huhu, tashin hankali da kuma ciwon huhu (ARDS).
Lokacin da ARDS ta faru, wani abu mai ban mamaki, ruwa mai guba, da kuma rarraba kwayoyin da ke cikin jiki yana haifar da sauƙin iska.
Kwayoyin cutar Type-1 da Type-2 masu aiki da kyau suna rage tasirin surfactant kuma suna kara yawan tashin hankali, kuma suna rage yiwuwar kumburi a cikin yaduwa kuma suna kara yiwuwar kumburi.
Bugu da ƙari, hotunan ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwal.
A ranar 18 ga Fabrairu, 2020, gwajin farko na cutar COVID-19 ya nuna cewa pneumocytes suna da kyau, ƙwayoyin hyaline suna da kyau, kuma lymphocytes suna da kyau a cikin interstices, kuma yawancin cututtukan syncytial a cikin huhu sun mutu saboda cutar, wanda ya biyo bayan kamuwa da kwayar cutar ta ARDS da kuma cutar SARS da MERS.
Ana amfani da gano SARS-CoV-2 RNA ta hanyar reverse-transcriptase polymerase chain reaction (RT-PCR) a matsayin farkon hanyar gano COVID-19.
Koyaya, saboda rashin daidaito da rashin tabbas, wanda zai iya haifar da cutar, an fara gwajin rigakafi (wanda ya dogara da RT-PCR) a China a ranar 13 ga Fabrairu 2020.
Irin wannan abu ya faru a cikin gwajin SARS.
Bugu da ƙari, tattara bayanan cutar, alamun asibiti, gwajin gwaji, da kuma binciken rediyo yana da mahimmanci da gaggawa don samar da ingantaccen bincike.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta ba da sanarwar cewa CRISPR ta yi amfani da samfurin tsarin SHERLOCK don gano SARS-CoV-2, wanda ke gano SARS-CoV-2 RNA na roba a 20 x 10-18 mol/L zuwa 200 x 10-18 mol/L (hotuna 10 zuwa 100 a cikin mL) tare da halattaccen hawan cikin rabin gishiri ba tare da wani tsari ba.
Mun yi imanin cewa, wannan sabon tsarin zai iya kara yawan lokutan bincike da kuma ingancin da ake samu a cikin magungunan asibiti.
Don mutane su iya kamuwa da sabon CoV, likitoci na iya yin gwaji na farko na kulawar marasa lafiya na COVID-19, sannan kuma su gwada hanyoyin da aka yi amfani da su ko kuma aka ɗauka kafin magance CoV kamar SARS-CoV da MERS-CoV da sauran cututtukan kwayar cuta (Table (Table 2).2).
Wadannan sun hada da maganin da ake yi yanzu ko kuma wanda zai iya zuwa tare da maganin kashe kwayoyin, maganin hana kamuwa da cuta, steroids, jini ga marasa lafiya da ake bi, maganin kasar Sin, da kuma taimakon lafiya.
Ko kuma jini a cikin marasa lafiya da ake gwadawa don magani.
Kamfanonin sayar da magunguna suna gwagwarmaya don samar da magunguna da kuma rigakafin da ba za su kashe kwayar cutar ba.
SARS-CoV-2 yana shafar ƙwayar cuta a farkon farawa kuma yana shafar, amma ba tare da cutar ba, sauran kwayoyin da ke nuna ACE2, kamar ciki da nono da kuma nono.
Duk da haka, cutar ta numfashi ta fi yawan cutarwa ga marasa lafiya kuma ita ce farkon bayyanar cutar.
Bugu da ƙari, taimakon numfashi yana da kyau don rage alamun cutar da ceton rayuka ta hanyar taimakon iska, iska mai iska, iska mai hana numfashi, da iska mai iska wanda ke da alaƙa da yanayin cutar.
Marasa lafiya da ke fama da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Bugu da kari, kiyaye tsarin electrolyte, rigakafi da kuma maganin cututtukan da ba a iya ganewa ba da kuma maganin cututtukan da ke tattare da cutar, da kuma ingantaccen tsarin rigakafi na da amfani ga masu cutar SARS-CoV-2.
An yi imanin cewa kwayar cytokine ta haifar da kwayar cutar ta hanyar kwayar cutar SARS da MERS.
Kwayar cytokine tana aiki a matsayin hanyar amsawa ta jiki wanda ke haifar da sakin cytokines kamar TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan cytokines suna haifar da cewa wadannan kwayoyin suna haifar da wasu cututtuka da suka haifar da yawancin ARDS da kuma cututtuka na cututtuka.
Immunosuppression yana da mahimmanci a maganin cututtukan cytokine, musamman ma a cikin marasa lafiya da ke fama da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan da cututtukan da cututtukan da cututtukan da cututtukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukukuk
Magungunan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Sauran hanyoyin maganin immunosuppression na cytokines sun hada da T-cell receptor; blockade IFN-γ, IL-1, da TNF; JAK release; blinatumomab; cytokine siginar sigina 4; da kuma HDAC inhibitors.
Ana iya amfani da steroids, a matsayin masu rigakafin cutar, a maganin SARS don rage yaduwar cutar.
Koyaya, magungunan steroid da aka yi amfani da su sosai ba su da tasiri sosai a cikin cutar SARS da COVID-19.
Hakanan, yana iya haifar da wasu cututtuka, musamman ma cututtukan jini, wanda ke shafar gwajin cutar.
Koyaya, ƙananan ko ƙananan nazarin maganin corticosteroid ana ba da shawarar kuma ya kamata a yi la'akari da shi a hankali don kula da marasa lafiya masu cutar COVID-19 masu tsanani.
A lokacin wannan rubutun, babu wani magani da zai iya kashe kwayar cutar da kuma cutar da aka gano.
Koyaya, yaduwar remdesivir a cikin jini, kamar nucleotide, ba a bayyana shi azaman yaduwar kwayar cutar a cikin jikin marasa lafiya da ke dauke da COVID-19 ba.
Remdesivir wani sabon maganin kashe kwayar cutar ne da Gilead ta samar wanda a halin yanzu yake maganin cutar Ebola da Marlburg.
Bayan haka, remdesivir ya kuma nuna cewa wasu ƙwayoyin cuta masu saurin kamuwa da cutar MERS da SARS suna fitar da RNA.
A baya dai, Gilead ta tura maganin zuwa China don yin gwaji kan cutar SARS-CoV-2, kuma ya tabbatar da cewa yana da tasiri sosai.
Bugu da ƙari, baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin na iya zama da amfani wajen kula da marasa lafiya da ke fama da ciwon kumburi da kuma ciwon kumburi.
Cutar, kamar su ciwon daji, rashin lafiyar jiki, da sauran matsaloli na iya ci gaba da maganin lopinavir/ritonavir.
Ya kamata a yi amfani da wannan magani tare da wasu magunguna a cikin marasa lafiya.
Jinin jini a cikin marasa lafiya da ke da cutar da kuma ciwon rigakafi
Jiki da aka samu daga marasa lafiya da suka haihu bayan kamuwa da cutar da ba ta cutar da jarirai don magance cututtukan cututtukan cututtukan cututtuka ko kare lafiyar mutane saboda ciwon daji da kuma cutar ta daɗaɗaɗaɗa yana da tarihin tarihi.
Bugu da ƙari, waɗanda suka kamu da cutar sun sami adadin ƙwayoyin cuta masu ƙwayoyin cuta a cikin jinin su.
Antimicrobial shine immunoglobulin (Ig) wanda kwayoyin lymphocyte ke samarwa don hulɗa da jijiyoyin jiki da kuma abubuwan da suka shiga cikin jiki kuma suna gano kwayoyin da ke cikin kwayoyin halitta da kuma kwayoyin halitta.
A wannan yanayin, an cire sinadarin jini daga jinin wani rukuni na marasa lafiya da suka kamu da cutar COVID-19 kuma an ba su kashi 10 na marasa lafiya.
A cikin awanni 24, alamun cutar sun ragu, cutar ta ragu, kuma yawan kwayar cutar ya ragu, kuma yawan zafin jiki ya karu.
Duk da haka, gwaji da kuma kulawa suna da muhimmanci don gano abin da zai iya amfani da kowa kafin a sami magani mai dacewa.
Bugu da ƙari, saboda amfanin magani, akwai wasu abubuwan da ba su dace da jini ba wanda ya kamata a kula da su.
Misali, kwayar cutar zata iya canza amsawar rigakafin ta hanyar fitar da kwayar cytokine, wanda zai iya cutar da rayuwar mutum.
Anadarin kwayar cutar a cikin jinin mutum ya ragu, saboda haka ana iya samun karin jini don magance cututtukan cututtuka.
Yana da wuya a gano da kuma samar da kwayoyin cutar da zasu iya magance cutar gaba daya.
Bugu da ƙari, yana da wuya a yi amfani da maganin don samar da ƙwayoyin B a cikin marasa lafiya da suka kamu da cutar kuma su sami lambar rigakafi wanda ya dace da ƙwayoyin cuta na jiki ko kuma gwajin rigakafi na kwayoyin cutar da suka dace.
Ta haka, za mu iya ƙara yawan rigakafin da jikinmu ya gama.
TCM ta kasance a matsayin magani don magance cututtuka daban-daban a cikin Sin tun dubban shekaru.
Koyaya, amfanin ya dogara da haɗuwa da abubuwa da yawa a cikin magunguna daban-daban da kuma binciken da aka samu a cikin nazarin TCM.
Mafi mahimmanci a cikin waɗannan abubuwa shine rashin fahimta ko rashin sani da kuma rashin fahimta saboda yana da ikon samarwa da kuma sarrafa abubuwa ko haɗuwa da su.
A halin yanzu, saboda maganin COVID-19 na musamman da kuma ingantaccen magani, TCM yana ɗaya daga cikin hanyoyin magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Misali, Shu Feng Jie Du da Lian Hua Qing Wen sun gano maganin da zai iya magance COVID-19 yadda ya kamata.
An gano adadin marasa lafiya na farko da suka kamu da COVID-19 a lardunan China da suka ba da TCM ga kashi 87% na marasa lafiya, tare da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei, wanda ya ba da TCM ga kashi 30% na marasa lafiya na COVID-19, ya sami mafi ƙarancin adadin marasa lafiya (13%).
Koyaya, yana da mahimmanci a rarrabe shi saboda akwai wasu batutuwa kamar ƙididdigar da kulawa da marasa lafiya waɗanda dole ne su kasance cikin binciken.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun fitar da wani bincike na gwada wasu magungunan gargajiya na Yammacin Turai (WM) da kuma hanyoyin da suka hada da WM da TCM.
An gano cewa lokacin da jiki ke buƙatar rage yawan kumburi, ƙimar bayyanar cututtuka, da kuma fitarwa daga asibiti zai kasance mafi tsayi a cikin WM + TWM fiye da sauran rukunin WM.
Mafi muni, yawan cututtukan da suka biyo baya (a cikin cututtukan cututtuka) sun ragu a cikin ƙungiyar WM+TCM kawai (7.4% zuwa 46.2%) kuma yawan fitowar ya ragu a cikin ƙungiyar WM+TCM kawai (8.8% zuwa 39%).
Duk da haka, amfanin da lafiyar TCM suna da kyau a cikin gwaji da aka yi a yanzu a cikin gida da kuma a wasu wurare.
Zai zama ma da wahala a tantance yawan ayyukan da kuma daidaita kayan aikin TCM da kyau ko kuma haɗuwa da su idan ya cancanta.
Mutanen da suka kamu da cutar ko kuma suka kamu da cutar COVID-19 sun fi fuskantar mummunan cututtuka da kuma mutuwa, kuma masu fama da cutar sun kuma nuna rashin jin daɗi, rashin kulawa, da kuma rashin jin daɗi.
Bugu da ƙari, alamun cututtuka kamar su ciwon jiki, rashin jin dadi, da kuma rashin jin daɗi da sauran magungunan da ke haifar da rashin jin daɗi na corticosteroids na iya haifar da rashin hankali da rashin jin daɗi.
A farkon barkewar cutar SARS, yawan mutanen da ke fama da rashin lafiya, rashin hankali, rashin hankali, rashin hankali, rashin fahimta, rashin magana, da mutuwa sun bayyana.
Yin hulɗa da keɓewa, kamar yadda yake a cikin martani ga cutar COVID-19, na iya ba da ra'ayoyi da kuma shawarwari ga mutane game da hulɗa, halartar shaidu, da kuma yadda mutane ke magana game da abubuwan da suka faru da abokan su.
Hakazalika, ya kamata a kiyaye lafiyar marasa lafiya na COVID-19, waɗanda ke da haɗari, da waɗanda ke tare da su da kuma duk al'ummomin da ke da bukata.
Tallafin lafiyar mutum ya kamata ya hada da shirya ƙungiyoyi masu ilimi daban-daban don kula da lafiyar mutum, ingantaccen bayani da kuma nazarin bayanan da ke tattare da cutar SARS-CoV-2 da shirye-shiryen magani da aiki tare da umarni da aikace-aikace masu dacewa don hana haɗuwa da yanayin mutum.
Kariya daga cutar tana da mahimmanci wajen hana kamuwa da cutar daga dabbobi da mutane masu kamuwa da cutar zuwa ga waɗanda zasu iya ɗaukar ta a cikin jikinsu kuma tana da alaƙa da maganin cutar ta hanyar rigakafin cutar.
An gabatar da dabarun samar da rigakafin da ya dogara da sinadarin S don samar da rigakafin cutar da kuma/ko kariya ga SARS-CoV.
An gwada kwayoyin cutar SARS a cikin dabbobi.
Koyaya, amfanin allurar rigakafin in vivo a cikin tsofaffi tare da tabbatar da mutuwa da rigakafin kamuwa da kwayar cutar ta hanyar kwayar cutar dabba dole ne a gano kafin binciken dakin gwaje-gwaje ya fito.
Wannan saboda SARS ya ɓace shekaru 17 da suka gabata kuma babu wani sabon kamuwa da cutar da aka gano tun daga lokacin.
Koyaya, akwai wasu cututtukan da suka faru a wasu yankuna na duniya da kuma na MERS wanda ya biyo bayan bayyanar a Gabas ta Tsakiya kuma ya bazu zuwa wasu yankuna ta hanyar kwayar cutar da aka samu daga dabbobi.
An samar da rigakafin cutar MERS ta hanyar amfani da kwayar cutar mai cutarwa, DNA plasmids, kwayar cutar mai saurin kamuwa da cuta, ƙananan ƙwayoyin cuta, ƙwayoyin cuta kamar cuta da kuma wasu nau'ikan sunadarai da za su iya haɗuwa da wasu da aka gano a cikin dabbobi.
Samun maganin rigakafin cutar SARS-CoV mai tasiri da kuma dacewa a cikin mutane marasa garkuwar jiki shine matakin gaggawa da kulawa don hana yaduwar cutar.
Duk da haka, yana da wuya a magance wannan matsala saboda yana da lokaci mai tsawo (duba shafi na 18) kafin a yi allurar rigakafi da kuma canza yanayin Covid-19.
A matsayin sabon annoba, COVID-19 ya fara nuna alamun cutar a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya na iya yin magana a hankali ba tare da barin kuskure ba.
Koyaya, sabanin SARS, COVID-19 yana da alaƙa da ƙimar da yawan mutuwar marasa lafiya masu cutar.
Bugu da ƙari, samar da sakamakon bincike yana da mahimmanci ga ƙungiyoyin kiwon lafiya don kula da ayyukan su, musamman a yankunan da ke da nisa.
A cikin binciken da aka yi a yanzu, waɗannan abubuwan da aka lissafa na iya shafar ko daidaitawa tare da kimantawar marasa lafiya na COVID-19 (Table (Table33):
Shekara: Shekara wani muhimmin abu ne a cikin binciken SARS, wanda kuma gaskiya ne a COVID-19.
COVID-19 yafi yaduwa tsakanin shekaru 30 zuwa 65 da 47.7% na waɗanda suka kamu da cutar sama da shekaru 50 a cikin binciken cututtuka 8,866 da aka lissafa a sama.
Marasa lafiya da ke buƙatar kulawa mai yawa galibi suna nuna alamun cututtuka da rikice-rikice kuma suna da shekaru masu yawa waɗanda ba su da yawa (tsakanin shekaru 66 da 51), suna nuna shekaru kamar yadda ake iya ganowa a cikin masu cutar COVID-19.
Yanayin: SARS-CoV ya fi rinjayar maza fiye da mata (0.31/100 000 vs. 0.27/100 000), kamar yadda aka lissafa a sama.
Yawan mutuwa da cututtuka: Marasa lafiya da ke da COVID-19 da ke buƙatar kulawa ta gida suna iya fuskantar ciwon zuciya da bugun zuciya.
Cutar zuciya ita ce kuma sanadin farko na mutuwa a cikin masu fama da cutar SARS.
An ce SARS-CoV-2 na iya haɗuwa da ACE2 mai kyau na cholangiocytes wanda zai iya rage aikin jini a cikin marasa lafiya na COVID-19.
Akwai kuma fahimtar cewa shekaru da kuma ciwon da ke biyo baya suna da daidaituwa kuma suna iya canzawa.
Amsar bincike da kuma amsawa: Matsayin C-reactive protein (CRP) a cikin jini yana nuna rashin lafiyar jijiya ko kuma yanayin jijiya kuma yana iya zama sakamakon bincike, amsawa ga magani, da ƙarshen magani.
An kuma tabbatar da daidaiton CRP da cutarwa da gwajin COVID-19.
Bugu da ƙari, ƙididdigar lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen gano abin da zai faru.
Ana sanya waɗannan sunadarai a cikin wasu sassan jiki, musamman a cikin zuciya da hanta, kuma ana fitar da su ta hanyar ƙirar ido.
Kuma, kamar dai alamu ne na rashin tausayi ko rashin hankali suna aiki da kyau.
Alamomin bayyanar cututtuka: radiation na zuciya da ci gaban bayyanar cututtuka dole ne a bincika su tare da wasu kayan aiki don tantance alamun da matsalolin COVID-19.
Yin amfani da steroids: Kamar yadda aka ambata a sama, steroids sune magungunan rigakafi na jiki wanda aka fi amfani dashi a matsayin magani na musamman don cututtuka na cututtuka don rage lalacewar cututtuka.
Yayin da aka yi amfani da maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Bugu da ƙari, idan ya cancanta, ya kamata a yi amfani da steroids tare da taka tsantsan kuma a cikin ɗan gajeren lokaci a cikin marasa lafiya na COVID-19.
Rashin jin daɗi: kamar yadda aka ambata a sama, a lokacin COVID-19, yawancin marasa lafiya sun sha wahala daga rashin jin daɗi na yau da kullun saboda sun kasance a cikin ɗaki su kaɗai kuma ba su san yadda za a yi musu magani ba kuma suna da tabbacin cewa danginsu suna cikin yanayin rashin lafiya.
Yana da mahimmanci a sami damar samun mai ba da lafiya da taimako a cikin lokaci don taimakawa marasa lafiya su sami abinci da kwanciyar hankali.
A cewar binciken da aka yi a cikin al'umma, COVID-19 ya bayyana cewa akwai bambance-bambance tsakanin shi da SARS.
Baya ga nunawa a cikin ƙananan ƙwayoyin cuta, SARS-CoV-2 na iya nunawa a cikin ƙananan ƙwayoyin cuta kuma yana iya haifar da ɗan gajeren lokaci ko rashin jin daɗi a farkon cutar kamar sauran CoVs masu rigakafin mura.
Koyaya, marasa lafiya da ke kamuwa da cutar a farkon ko farkon lokaci na iya ɗaukar kwayar cutar ta hanyar hasken rana, wanda ke haifar da rashin ƙarfi.
Koyaya, kamuwa da SARS-CoV yana da mahimmanci a cikin marasa lafiya masu rauni, kuma ana iya samun raguwar kamuwa da cutar a farkon matakin.
Bugu da kari, cutar COVID-19 ta yanzu ta fi tsanani kuma ta fi wahalar shawo kan cutar SARS.
An kafa takunkumi da dama a kan dokar hana fita a kasar Sin da kuma takunkumin hana fita a Wuhan da garuruwan da ke kewaye da ita da kuma ci gaba da dokar hana fita na jama'a da ke hana yiwuwar kamuwa da cutar SARS-CoV-2.
Kodayake wannan aikin ya rage yawan mutane da kungiyoyin aiki na kasa da kasa, yawan sabbin masu kamuwa da cutar ya ragu, wannan yana nuna cewa cutar ta kusan karewa.
Masu hangen nesa sun yi hasashen cewa cutar za ta kare a karshen watan Maris kuma za a iya rarraba ta zuwa matakai 3 zuwa 4.
Amma duk da haka, wasu mutane ba su yarda da ku ba.
Paul Hunter, et al. sun yi imanin cewa COVID-19, wanda ya kasance mafi muni a farkon SARS, ba zai ƙare ba har zuwa 2020.
Ira Longini, da sauransu, sun ba da rahoton cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wani rukunin masu binciken na Kanada ya nuna cewa SARS-CoV-2 an gano shi a kan kwayar cutar da aka ɗauka a cikin hanci da kuma cikin hanci na marasa lafiya da aka yi musu allurar rigakafi da suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar da aka gano ba ta da wata hanyar yaduwa a cikin gida kamar yadda cutar ta kamu da ita.
Koyaya, an sami ci gaba mai ban sha'awa a cikin China dangane da ƙaruwar sabbin lamura, wanda ke nuna cewa hanyoyin yanzu na iya zama masu tasiri.
An yi hasashen cewa cutar Ebola za ta iya cutar mutane miliyan daya kuma ta kashe mutane miliyan daya da rabi.
Duk da haka, ta hanyar keɓewa, cutar ta zama mai yiwuwa ga mutane.
Zai yiwu, kamar SARS-CoV, cewa SARS-CoV-2 zai rage yawan yaduwa kuma zai iya ɓace ko kuma cutar ba za ta iya cutar da ɗan adam ba.
An nuna a ƙasa sakamakon cutar COVID-19 da cutar SARS da MERS (Hoto (Hoto55).
SARS-CoV-2 na iya kamuwa ta hanyar numfashi ko kuma ta hanyar hanci, kuma yana iya kamuwa ta hanyar taɓawa da kayan da cutar ta kamu da su.
An kuma gano kwayar cutar a cikin busassun abubuwa, wanda ke nuna cewa za a iya yada ta ta hanyar busassun abubuwa a baki.
Wani sabon bincike na marasa lafiya 138 ya nuna cewa kashi 41% na masu cutar na iya kamuwa da cutar ta hanyar jijiyoyin jini, tare da 17 da suka kamu da cutar ta hanyar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Ya kamata kuma a yi aiki da hankali wajen kare mutum, musamman ma masu kula da lafiya, ma'aikatan gwamnati, masu kula da gida, masu sayarwa, da kuma wadanda ke hulɗa da marasa lafiya ko kuma mutanen da ke da cutar.
Hanyar farko da za a iya amfani da ita don rage yaduwar cutar ita ce sanya kayan rufe fuska; sanya kayan N95 masu numfashi (lambar 1860s) na taimakawa wajen yada kwayar cutar.
Takunkumin fuska yana hana kamuwa da cutar daga mutum wanda ke da cutar kuma wanda ya kamu da iska ko taɓawa akan abubuwa, zai iya yaduwa ga wasu.
Koyaya, N95 masks (lambar # 1860s) na iya zama mai saurin kamuwa da ƙananan ƙwayoyin cuta na 10 zuwa 80 nm, tare da 5% na ƙananan ƙwayoyin cuta waɗanda zasu iya shiga gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV kuma dukansu suna yin nisan nisan nisan nisan 85.
Kamar yadda kuraje na iya shiga cikin kayan shafawa na ido ko kuma a cikin haɗuwa, masu kula da lafiyar da ke hulɗa da marasa lafiya dole ne su sanya kayan shafawa na N95 (lambar # 1860s) ko kuma su yi amfani da kayan shafawa na ido.
Baya ga kayan kariya na fuska, masu kula da lafiya dole ne su sanya kayan kariya na yau da kullun don rage yaduwar kwayar cutar.
Hakanan za'a iya samun kwayar cutar ta hanyar ido.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2 duk da cewa yana sanye da takalmin rufe fuska na N95; kuma ana iya cewa kwayar cutar ta shiga jikinsa ta hanyar idanu masu cutarwa.
Sa'an nan kuma, masu kula da lafiyar jiki dole ne su sanya sutura da sutura masu sutura yayin da suke kula da marasa lafiya.
Ga dukkan al'umma a cikin yankuna masu kamuwa da cutar ko kuma wadanda za su iya kamuwa da cutar, yana da muhimmanci cewa kowa ya wanke hannayensa da sabulu a kai a kai, kuma ya dauki mataki na nesa don kasancewa a gida da kuma rage hulɗa da mutanen da ke iya kamuwa da cutar.
Ya kamata mutum ya kasance a cikin jama'a don ya iya saduwa da mai cutar.
Wadannan ayyuka sune muhimman matakai don rage kamuwa da cutar da kuma hana yaduwar kwayar cutar gaba daya.
Kodayake SARS-CoV-2 ya isa matsayin sabon kwayar cutar a cikin ɗan adam, kamannin sa da SARS-CoV kamar yadda aka lissafa a ranar 7 ga Janairu 2020 zai buɗe hanyar da China ke da alhakin sakamakon cutar SARS ta 2003.
Koyaya, har zuwa 19 ga Janairu 2020 mai kula da cutar ta Wuhan ya kasance yana ɓoye jama'a ta hanyar bayyana cewa sabon kwayar cutar ba ta da saurin yaduwa da kuma yaduwa daga mutum zuwa mutum kuma zai zama batun rigakafi da cutar.
Wannan sanarwar ta janyo fargaba, musamman ma a yayin da kasar ke shirin gudanar da bikin bazara, kuma ba a san lokacin da za a kawo karshen annobar ba kamar yadda aka tsara a Wuhan.
Ƙungiyoyin kula da cutar a China na iya yin tunani da kansu da kuma sake nazarin dabarun su a nan gaba.
Misali, waɗannan ƙa'idodin sun buƙaci (1) kulawa sosai wajen ba da bayanai ga jama'a saboda duk wata magana tana da daraja a idanun ɗan ƙasa kuma yana iya keta haƙƙoƙin haƙƙoƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin
Cutar COVID-19 ta sabon kwayar cutar da ake kira SARS-CoV-2 ta fara ne a ƙarshen Disamba 2019.
A cikin nau'ikan biyu, sun yadu a duk faɗin China da kusan ƙasashe 50 a duniya a lokacin wannan rahoton.
Saboda kwayar cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da na COVID-19 da SARS, cutar COVID-19 ta zama kamar wani nau'in SARS ne.
Koyaya, akwai bambance-bambance masu yawa tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don hana cutar da kuma magance cutar.
COVID-19 ya fi shafar tsofaffi fiye da mata, tare da kamuwa da cutar da yawan mutuwa a cikin tsofaffi fiye da mata.
SARS ya fi COVID-19 kisa (10.91% zuwa 1.44%).
Masu cutar COVID-19 suna iya yada kwayar cutar ko da kuwa suna nuna alamun cutar, amma masu cutar SARS suna iya yin hakan har sai an daina maganin, wanda ke sanya cutar COVID-19 ta zama mai saurin kamuwa da cutar SARS.
Wannan ya nuna cewa SARS-CoV-2 ya fi SARS-CoV sau da yawa kuma ya fi yaduwa.
Ana iya gano kwayar cutar SARS-CoV-2 ta RNA a wasu cututtukan COVID-19.
A wasu lokuta, masu cutar da suka kamu da cutar za su iya kamuwa da cutar.
Wadannan bincike sun hana yaduwar kwayar cutar.
Saboda irin wannan ci gaba a binciken COVID-19, akwai tambayoyi da yawa da za a amsa, kamar:
SARS-CoV-2 ya samo asali ne daga dabbobi?
Duk da cewa an samu daidaiton kashi 96 cikin 100 tsakanin SARS-CoV-2 da SARS-CoV-2 masu kama da COV, ba za a iya cewa SARS-CoV-2 ya samo asali ne daga tsuntsaye ba.
Wane dabba ne ya kasance na tsakiya a cikin dabbobi da suka kamu da cutar daga farkon gida, wato tsuntsaye, zuwa ga mutane?
Ba tare da sanin amsoshin #1 da 2 ba, ba za mu iya samun cutar ba, kuma cutar za ta iya sake faruwa a kowane lokaci.
Ko da yake binciken kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar halittar kwayoyin halittar halittar kwayoyin halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar
Wannan kwayar cutar ta kuma hana bayyanar kwayoyin ACE2 a wasu sassan jikin mutum.
Idan ba a sami amsa mai kyau ba ga waɗannan tambayoyin, ba za a iya yin bincike da kyau ba kuma a sami magani mai kyau.
Har yaushe za a ci gaba da cutar?
Ta yaya cutar ta ci gaba daga farkon zuwa kamuwa da mutum?
Shin za a iya ganin yadda cutar ta duniya za ta kare kamar SARS ko kuma ta sake tashi a lokaci kamar cutar zazzabin cizon sauro?
Yana da muhimmanci a san cewa zai iya ɗaukar lokaci don amsa tambayoyin da ke sama da kuma sauran tambayoyin.
Amma, duk da haka, ba mu da wani zaɓi, don dakatar da cutar kamar yadda za mu iya da kuma dawo da rayuwarmu yadda ta kasance.
Cutar kwayar cutar mutum ta hanyar dabbobi
Kwayoyin halitta da kuma na halitta sun iya yada kwayar cutar coronavirus (CoV) da kuma masu kamuwa da ita, da kuma mutane, a cikin shekarun da aka tsara.
Kafin 2003, an gano cewa kwayar cutar mutum (HCoVs) guda biyu tana haifar da cututtuka masu saurin kamuwa da cuta, kamar mura.
Cutar cutar sankara ta SARS da cutar sankarar sankara ta Middle East (MERS) sun canza kansu kuma sun nuna yadda wannan cuta ta shafi maza.
Bayyanar SARS-CoV-2 a tsakiyar kasar Sin a karshen shekarar 2019 ya shawo kan cutar CoV ta kasar Sin kuma ya sa mu shawo kan cutar da ta fi cutar SARS-CoV.
HCoVs suna da tasiri a cikin dabbobi kuma fahimtar asalin da ke haifar da HCoVs na iya zama da amfani a gare mu.
Yawancin HCoVs sun fito ne daga tsuntsaye kuma ba su da cutarwa.
An kuma gano wasu gidajen da ke da cibiyar kwayar cutar HCoV.
Yin nazarin dabbobi masu kama da gida yana da mahimmanci don sanin yadda mutum zai iya kula da kansa.
Binciken halayen CoV a cikin dabbobi ya tabbatar da yadda asalin CoV ke yaduwa zuwa ga mutane.
A cikin wannan binciken, za mu yi nazarin abin da muka sani game da kwayar cutar HCoV guda shida da biyu, kuma mu koyi game da tarihin su da kuma nau'in da suka fito daga wurin da kuma hulɗar su.
Hakanan yana da mahimmanci, muna gwadawa da kuma bincika bambance-bambance tsakanin HCoVs dangane da kwayar cutar da kuma tsarin kwayoyin halitta.
An kuma gano cutar CoV 2019 (COVID-19) a cikin wannan binciken.
Bugu da ƙari, muna ƙididdige abubuwan da ke haifar da ƙwayoyin cuta a cikin jikin mutum a cikin ɗakunan da kuma cutar da su a cikin tsarin cutar.
Kwayar cuta ta Coronavirus (CoV) tana cikin jerin Coronaviridae, wanda ya ƙunshi rukuni na ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta, waɗanda ke da RNA guda ɗaya.
Kwayoyin cuta da ke da kwayar halitta mai girma 26 zuwa 32 kilobase a cikin RNA suna da sunan "CoV" saboda suna da matukar damuwa da yadda ake gani a cikin microscope.
Ta hanyar rarrabe kwayoyin, CoVs ba su da kwayoyin halittar da suka dace da kwayoyin halittar daya.
Kwayoyin biyu a cikin kwayoyin sunaye uku suna da kwayoyin halitta guda biyu masu rarraba don karantawa (ORF1a da ORF1b), wanda ke haifar da pp1a da pp1ab polyprotein replicase.
Ana iya amfani da polyproteins na layin don samar da sunadarai 16, wanda aka tsara a matsayin nsp1~16.
Sashin asalin kwayoyin halitta yana dauke da ORFs na sunadarai, ciki har da kai (S), jiki (E), jiki (M) da nucleoprotein (N).
Akwai lambobin sunadarai masu daidaituwa waɗanda ke da lambar asalin CoV daban-daban.
Dangane da rarrabuwa a cikin ƙwayoyin cuta, ana iya rarraba CoVs zuwa rukuni huɗu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), wanda beta-CoVs ke da mafi yawan CoVs kuma suna da ƙananan ƙwayoyin cuta huɗu (A, B, C da D).
Binciken ilimin halitta ya nuna cewa tsuntsaye da abinci sun kasance farkon farkon CoVs ji-alpha da CoV ji-beta, kuma sanyi shine farkon CoV ji-gamma da CoV ji-delta.
Shekaru dubu huɗu da suka gabata, CoVs sun wuce daga dabba zuwa dabba kuma wasu sun kasance masu cutarwa ga jikin mutum.
A halin yanzu, akwai nau'ikan CoV guda shida na mutum (HCoVs) da aka sani.
Daga cikin su HCoV-229E da HCoV-NL63 sune alpha-CoVs.
Wasu nau'ikan beta-CoV masu ban mamaki sune HCoV-OC43, HCoV-HKU1, coronavirus mai saurin kamuwa da cutar sankara (SARS-CoV), cutar coronavirus na ciwon huhu na Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 suna haifar da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Koyaya, sabbin SARS-CoV, MERS-CoV da SARS-CoV-2 suna da matukar tasiri ga mutane, suna haifar da ƙananan cututtukan huhu a cikin yawancin marasa lafiya waɗanda ke da sa'a don samun rigakafin cutar sankarar bargo (ARDS) tare da ƙwayoyin cuta masu ƙwayoyin cuta kawai.
An gano kwayar cutar HCoV-229E ta farko, B814, a cikin wani kwayar cuta mai kama da cutar da aka sani a shekarar 1960.
Tun daga wannan lokacin, an sami ƙarin bayani ta hanyar nazarin da yawa game da HCoV-229E da HCoV-OC43, dukansu suna nuna bambancin yanayin cutar.
Koyaya, an yarda da cewa cutar HCoV ba ta da tasiri kafin barkewar cutar SARS.
Cutar SARS ta bullo a 2003 kuma ta kasance daya daga cikin cututtukan da suka fi muni a tarihin duniya, inda ta kashe mutane 8,000 tare da mutuwar kusan 10%.
Shekaru da dama da suka gabata, cutar MERS ta kasance wata cuta mai saurin barkewa a yankin Larabawa da kuma sauran kasashen duniya.
Sabuwar kwayar cutar HCoV 2019 (2019-nCoV), wacce aka sake masa suna daga SARS-CoV-2, ita ce cutar coronavirus 2019 (COVID-19), wacce ta kashe mutane 3,100 kuma ta kamu da mutane sama da 91,000 a ranar 3 ga Maris, 2020.
Akwai bayanai masu yawa a duniya da ke buƙatar tsarawa don barkewar cutar SARS-CoV-2 a nan gaba.
HCoVs sun samo asali ne daga tsuntsaye, dabbobin daji da dabbobi masu shayarwa.
Yawancin bincike sun ba da shawarar cewa HCoV ya samo asali ne daga tsuntsaye, inda kwayar cutar ta canza jikinta kuma ta lalace amma ta nuna halaye daban-daban.
Cutar COVID-19 ta haifar da mummunan sakamako ga likitoci, masu bincike, jama'a, da kuma masana kimiyya a China da duniya.
Gano asalin kwayar HCoV yana ba da damar fahimtar tarihinta, abin da ya haifar da ita da kuma yiwuwar canza jikinta.
Wannan zai iya haifar da ko kuma hana gwajin farko na laboratory, na biyu na laboratory da na SARS-CoV-2 na laboratory (kwayoyin cutar) ko kuma tsarin rigakafi wanda zai iya cutar da mutane.
Wannan labarin ya danganci binciken da aka yi a cikin dabbobi, hulɗa tsakanin ƙungiyoyi da farkon kamuwa da cutar HCoV.
A mafi yawancin lokuta, muna nunawa da kuma nuna damuwa game da ra'ayin cewa kwayar cutar HCoV ta iya zama mara lafiya a cikin kwayar halittar ta farko amma ta iya cutar da wani ta hanyar watsawa ta hanyar wasu dabbobi a cikin sabon kwayar halitta.
Mun kuma bincika yadda cutar HCoV ke yaduwa ta hanyar rage yawan kamuwa da cutar.
An gano cewa cutar SARS-CoV mai saurin yaduwa ba za a iya tantance ta ba.
An gano CoVs a cikin dabbobi tun 1930.
Kafin a fara gano kwayar cutar HCoV-29E B814 a cikin kwayar cutar da aka sani da cutar sankara, CoVs sun bambanta a cikin dabbobi da yawa masu kamuwa da cutar kamar su naman alade, dabbobin daji, dabbobin daji, dabbobin daji, dabbobin daji da kuma dabbobi masu cutar.
A cikin shekaru goma da suka gabata, an gano nau'ikan HCoV guda shida da biyu.
Akwai tarihin ganowar HCoVs da aka lissafa tare da lokaci da shekara (Table 1) wanda zai iya zama mai amfani ga bayanai da karatu.
An gano kwayar HCoV-229 a cikin kwayar cutar huhu ta marasa lafiya da ke fama da cutar sankarar bargo a 1966, kuma an canza tsarin jikinta kuma ya girma a cikin kwayar cutar WI-38.
Masu kamuwa da cutar HCoV-229E suna da alamun cutar da aka saba da su na mura, tare da kumburi, tari, kumburi, kumburi da kumburi a tsakanin kashi 10 zuwa 20%.
Daga baya a 1967, an gano HCoV-OC43 a cikin gwajin kwayoyin da ke da lambar wucewa ta rayuwa a cikin kwakwalwar kwayar cutar.
Alamar cutar HCoV-OC43 ta yi kama da ta wasu kwayoyin cutar HCoV-229E, wanda alamun cutar ke kama da na wasu ƙwayoyin cuta na numfashi kamar su kwayar cutar A da kwayar cutar mura.
Dukansu HCoV-229E da HCoV-OC43 sun yadu a duniya, kuma suna iya kamuwa da cutar ta hanyar tsire-tsire na hunturu a cikin yanayi mai kyau.
A mafi yawan lokuta, lokacin bayyanar kwayar cutar yana zuwa mako guda, wanda ya ci gaba da cutar har zuwa makonni 2.
A cewar wasu binciken, marasa lafiya da suka yarda su sami kwayar cutar HCoV-229E a cikin jikinsu sun kamu da cutar.
Wasu 'yan marasa lafiya da ke da rigakafin jiki sun kamu da cutar sankarar huhu.
SARS, wanda kuma ake kira "atypical pneumonia", shine farkon cutar da HCoV ya kawo a cikin tarihin al'umma kuma asalin cutar shine SARS-CoV, nau'in HCoV na uku da aka gano.
An gano cutar SARS ta farko a shekarar 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta yi sanadiyar kamuwa da mutane 8,096 da mutuwar mutane 774, wanda ya bazu a kasashe da dama a duniya.
Bayan yaduwar cutar, an gano cewa kowane mutum na iya haifar da cututtuka daban-daban guda biyu, tare da lokacin bayyanar tsakanin kwanaki 4 da 7 da kuma adadin ƙwayoyin cuta mafi girma da ke bayyana bayan kwanaki 10 na kamuwa da cuta.
Masu kamuwa da cutar SARS-CoV suna nuna rashin jin daɗi, ciwon hanci, kumburi, kumburi da kumburi, tare da damuwa da kumburi, kumburi, wahalar numfashi a matsayin ƙarshen bayyanar cututtuka.
Lymphopenia, lokacin gwajin aikin jini, da creatine kinase sune abubuwan da ke haifar da gwajin SARS a cikin dakin gwaje-gwaje.
An gano wasu cututtuka a cikin alveoli, ƙarancin ƙwayoyin epithelial da kuma ƙaruwa na macrophages a cikin marasa lafiya na SARS.
Kusan kashi 20 zuwa 30% na marasa lafiya suna buƙatar kulawa da yawa kuma suna buƙatar ƙarin umarni.
Baya ga raguwar numfashi, wasu sassan jiki kamar hanci, hanci da kuma hanci na iya zama masu rauni yayin da cutar ta ci gaba, wanda ya biyo bayan wani lokaci tare da maganin cytokine, wanda zai iya kashe marasa lafiya marasa lafiya.
Kwayar cutar ta kasance mai tasiri a farkon binciken da aka yi na kwayar cutar huhu ta wani mutum da ya yi tafiya zuwa Guangzhou na Hong Kong.
Tun daga wannan lokacin, an yi wasu matakai don gano HCoV.
HCoV-NL63 ya kasance mai cutarwa a cikin wani yaro dan shekara 7 da aka gano a Netherlands a ƙarshen 2004.
An fara gano cewa ya fi bayyana a cikin yara ƙanana, tsofaffi da marasa lafiya tare da cututtukan huhu waɗanda ke da rauni.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Wani bincike ya nuna cewa an kamu da kwayar cutar ta hanyar kwayar cutar kanjamau a cikin jariri mai wata takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a cikin Netherlands, yanzu ya yadu a duk faɗin duniya.
An gano cewa HCoV-NL63 yana da alhakin kusan kashi 4.7% na cututtukan huhu, tare da mafi yawan cututtukan cutar da ke faruwa a lokacin rani, bazara da hunturu.
HCoV-NL63 yana da alaƙa da kwayar cutar da ke rufe ƙofar, wanda ake kira croup.
A wannan shekarar, an gano HCoV-HKU1 a cikin wani tsoho mai shekaru 71 da aka yi wa asibiti saboda ciwon huhu da kuma cutar sankarar bargo a Hong Kong.
Bugu da ƙari ga cutar ta hanzari da kuma na yau da kullun, HCoV-HKU1 an ce yana da alaƙa da cutar ta ƙwayoyin cuta.
A cikin jerin HCoV-NL63, HCoV-229E da HCoV-OC43, HCoV-HKU1 ba a gano su a duniya ba, kuma suna haifar da cututtukan huhu.
HCoVs masu cutarwa a cikin al'umma suna iya zama marasa lafiya a cikin jikin mutum kuma suna iya canzawa don haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut
A mafi yawan lokuta, idan nau'in HCoV ya sami hanyar watsawa mai kyau kuma ya riƙe kansa a cikin jikin mutum, zai zama mai saurin kamuwa da cuta ko kuma nuna alamun kamuwa da cuta.
An fara gano kwayar cutar MERS-CoV a shekarar 2012 a wani sabon kamuwa da cutar da ta kai shekaru 60 da suka gabata, wanda ya haifar da cutar sankarar bargo da kuma cutar korona a yankin Larabawa.
An gano cewa, cutar ta samo asali ne daga yankin Gabas ta Tsakiya, kuma an samu rahoton cututtuka da suka samo asali daga kasashen waje da kuma rigakafin kamuwa da cutar a kasashen Turai da Tunisia.
Wani sabon kamuwa da cuta ya faru ne a Koriya ta Kudu a shekarar 2015 inda aka samu mutum 186.
Alamar cutar ta MERS ta yi kama da ta SARS, wadda ke da ciwon huhu mai saurin kamuwa da cutar.
Baya ga SARS, yawancin mutanen da ke dauke da cutar MERS suna nuna cutar kwayar cutar ta MERS, wacce ke da bambanci da cutar HCoV.
Fiye da kashi 30% na marasa lafiya suna nuna alamun rashin lafiyar ciki da na ciki, kamar su fitsari da kumburi.
Tun daga ranar 14 ga watan Fabrairun 2020, sama da mutane 2500 da suka kamu da cutar sun kamu da cutar tare da mutuwar kusan kashi 34.4%, wanda ya sanya MERS-CoV a cikin cututtukan da suka fi kowa mutuwa a cikin mutum.
Daga tsakiyar zuwa ƙarshen Disamba, an gano cutar huhu a cikin marasa lafiya waɗanda ba a gano su ba tare da cutar SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta sanar da cewa cutar sankarar huhu da SARS-CoV-2 ya haifar ta zama gaggawa ta lafiyar jama'a a duk fadin duniya kuma ta kira cutar COVID-19.
Ya zuwa ranar 3 ga Maris, 2020, an sami kamuwa da cutar 90,053 a duniya, tare da mutuwar mutum 3.4 cikin 100.
Yawan mutuwar a Hubei, China ya kai 4.2%, yayin da na waje ya kai 1.2%.
SARS-CoV-2 na haifar da cututtukan huhu masu saurin kamuwa da cutar kamar SARS-CoV da MERS-CoV, wanda ke haifar da rashin lafiya, rashin jin daɗi da wahalar numfashi.
An kuma ba da rahoton cutar a wasu marasa lafiya.
Cutar huhu na da matukar hadari kuma yana iya zama kamar cutar huhu.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya saboda tsarin su na nucleotide ya daidaita da kashi 82%, sun haɗu da asali daban-daban a cikin kwayar halitta.
SARS-CoV-2 ya kasance mai saurin kamuwa da cutar amma ya fi SARS-CoV da MERS-CoV kamuwa da cutar.
Wadanda ke dauke da cutar SARS-CoV-2 amma ba su nuna alamun cutar ba za a iya gano su kuma hakan na iya zama sanadin yaduwar cutar a duniya.
Binciken da aka yi na SARS-CoV-2 da HCoVs guda shida ya nuna bambance-bambance da bambance-bambance masu ban sha'awa.
Da farko, lokacin bayyanar da cutar HCoV ya kasance daidai.
A gefe guda, SARS-CoV-2 yana bin hanyar HCoV a kowane lokaci.
Na biyu, cutar ta COVID-19 ta kasance mai haɗari tsakanin SARS-CoV da kuma manyan HCoVs huɗu masu cutarwa (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A wani bangare kuma, cutar SARS-CoV-2 tana nuna alamun da aka saba samu a yayin kamuwa da HCoV da kuma bayyanar cututtuka daban-daban, na yau da kullun ko na yau da kullun.
A wani bangare kuma, ƙananan ƙididdigar COVID-19 na iya zama masu rikitarwa kamar yadda yake a cikin cutar SARS-CoV, kodayake ƙimar ta ragu sosai.
Na uku, cutar SARS-CoV-2 tana nuna alamun rashin lafiya da ke tattare da kamuwa da kwayar cutar HCoV da SARS-CoV a cikin al'umma.
A wasu lokuta, cutar SARS-CoV-2 tana iya zama daidai da cutar HCoV a cikin al'umma.
A wasu lokuta, ana bukatar a sake tantance ko cutar SARS-CoV-2 ta ragu bayan kamuwa da mutum kamar yadda aka yi a SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, SARS-CoV-2 za a iya gano shi a cikin ƙwayoyin cuta.
Idan cutar SARS-CoV-2 ta hanyar magungunan baki tana da mahimmanci kamar yadda yake a cikin SARS-CoV, to lallai ne a sake nazarin wannan a cikin karatun gaba.
A cikin wannan yanayin, SARS-CoV-2 zai iya zama mai saurin kamuwa da cutar a matsayin HCoV wanda ba zai iya cutar da sauran al'umma ba.
Koyaya, bayyanar cututtukan SARS-CoV-2 da kuma kamuwa da cuta, alamun bayyanar, da kuma yaduwar su a cikin jikin mutum sun isa su tantance yiwuwar cutar COVID-19 ta yanzu.
HCoVs guda huɗu masu kamuwa da cuta na al'umma suna haifar da alamun rashin daidaituwa da ke tattare da kwayar cutar.
A wani bangare kuma, yana iya zama gaskiya cewa cutar mutum na iya zama cikakke tare da HCoVs gaba ɗaya.
A takaice dai, duka biyun na iya zama masu cutar HCoV na farko.
HCoVs masu cutarwa ga mutane da kuma mutanen da ke da cutar HCoV na farko sun shiga cikin jerin.
Don yaduwa, HCoVs dole ne su sake bayyana a cikin mutum saboda dole ne suyi haɗuwa da canje-canje masu gudana a cikin yanayin raguwa.
Hakazalika, idan cutar SARS-CoV-2 ta kamu da mutane da yawa, lokaci na kamuwa da cutar zai iya bambanta da yanayin jikin mutum.
Idan ba a yi daidai ba, cutar za ta iya zama da wuya a hana shi shiga cikin rigakafi ko kuma wasu matakan rigakafi.
Shekaru da dama, CoVs masu cutarwa sun kasance suna yaduwa a cikin al'umma, suna ba da rigakafin rigakafi ga manoma waɗanda ke da rigakafin rigakafi.
Ba a buƙatar kwayar cutar a cikin dabba.
Kwayoyin cutar SARS-CoV da MERS-CoV ba su da alaƙa da jikin mutum kuma ba za a iya samun su cikin al'umma ba.
Suna bukatar su ci gaba da gudanar da bincike a dakunan karatunsu da kuma gano hanyoyin da za su iya kaiwa ga mutum, ko dai ta hanyar gida ko kuma gidaje inda ba za a iya yada cutar ba.
SARS-CoV-2 yana da alamun cutar da SARS-CoV/MERS-CoV da kuma HCoV na hudu da ke kamuwa da jama'a.
Akwai yiwuwar kamuwa da cutar kamar yadda HCoVs ke iya kamuwa da jama'a, yayin da ake samun yiwuwar.
Koyaya, mafi munin cutar HCoVs a cikin al'umma da ƙananan cutar SARS-CoV ko MERS-CoV.
Ka kuma bincika ko zai yiwu mutum ya yi tafiya a cikin jama'a ba tare da samun gida ko dabba da zai iya ɗaukar shi a jikinsa ba.
Kafin muyi magana game da bayyanar HCoVs a cikin dabbobi, yana da matukar mahimmanci mu fahimci menene HCoVs, da kuma wuraren farko, matsakaici da kuma na kamuwa da cuta.
Kwayar cutar ta zama kamar gidan HCoV ta hanyar adana takunkumin da zai iya zama asalinsa wanda ya fi dacewa da yankin da ke cikin jikinsa.
Kwayar cutar ta iya zama mai saurin yaduwa kuma tana yaduwa a cikin ɗakin mahaifiyar.
Hakanan, ɗakin ajiya yana riƙe da HCoV a cikin kwayar halitta da kuma cikin ƙwayar cuta.
A cikin wannan yanayin, ana iya samun cutar a cikin kwayar halitta.
Koyaya, idan HCoV ya shiga sabon yanayi a cikin wani yanayi na ciki kafin ko lokacin shigar mutum, ba zai iya daidaitawa da sabon yanayi ba kuma yana da cutarwa.
Wannan matsakaiciyar hanyar za ta iya zama hanyar hana kamuwa da cutar daga dabba zuwa mutum kuma tana aiki a matsayin hanyar hana kamuwa da cutar ta hanyar barin kwayar cutar ta kamu da ita kuma ta wuce ta zuwa ga mutum don ci gaba da kamuwa da cutar.
HCoV zai iya zama mai mutuwa idan ba a iya watsa shi ta hanyar hanyoyin da suka dace kafin ya isa jikin mutum.
A gefe guda, HCoVs na iya zama masu daidaitawa a cikin gida kuma suna iya zama masu saurin kamuwa da cutar a cikin shekaru da yawa.
Ƙari ga haka, za a yi wa babban tanti na farko ado.
Rahotanni sun nuna cewa akwai wasu ƙananan ƙwayoyin SARS da suka dace da dabbobi.
Binciken da aka yi a kan kwayar cutar ya nuna cewa dabbobi masu shayarwa suna da matakan anti-SARS-CoV IgG idan aka kwatanta da na al'umma.
Wasu dabbobi kamar su dabbar tururuwa (Paguma larvata) da wasu dabbobi kamar su dabbar dabba sun kasance farkon wadanda suka kamu da kwayar cutar SARS-CoV da ke da alaƙa da SARS-CoV.
Wannan ya sa an samu karin bayanai kan cewa babu wani SARS da aka samu bayan kashe dukkanin dabbobi a cikin wannan yankin.
Koyaya, an ba da rahoton cewa dabbobi kamar su dabbobi masu daji ko dabbobi masu shayarwa waɗanda ke shiga cikin dabbobi masu shayarwa ba su da cikakkiyar cutar SARS-CoV, wanda ke nuna cewa irin waɗannan dabbobi na iya zama kamar matsakaiciyar gida mai kariya amma ba ainihin gidan SARS-CoV ba.
Misali, yayin da kashi 80% na nau'ikan dabbobi a Guangzhou sun sami rigakafin SARS-CoV, ana iya samun wasu ƙananan dabbobi a matsayin cibiyoyin cutar SARS-CoV.
Wannan shine farkon bayyanar SARS-CoV.
Binciken da aka yi a kan dabba da ke da matsayin kwayar cutar SARS-CoV ta gano wani CoV mai kama da na wasu tsuntsaye, wanda ake kira CoV na tsuntsaye HKU3 (SARSr-Rh-BatCoV HKU3) wanda ya yi kama da na Rhinolophus, wanda aka gano a cikin wasu tsuntsaye a China.
Kwayar tana da rigakafin cutar anti-SARS-CoV wanda ke da nasaba da kwayar SARS-Rh-BatCoV HKU3.
CoVs na wannan kwayar cutar da sauran kwayoyin suna da kashi 88-92% na kwayar nucleotide da SARS-CoV.
Kwalejin sune sabon tsarin halitta wanda ƙwayoyin cuta ke da alamun da suka samo asali daga mutum.
An gano cewa wasu nau'in CoVs masu kama da SARS (SL-CoVs) sun kamu da cutar a cikin tsuntsaye, amma babu wani daga cikin su da ke nuna cewa WIV1 zai iya zama mai zaman kansa kamar yadda kwayar cutar ke iya zama.
Tsarin aikin angiotensin 2 (ACE2) ya kasance mai tasiri a cikin maganin SARS-CoV.
WIV1 wanda aka samo a cikin kwayar tsuntsaye yana nuna tsuntsaye, tsuntsaye da kuma ACE2 na mutum a matsayin mai karɓar ƙwayoyin cuta.
Bugu da ƙari, ƙwayoyin jini na marasa lafiya na SARS da aka yi wa allurar rigakafi na iya kamuwa da cutar WIV1.
Bugu da ƙari, WIV1 yana nuna ainihin asalin SARS-CoV a cikin tsuntsaye, suna rarraba kashi 95% na tsarin nucleotide.
Duk da cewa akwai kamanceceniya da yawa tsakanin kwayar cutar biyu, an yi imanin cewa WIV1 na iya zama asalin kwayar cutar SARS-CoV da kuma wasu ƙwayoyin cuta na iya zama tushen SARS-CoV.
Binciken ilimin halitta ya gano MERS-CoV da kuma irin nau'in CoV-HKU4 da CoV-HKU5.
Kwayoyin CoV-HKU4 da MERS-CoV suna da mai karɓa guda ɗaya, dipeptidyl peptidase 4 (DPP4), don shigar da kwayar cutar.
An gano hanyoyin polymerase RNA na RNA-dependent MERS-CoV ta hanyar gano su a cikin beta-CoVs da aka gano a cikin Turai da Afirka.
A halin yanzu, ba a gano kwayar cutar MERS-CoV a cikin tsuntsaye ba.
MERS-CoV da kuma CoV-HKU25 sun hada da kashi 87% na kwayar halittar su.
Bugu da ƙari, tsuntsaye ba su da wata hanyar shiga cikin MERS-CoV.
A wani bangare kuma, binciken da aka yi a nahiyar turai ya nuna cewa raƙuman sun kamu da kwayar cutar MERS-CoV da ke haifar da cututtukan kiwon lafiya, irin na raƙuman turai da suka bayyana a wasu ƙasashen Afirka.
An gano kwayar cutar MERS-CoV da ke kama da mutum a cikin kwayar halitta a cikin kwayar halitta na raƙuma, wanda ya nuna cewa raƙuma sun kasance masu karɓar kwayar halitta na MERS-CoV.
Ya kuma lura cewa mafi yawan cututtukan da suka shafi kamuwa da kwayar cutar sun faru ne a kan raƙuman da aka kamu da su da cutar MERS-CoV.
Kwayoyin da suka kamu da cutar ba su fitar da kwayar cutar ba kawai ta numfashi amma kuma ta hanci da hanci, wanda kuma shine babban hanyar fitar da kwayar cutar a cikin tsuntsaye.
Koyaya, a halin yanzu akwai wasu ra'ayoyi game da wasu nau'ikan MERS da aka sani waɗanda ba su taɓa haɗuwa da raƙuma ba kafin farkon kamuwa da cutar, kamar su cewa mutum ya iya watsa shi ga mutum ko kuma ƙwayoyin cuta na asali da kuma asalin dabbobi masu karɓar MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na kwayar nucleotide kuma kwayar CoV RaTG13 da aka fitar ta hanyar Rhinolophus affinis.
Kamar SARS-CoV da MERS-CoV, tushen bambanci tsakanin SARS-CoV-2 da RaTG13 shine mabuɗin don hana shi daga kamuwa da cuta.
A takaice, tsuntsaye ba za su iya zama tushen ko kuma tushen SARS-CoV-2 ba idan an gano CoV na yau da kullun daga tsuntsaye a nan gaba.
Muna tsammanin cewa, dabbobi masu yiwuwa masu amfani da SARS-CoV-2 za su kasance a cikin dabbobin daji da aka yi musu bulala ko kuma suka kamu da cutar a Kasuwar Dabbobi ta Huanan, kuma abin da yawancin farkon cutar COVID-19 ke ciki, wanda zai iya nuna cewa kamuwa da cuta ta wuce daga dabba zuwa mutum.
Yawancin binciken da aka yi kwanan nan game da ƙwayoyin cuta sun nuna cewa ƙananan ƙananan dabbobi masu suna pangolin (Manis javanica) na iya ɗaukar kwayar cutar beta-CoV mai kama da SARS-CoV-2.
Sabon CoV na pangolin yana da kashi 85-92% na asalin nucleotide wanda yayi kama da na SARS-CoV-2.
Duk da haka, suna da kusan kusan kusan RaTG13 tare da 90% na daidaituwa a cikin tsarin nucleotide.
Sun bambanta a cikin nau'ikan da suka dace da SARS-CoV-2-virus daban-daban a cikin asalin su, ɗayan an gano ta hanyar mai karɓar mai karɓar (RBD) tare da SARS-CoV-2, tare da 97.4% na tushen gano amino acid.
Koyaya, RBD na SARS-CoV-2 da RaTG13 sun fi rarrabuwa, kodayake tsarin su na kwayoyin halitta ya yi kama sosai.
A cikin binciken farko na pangolin da ke da cutar, an gano kwayar cutar a cikin kwayar cutar huhu, wanda ke da alaƙa da SARS-CoV-2.
Wannan binciken ya dauki matakai biyu na hada-hadar hannu da kuma yin amfani da kayan aiki don samar da wani nau'in kwayoyin halitta wanda ya kai kashi 86.3% na kwayar cutar.
Ba za mu iya yin watsi da cewa binciken da aka yi ya nuna cewa pangolin yana ɗaya daga cikin dabbobin da ke cikin cibiyar SARS-CoV-2.
Koyaya, a halin yanzu babu wata hujja da ta nuna cewa pangolin shine asalin SARS-CoV-2 saboda akwai bambancin tsarin halitta tsakanin SARS-CoV-2 da beta-CoV SARS-CoV-2-pangolin.
Bugu da ƙari, daidaiton tsakanin SARS-CoV-2 da RaTG13 ya yi ƙasa da na SARS-CoV-2 da CoV-pangolin da beta-CoV na SARS-CoV-2-pangolin.
Ya kamata a yi la'akari da yadda SARS-CoV-2 ke gudana a cikin tsuntsaye, pangolins da sauran dabbobi.
Kamar yadda aka gano a cikin RBD na yau da kullun tsakanin SARS-CoV-2 da pangolin, beta-CoVs SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da daidaito na yau da kullun a cikin tsarin su na genomic.
An yi magana game da yiwuwar dangantaka tsakanin RBD na beta-CoV da SARS-CoV-2 da SARS-CoV-2 wanda ke dogara ne akan zaɓi don haɗuwa.
Akwai wasu bincike da ke neman gano alaƙar beta-CoV SARS-CoV-2 PANGOLIN da RaTG13 a cikin kwayar halitta ta uku.
A matsayin ci gaba, ana iya samun yaduwar kwayar cutar beta-CoVs.
Masu bincike sun gano cewa SARS-CoV-2 ya kamu da cutar.
Bugu da ƙari, an gano cewa akwai wasu cututtuka masu cutarwa na HCoVs, wanda aka gano cewa HCoV-229E a cikin dabbobi, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Binciken asalin ya nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali ne daga CoVs na tsuntsaye, amma an gano asalin kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin namomin kaza.
An kuma gano cewa kwayar cutar CoV mai suna ARCoV.2 (Appalachian Ridge CoV) da aka gano a cikin kwayar cutar ta Arewacin Amurka mai nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
A wani bangare kuma, kwayar HCoV-229E ta yi karo da kwayar cutar tsuntsaye, Hipposideros/GhanaKwam/19/2008, wacce aka gano a Ghana, kuma an dauki raƙuma a matsayin tushen cutar.
Don sauƙaƙe magana, an haɗa ilimin yanzu game da kwayar cutar HCoV da aka gano a cikin Hoto na 1 da Tebur na 2.
Binciken da aka yi a baya ya nuna cewa akwai yiwuwar kamuwa da kwayar cutar HCoVs tsakanin dabbobi da mutane a tarihi.
Lokacin da HCoV-OC43 ya wuce daga dabbobi zuwa mutane ta hanyar dabbobi a cikin shekarun 1890, akwai yiwuwar kamuwa da cutar huhu.
An kuma gano cewa cutar HCoV-229E ba ta da tasiri sosai.
An gano alpha-CoVs masu kama da HCoV-229E.
Daga cikinsu akwai wani nau'in alpha-CoV alpaka.
Wasu bincike sun nuna cewa cutar ta wuce daga tsuntsaye zuwa mutum.
Da farko, mutum amma ba alpacas ba zai iya haɗuwa da tsuntsaye a cikin yanayi ɗaya.
A wannan yanayin, mutane suna yin gwaji tare da alpacas.
Na biyu, alpha-CoV na HCoV-229E ya kasance mai daidaituwa kuma ba shi da alamun cutar a cikin tsuntsaye, amma alpha-CoV alpaka ya haifar da cutar huhu a cikin dabbobi da suka kamu da kwayar cutar.
A ƙarshe, alpha-CoV alpaka yana cikin jikin dabbobi.
A wannan yanayin, ba za a iya tantance ko alpacas sun sami kwayar cutar alpha-CoV hcOv-229E a cikin ɗan adam ba.
A cewarsa, wannan kwayar cutar ita ce kwayar cutar da ke haifar da cututtukan da ke haifar da cutar a cikin mutane da suka hada da kwayar cutar rabies, kwayar cutar Ebola, kwayar cutar Nipah da kwayar cutar Hendra.
An kuma ce tsuntsaye na iya zama masu watsa HCoV-229 zuwa ga mutane ba tare da wata hanyar sadarwa ba.
Ko kuma, saboda alpha-CoV na tsuntsaye yana cikin tsarin kwayar HCoV-229E, alpacas da raƙuma na iya zama matsakaiciyar hanyar watsa kwayar cutar zuwa ɗan adam, kamar yadda aka saba da MERS-CoV.
MERS-CoV ya kasance muhimmiyar hanyar watsa cutar daga tsuntsaye zuwa raƙuma da kuma daga raƙuma zuwa mutum.
An gano yiwuwar kamuwa da cutar MERS-CoV daga tsuntsaye a farkon cutar kuma an tabbatar da hakan ta hanyar binciken da aka yi.
A gaskiya ma, tsuntsaye suna kama da kwayar cutar ta hanyar rarraba kwayoyin halitta tsakanin mata da kuma watsawa ga mutane.
Tsuntsaye, haɗuwa a cikin rukuni, kasancewa a cikin jama'a da kuma yin amfani da iska suna da alaƙa da abubuwan da ke sa tsuntsaye su zama 'mai watsa kwayar cuta'.
A wani bangare kuma, an gano MERS-CoV a jikin raƙuma sama da shekaru goma.
Ya dace da camels da aka canza daga tsakiyar ɗakin zuwa farkon ɗakin da aka ajiye.
MERS-CoV yana haifar da cutar mai saurin kamuwa da cuta kuma yana sa kwayoyin cutar su zama marasa canji.
Cutar cutar ta MERS-CoV ta zama sananne kuma mutum zai zama na ƙarshe a cikin gidajen MERS-CoV saboda ba a iya samun sauyin sauyin yanayi.
Ba kamar rawar raƙuma a watsa MERS-CoV ba, rawar da mahaukaci, idan akwai, a watsa SARS-CoV-2 na daban.
Mafi yawan lokuta, beta-CoVs na pangolin suna da cututtuka da cututtuka.
Za a iya rarrabe ƙwayoyin beta-CoV na SARS-CoV-2 daga na SARS-CoV-2 a matsayin kwayoyin cuta.
Ana buƙatar bincika hanyoyin da yawa don watsa SARS-CoV-2 daga dabbobi zuwa ɗan adam a cikin da kuma waje a cikin karatun gaba.
Da farko, tsuntsaye na iya zama tushen kwayar cutar SARS-CoV-2 wacce ke da alaƙa da SARS-CoV-2.
Mutum na iya samun wurin zama tare da tsuntsaye ta hanyar cinye dabbobi ko kuma yin amfani da ƙasa.
Na biyu, bangarori na iya zama cibiyar sadarwa don cutar SARS-CoV-2 wacce ta shiga cikin binciken kwanan nan.
Mutum yakan kamu da kwayar cutar ta hanyar cin naman dabbobin daji.
Akwai yiwuwar cewa dabbobi masu shayarwa da dabbobi masu shayarwa na iya kamuwa da SARS-CoV-2.
Binciken dabbobi da na daji don rigakafin jiki yana da nasa.
Na uku, kamar yadda aka ambata a sama, haɗuwa da cutar SARS-CoV-2 na iya wucewa zuwa nau'ikan dabbobi masu rarrafe na uku tare da tsuntsaye da pangolins.
Binciken cutar SARS-CoV-2 a cikin dabbobi yana ci gaba.
Baya ga wasu hanyoyin da ake amfani da su wajen daukar kwayar cutar, akwai wasu matakai guda uku da ake dauka kan ko kwayar cutar tana da muhimmanci wajen samun sauki a kamuwa da cutar ta CoV.
Tun da farko, mun san cewa suna daidaita RNA ɗin su ta hanyar layi.
Idan aka kwatanta da wasu ƙwayoyin cuta masu ƙwayoyin RNA guda ɗaya, ana iya ɗaukar adadin canjin CoV a matsayin dehydroxy a cikin dehydroxy tare da canjin canji daga ~10-4 a shekara a cikin kashi na 2, dangane da ci gaban gwajin canjin CoV a cikin sabbin gidajen.
Wannan CoV yana da mai ba da izinin exoribonuclease, wanda hakan ke haifar da sauya yanayin haɓakar zuwa raguwa ko mutuwa.
Abin farin ciki, an gano cewa irin wannan nucleotide na Remdesivir yana da tasiri wajen kawar da CoV ta hanyar lalata wannan exoribonuclease tare da RNA mai amfani da RNA polymerase.
Remdesivir yana daya daga cikin kwayoyin cutar SARS-CoV-2 da ake iya ganowa a cikin bincike.
Koyaya, yawan kwayar cutar CoV ya ninka na mutane miliyan fiye da na gida.
Bugu da ƙari, yawan adadin ƙwayoyin cuta yana da mahimmanci idan COV zai dace da ɗakin.
Idan aka kwatanta da SARS-CoV wanda ke da yawan canji, SARS-CoV-2 yana da ƙananan canji, wanda ke nufin cewa zai iya daidaitawa da jikin mutum.
Ana tsammanin cewa, ana iya samun daidaituwa tare da mai karɓa wanda yake kusa da mutum.
Bugu da ƙari ga SARS-CoV-2, wannan ya haɗa da MERS-CoV, wanda ke da alaƙa da jikin raƙuma.
A wannan yanayin, ba za a iya samun sauye-sauyen kwayoyin halitta da ke haifar da allurar rigakafi ko maganin SARS-CoV-2 ba don rage ƙarfin cutar.
Na biyu, kwayar halitta mai mahimmanci ga CoVs tana ba da izinin kwayar halitta don canzawa da haɗuwa, ta hanyar haɓaka haɓakar kwayar halitta tsakanin dabbobi daban-daban, wanda ke da fa'ida don sabbin kwayar cutar CoVs idan kayan aikin sun canza.
An rarrabe shi ta hanyar jikin da aka rufe da kuma takarda mai lamba ta hanyar 3' na baya.
Na uku, CoVs suna canzawa ta hanyar kwafin RNA ta hanyar tsari da ake kira "copy-choice".
A cikin wani ɗaki mai kama da mai sarrafa abubuwa, canji yana gudana a lokacin rubutun RNA.
Ana iya amfani da RNA mai tsayi da kuma tsayi don samar da sabon nau'in CoV.
An gano asalin asalin asalin asalin HCoV-HKU1 da HCoV-OC43 duka, tare da CoV na dabbobi kamar su SL-CoV da CoV-HKU9.
Fayil na gidan kwayar cutar da watsawa
Baya ga nau'ikan kwayar cutar guda uku da aka lissafa a sama, kwayar cutar da mai karɓar kwayar cutar suna da mahimmanci a cikin watsawa tsakanin dabbobi da mutane.
A halin yanzu, ana daukar kwayar cutar SARS-CoV a matsayin wata muhimmiyar hujja, wanda kuma ke nuna zabin da ake yi na kwayar cutar a yayin yaduwar cutar tsakanin dabbobi da mutane.
Bisa ga binciken da aka yi a kan bambancin SARS-CoV na mutum da kuma na dabbobi masu zaman kansu, SARS-CoV ya bayyana a matsayin mai sauyawa a cikin kwayar halitta ko na mutum, musamman ta hanyar sauyawa a cikin yankin RBD na furotin S.
A mafi yawan lokuta, RBD a cikin wasu sunadarai na S CoV suna haɗuwa da mai karɓar kwayar halitta kuma ana iya tantance su ta hanyar amsawar rigakafi.
A cikin SARS-CoV, RBD yana da girman tsakanin 318 zuwa 510 amino acid j a kan S1 tushe, wanda ke haɗuwa da ACE2 tare da masu karɓar kwayar cutar.
RBD na SARS-CoV na iya tantance masu karɓar ACE2 a cikin dabbobi daban-daban, gami da, tsuntsaye, dabbobin daji, dabbobin daji da kuma dabbobi masu shayarwa, wanda ke haifar da yaduwar kwayar cutar tsakanin dabbobi da mutane.
A zahiri, an gano nau'ikan amino acid guda 6 a matsayin masu bambanci da kwayar cutar da ke ɓoye a cikin kwayar ɗan adam da naman alade a cikin RBD kuma 4 daga cikinsu suna cikin mahaɗin mai karɓar don haɗuwa da mai karɓar ACE2.
Kwayoyin cutar SARS-CoV sun hada da K479N da S487T a cikin RBD, wanda zai iya kara yawan kwayar cutar da ke dauke da kwayar cutar.
Misali, waɗannan amino acid guda biyu na iya zama masu tasiri a cikin kwayar cutar kwayar cutar a cikin mutum.
Yana da mahimmanci a lura cewa SARS-CoV-2 yana da kwayar halitta iri ɗaya da SARS-CoV.
Bambancin kashi 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 protein S na nufin cewa tsarin hada-hadar S protein da ACE2 na mutum ya canza.
A zahiri, nazarin cryo-EM ya nuna kusan sau 10 zuwa 20 na daidaito tsakanin ACE2 na ɗan adam da kuma furotin S ACE2 na SARS-CoV.
Hakanan yana da mahimmanci a gano ko akwai wasu masu karɓar cutar da za a iya amfani da su don watsa SARS-CoV-2.
A zahiri, HCoV-NL63 yana haɗuwa da ACE2 amma tare da wani nau'in S.
Akwai wasu masu karɓar HCoV, kamar aminopeptidase N na HCoV-229E, da 9-O-acetylated sialic acid na HCoV-OC43.
Ana iya amfani da su don canza CoVs a cikin jikin mutum bayan yaduwar tsakanin dabbobi daga ɗakin ajiyar su.
Bugu da ƙari ga masu karɓar ƙwayoyin cuta, ana iya gano cewa watsa HCoV tsakanin dabbobi wanda wasu kayan ajiya ba su kare shi ba.
Rarraba gidajen sunadarai na mutum da kuma na HCoV na tsuntsaye, raƙuma, ko kuma dabbobi na iya zama abin hana yaduwar cutar tsakanin dabbobi.
HCoVs dole ne su kasance masu tasiri ga tsarin rigakafi da kuma canzawa wanda zai hana kwayar cutar daga yaduwa tsakanin dabbobi.
Hakanan, masu gano kwayoyin a cikin rukunin kwayar cutar dole ne su san cewa suna ba da aiki.
Akwai wasu gwaje-gwaje na yau da kullun na SARS-CoV-2 da kuma kayan aikin ragewa ta hanyar tsarin CRISPR wanda zai iya ba da izini ga yara.
Bayyanar sabon nau'in HCoV: dawowa a farkon
An gano cewa wannan CoV yana ba da damar da yawa don bayyanar sabon HCoV.
Bugu da ƙari, CoV na tsuntsaye yana kama da ɓoye na kwayar HCoV.
Bugu da ƙari, canjin kwayar halitta da kuma haɗuwa na asali na iya haifar da ci gaba da HCoVs kuma ya haifar da ƙwayoyin cuta biyu a cikin kwayar halitta.
Misali, samun ko rasa sabon kwayar halitta na iya canza fasalin kwayar cutar da kyau.
Daga cikin sunadarai masu taimakawa SARS-CoV, ORF8 yana da mahimmanci a cikin canji a cikin ɗan adam, kamar yadda kwayar cutar SARS-CoV ba ta da kariya amma tana da wasu ƙwayoyin ORF8 masu mahimmanci.
An gano bambance-bambance 29-nucleotide da ke nuna SARS-CoVs a cikin kwayoyin da aka ware a farkon kamuwa da cutar a cikin mutane.
Wannan juyin halitta ya rarraba ORF8 zuwa ORF8a da ORF8b kuma ana tsammanin ya zama mai zaman kansa ko kuma mai canzawa.
Bugu da ƙari, SARS-CoV na iya samun tarihin haɗuwa da asalin CoV na alpha- da gamma, kuma an gano ƙananan ƙananan ƙananan masu haɗuwa a cikin RNA mai polymerase wanda ke da alaƙa da RNA.
An kuma gano wuraren haɗin gwiwa a cikin nsp9, musamman nsp10, da kuma a cikin nsp14 na'urori.
Bugu da kari, an gano cewa cutar MERS-CoV ta hada da wasu kwayoyin halittar da suka samo asali daga wasu nau'ikan kwayoyin halittar da aka gano a kan raƙuma a Saudi Arabiya.
Baya ga SARS-CoV da MERS-CoV, an gano abubuwan da ke tattare da HCoVs na wasu nau'ikan, inda HCoVs ke haɗuwa da CoVs na wasu nau'ikan dabbobi a cikin ƙwayoyin halittar su da ba a gano su ba.
Ya kuma lura cewa zabin na iya zama da amfani don canza kwayoyin cutar da ba su da kyau, musamman waɗanda suka tashi daga kwayar cutar a cikin zabin na gaba, a matsayin tsarin rigakafi na gida.
An gano wannan sakamakon ne ta hanyar rashin daidaiton ORF4 a cikin kwayar cutar HCoV-229E, wanda ke da alaƙa da kwayar nucleotide biyu.
Yayin da aka gano ORF4 mai gudana a cikin kwayar cutar HCoV-229E da kwayar cutar raƙumi, alpha-CoV na alpaca yana nuna shigar nucleotide guda ɗaya, wanda ke haifar da canje-canje a cikin jiki.
A ƙarshe amma mafi mahimmanci, ana iya samun kwayar HCoV ta hanyar zabin gaggawa a cikin ɗakunan ajiya.
An gano alamun cutar da ba a san su ba ko kuma ba a san su ba a lokacin da tsuntsaye suka kamu da CoV, wanda ke nuna cewa ba a canzawa tsakanin CoV da tsuntsaye.
Tsuntsaye kamar tsuntsaye suna da kyakkyawar alaƙa da CoV ta hanyar jikinsu da kuma tsarin su.
Misali, ƙuntatawa a cikin samar da amsa ta hanyar tasiri a cikin tsuntsaye yana rage ingancin cutar da CoV ke haifarwa.
Bugu da ƙari, ƙwayoyin cuta a cikin tsuntsaye sun ragu saboda bayyanar NKG2/CD94 da kuma rage rayuwar mutum.
Bugu da ƙari, yawancin iskar oxygen (ROS) da ke faruwa ta hanyar abinci a cikin tsuntsaye na iya haifar da cutar CoV kuma yana shafar ilimin ta hanyar exoribonuclease, wanda ke haifar da saurin asalin cutar ta hanyar tsinkayewa a cikin dakin.
Hakanan za'a iya watsa kwayar cutar CoV mai yawa ta hanyar haɗuwa, wanda ke haifar da sabbin sunadarai ko kuma alamun canzawar sunadarai.
A wannan lokacin, akwai yiwuwar cewa za a sami sabbin nau'ikan HCoVs guda uku a cikin shekaru ashirin da suka gabata.
Wannan CoV ba mai cutarwa ba ne ko kuma yana nuna alamun kamuwa da cuta a cikin ɗakin mai karɓa kamar tsuntsaye da raƙuma.
Suna da ƙarfin zuciya kuma ba sa koyan yadda za su ba da amsa mai kyau ga waɗanda suke hamayya da su.
A nan ne kuma aka gano wasu marasa lafiya da ba su da wata cuta da ke damun mutane.
Alamar cutar sau da yawa tana haifar da amsawar rigakafi da kuma yawan kwayar cytokine, saboda idan ba a amsa ba, za a iya ƙara yawan ciwon huhu.
Koyaya, a cikin yanayin yau, maganin rigakafi ya bambanta da yarda da CoV.
Irin wannan rarrabawar amsawar rigakafi na iya zama mahimmanci a cikin maganin anti-SARS-CoV-2.
Amsar interferon tana da ƙarfi sosai a cikin tsuntsaye.
Hakanan, bayar da interferon nau'in I aƙalla a farkon matakin kamuwa da cutar SARS-CoV-2 a cikin ɗan adam zai zama dole.
Bugu da ƙari, an gano cewa ƙwayoyin cuta na NLRP3 suna da haɗari.
A cikin irin wannan tunanin, kwayar NLRP3 mai kumburi tare da MCC950 na iya zama da amfani wajen maganin COVID-19.
Sakamakon SARS-CoV-2 ya biyo bayan yanayin da SARS-CoV da MERS-CoV suka bayyana.
Yayin da aka gano kashi 95% na kwayar cutar nucleotide ta SARS-CoV, akwai kuma kashi 96% na kwayar cutar CoV ta SARS-CoV-2.
Yayin da aka gano wasu ƙwayoyin cuta da dabbobi a cikin kwayar halitta a matsayin masu riƙe da kwayar cutar SARS-CoV a cikin jikinsu, an gano maɓallin ajiyar SARS-CoV-2 na farko.
An gano beta-CoVs masu kama da SARS-CoV-2 wanda ke nuna cewa pangolin na iya zama matsakaiciyar ajiya ko kuma yiwuwar beta-CoVs ko kuma tsarin kwayar cutar SARS-CoV-2.
Duk da cewa akwai wasu bayanai, an tabbatar da cewa SARS-CoV-2 ya kamu da mutum ne da gangan ko kuma ta hanyar wucewa.
CoVs sun sake dawowa saboda sabon kamuwa da cutar SARS-CoV-2.
Nazarin CoVs a cikin tsuntsaye da sauran dabbobi ya canza tunaninmu game da tasirin bayyanar dabbobi da kuma ma'adinan HCoVs akan watsawa a cikin jikin mutum.
Binciken da aka yi a gani ya nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga tsuntsaye kuma sun kamu da mutane ta hanyar wasu nau'ikan dabbobi.
Lokacin da cutar SARS-CoV ta taso ne ta hanyar hulɗa da mutane da dabbobi a cikin gidajen abinci, rufe gidajen abinci da ke sayar da dabbobi masu shayarwa da kuma ajiye dabbobi a can na iya hana cutar SARS.
A irin wannan tunanin, dole ne a samar da pangolins a cikin dabbobi don hana kamuwa da cutar daga dabbobi, kamar yadda aka nuna a cikin kwatancen beta-CoVs na pangolins da SARS-CoV-2.
Koyaya, ko SARS-CoV-2 ya kamuwa da mutum ta hanyar pangolin da sauran dabbobi da kuma yadda za a magance shi a cikin binciken da zai biyo baya.
A wani bangare kuma, MERS-CoV ya kasance a cikin raƙuman ruwa tun zamanin da.
Kamel ɗin ya zama mai amfani don sufuri da jigilar kaya kuma yana ba da abinci, kayan abinci, kayan abinci da gashi ga jama'a.
An rarraba su ko'ina cikin Gabas ta Tsakiya da Afirka.
Ba ma bukatar kashe dukkan raƙuma don kamuwa da cutar MERS, kuma an yi amfani da shi a masana'antar dabbobi a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana yaduwar cutar MERS, an samar da wata hanyar da za ta samar da maganin MERS-CoV a cikin raƙuman ruwa, tare da wasu hanyoyin rigakafi.
Saboda ba za mu iya kamuwa da wannan kwayar cutar ba, wasu nau'ikan kwayoyin halitta na iya haifar da wasu cututtuka.
An yi amfani da maganin CoV na dabbobi a cikin daji.
A mafi yawancin lokuta, CoVs na kwayar cuta waɗanda za a iya ɗauka ta hanyar dabbobi suna da kyau.
Akwai wasu hanyoyi masu mahimmanci da kwayar cutar ta CoV da ke yaduwa ta hanyar dabbobi ke daidaitawa da haɗuwa, wanda ke hana kwayar cutar CoV mai saurin kamuwa da cuta da kuma/ko kisa a nan gaba.
A wasu sassan kasar Sin, ya kamata a daina cin dabbobin daji domin rage hulda tsakanin mutane da dabbobi.
A yayin da ake fuskantar SARS, MERS da COVID-19, ya zama wajibi a samar da tsarin da ya dace da kuma shirin da ya dace.
A gaskiya, yawancin ƙwayoyin cuta sun kasance a duniya tun da daɗewa.
Suna cikin ɗakunan ajiya a lokacin da suke rarraba.
Kodayake tsuntsaye suna da hanyoyi masu yawa na yada kwayar cutar, ana iya rage yiwuwar hulɗa da tsuntsaye da sauran dabbobi ta hanyar koyar da mutane su kasance tare da su.
Binciken rigakafi a cikin dabbobi yana da mahimmanci don fahimtar yanayin rayuwar CoV da ainihin yanayin rayuwarsu, wanda ke nuna yadda za a iya watsa cutar daga dabbobi zuwa ga mutane da kuma yiwuwar kamuwa da cuta a nan gaba.
A ƙarshe, hanya mafi mahimmanci don hana yaduwar kwayar cutar daga dabbobi shine mutum ya zama mai kula da wuraren ajiyar kwayar cutar.
Akwai wasu abubuwa da yawa a cikin yanayin da ke nuna bayyanar SARS-CoV-2 ta hanyar dabbobi.
Da farko, idan tsuntsaye suka watsa kwayar cutar SARS-CoV-2 a cikin tsuntsaye, yana da matukar muhimmanci mu bincika yadda tsuntsaye da tsuntsaye suke da haɗin kai.
Na biyu, idan tsuntsaye sun zama masu cutarwa ga mutane, to, yadda mutane ke hulɗa da tsuntsaye ya kamata a fahimta.
Na uku, idan akwai dabba ta uku da ke da matsayin matsakaiciyar tsari, to ya kamata a kula da yadda ake hulɗa da sauran dabbobi kuma ya haɗa da mutane, tsuntsaye da tsuntsaye.
A ƙarshe, saboda yawancin dabbobi da dabbobi masu gida suna iya kamuwa da SARS-CoV-2, duka rigakafi da bincike na cutar dole ne su kasance.
Ko dai tsuntsaye ne, pangolin ko wasu dabbobi masu shayarwa, ya kamata mu fahimci cewa cutar SARS-CoV-2 ko kuma kakanninta na yau da kullun suna iya shiga cikin ɗakin ajiya na farko.
Ci gaba da bincike a wannan fannin zai bincika yadda SARS-CoV-2 ke gudana a cikin dabbobi, da kuma hanyoyin da za a iya amfani da su wajen gano cutar COVID-19 a cikin mutum.
Rashin daidaita tsarin gwajin "mai yiwuwa" da "mai yiwuwa" COVID-19 ya kasance mai rikitarwa.
A ranar 6 ga Fabrairu, 2020, rukuninmu ya buga wani bita na kasa game da binciken cutar coronavirus na 2019 (2019-nCoV) da kuma maganin cutar kuma wannan labarin ya nuna iliminmu da hanyoyin magance cutar.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, kuma tsarinmu da iliminmu suna da matukar mahimmanci saboda fitowar sakamakon bincike da kuma bayyanar cututtukan asibiti; haka kuma, ana sake nazarin hanyoyin bincike da magani.
A cikin wannan labarin, mun amsa wasu bayanai game da labarinmu da kuma game da sabon tsarin gwajin "mai yiwuwa mai cutar" da "ba mai cutar ba" kamar yadda aka gano a cikin Labarin Kula da Kula da COVID-19 (sabon sakin layi) wanda Kwamitin Lafiya na Kasa na China ya fitar.
A watan Disamba na 2019, sabon kwayar cutar coronavirus ta 2019 (2019-nCoV) ta bayyana wani nau'in cutar, wanda a yanzu ake kira cutar coronavirus ta 2019 (COVID-19) kuma wannan kwayar cutar ta kasance nau'in cutar coronavirus na numfashi na 2 (SARS-CoV-2).
A ranar 11 ga Maris, WHO ta ayyana COVID-19 a matsayin annoba ta duniya.
Dangane da cutar SARS-CoV-2, rukuninmu ya gabatar da jerin abubuwan da suka faru na yau da kullun da aka gano a cikin rahoton da Hukumar Kula da Lafiya ta Sojoji ta gabatar a ranar 6 ga Fabrairu.
Ya shiga cikin tunanin kowa tun daga farkon.
Duk da cewa cutar COVID-19 ba ta da kyau, shirye-shiryenmu da iliminmu sun dogara ne da sakamakon bincike da kuma gwajin asibiti; haka kuma, hanyoyin bincike da magani suna ci gaba da yin nazari.
Misali, Rahoton Bincike da Kula da Cutar COVID-19 da Kwamitin Lafiya na Kasa na kasar Sin (http://www.nhc.gov.cn/), tsakanin 6 ga Janairu, 2020 da 3 ga Maris, 2020, ya fitar da nazarin guda shida da kuma wasu bayanan da aka gyara.
Yanzu mu labarin ya zo da Zhou et al., suka gabatar da wani abu na bayar da tabbacin game da abin da suka koya a asibiti.
Wannan aikin ya hada da sabon bayani a cikin mujallarmu wanda ke nuna bayanan da suka dace game da cutar.
Muna godiya ƙwarai da gaske saboda wannan.
Amma kuma aikin yana buƙatar a bincika shi kamar yadda aka lissafa a cikin Labarin Kula da Kula da COVID-19 (ƙididdigar ƙididdigar ƙididdiga da ƙididdigar ƙididdiga) tare da sababbin cibiyoyi.
A cikin takardar fitarwa (3 Maris 2020), don gano mutanen da ke da cutar, dole ne a haɗa abubuwan da suka shafi tarihin ci gaban cutar tare da jerin alamun alamun biyu don samar da cikakkun bayanai, ko kuma dole ne a haɗa abubuwan alamun uku idan babu tarihin ci gaba:
Bayanan cutar: (1) tarihin tafiya ko zama a Wuhan da ke kewaye, da kuma al'ummomin da aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) tarihin haɗuwa da mutanen da ke da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai dacewa); (3) tarihin haɗuwa da mutanen da ke da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Alamun cutar sune: (1) kumburi/ko matsalolin numfashi; (2) tare da alamun cutar COVID-19; (3) yawan jini mai guba, raguwa, ko kuma raguwar yawan lymphocytes a farkon cutar.
Aikace-aikacen da aka kammala na ƙwayoyin cuta na ƙwayoyin cuta dole ne ya kasance tare da ƙididdigar alamun cututtuka ko alamun kwayar halitta kamar: (1) PCR da aka bincika yana da tasirin SARS-CoV-2; (2) nazarin kwayar cutar gaba ɗaya yana nuna daidaito mai yawa tare da sabbin ƙwayoyin cuta da aka gano; (3) akwai kwayar IgM daban da kwayar IgG zuwa SARS-CoV-2 a cikin gwajin kwayar halitta; ko kuma ba a sami sauyawar kwayar IgG zuwa SARS-CoV-2 ba, ko kuma ya karu da yawa ko 4 a lokacin da aka ba da magani fiye da lokacin da aka ba da magani.
Za mu iya yin gwajin PCR don kwayar nucleic acid a cikin huhu ko kuma ƙwayoyin jini a cikin zagaye na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
Tables na jini sun karu a karo na hudu (27 Janairu 2020) da na shida (8 Fabrairu 2020); kuma an samu karuwar sinadarin jini a karo na shida.
Wannan binciken ya dogara ne akan aikin masu bincike na gaba don gano kayan aikin gwajin nucleic acid wanda ya fi dacewa don bincike mai zurfi, tare da kwayoyin da aka ɗauka daga huhu da jini, wanda baya ga kasancewa mai rarrabewa, yana haifar da ƙwayoyin da ke haifar da cutar ta hanyar da ba a sani ba.
Bugu da ƙari, akwai ƙarin bayani game da abubuwan da suka faru da ke tunatar da mu mu kula da marasa lafiya waɗanda ke nuna alamun ko ba su nuna alamun ba.
Bugu da ƙari, ya kamata a bincika ci gaban Zhou et al., saboda an lissafa mutanen da ba su nuna alamun cutar a matsayin "mafi yawan yau da kullun".
Ya kamata a yi la'akari da tsarin lissafin ma'aikata a wuraren aiki da makarantu.
A ƙarshe, muna fatan cewa bayanan suna nan kuma suna ƙarfafa masu karatu suyi tunani game da su.
Don tantance "ƙwararrun masu amfani" da "ƙwararrun masu amfani", muna ba da shawarar ganowa da kuma bin sababbin ƙa'idodin ƙasashensu.
Ƙungiyarmu za ta sanar da ku game da sababbin hanyoyin da za mu iya taimaka wa.
Bangladesh ta ba da rahoton mutuwar COVID-19, NS
Kenya da Bangladesh sun samu sabbin mutuwar COVID-19 a cikin kwana daya.
Wannan shi ne mafi girman adadin a cikin kwanaki don cutar.
Daga Kenya, Cibiyar Kula da Cututtuka ta Kasa ta Bangladesh (IEDCR) ta sanar da adadin wadanda suka kamu da cutar wanda ya nuna mutane 114 sun kamu da cutar kuma 33 sun ci gaba da zama a gida.
Jimlar adadin da aka ruwaito ya kai 17.
A cikin wata sanarwa ta yanar gizo, shugaban IEDCR, Dr Meerjady Sabrina Flora, ya ce a cikin wadanda suka mutu akwai maza hudu da mace daya.
A cewar Dr Meerjady, mutane biyu sun kasance a cikin shekaru 60, biyu tsakanin 51 da 60 da kuma daya tsakanin 41 da 50.
Ya kuma ce biyu daga cikin wadanda suka kamu da cutar sun fito ne daga Dhaka.
Hukumar Lafiya ta Duniya (WHO) ta ayyana cutar COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in tsaro ya shaida wa kamfanin dillancin labarai na Anadolu Agency cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, shugaban hukumar yaki da cin hanci da rashawa ta Bengali, wanda ke kwance a asibitin Kuwait Maitree.
A ranar Asabar, a cikin wani bidiyo na kasa da kasa, Ministan Sufuri da Bridges na Bangladesh Obaidul Quader ya bayyana cewa za a dakatar da zirga-zirgar jama'a fiye da yadda aka tsara, har zuwa ranar Asabar mai zuwa.
Wannan zanga-zangar ta jama'a ta fara ne a ranar 26 ga watan Maris kuma za ta ci gaba har zuwa ranar Asabar, 4 ga watan Afrilu.
Ana samun wadataccen kayayyakin rayuwa, magunguna, man fetur da abinci.
An samu rahoton farko na cutar COVID-19 a Bangladesh a ranar 8 ga Maris, a cikin mutane biyu da suka dawo daga Italiya da mace ɗaya.
A ranar 19 ga watan Maris, dukansu uku sun ci abinci.
SARS-CoV-2 ya kai fiye da miliyan daya a duniya.
A ranar Alhamis, adadin mutanen da ke dauke da cutar SARS-CoV-2 a duniya ya kai miliyan daya, a cewar bayanan da Jami'ar Johns Hopkins ta fitar.
Aƙalla 52 dubu ne suka mutu sakamakon COVID-19, cutar da coronavirus ke haifarwa.
Lamarin ya kara tsananta a ranar da Malawi ta bada rahoton kamuwa da cutar ta coronavirus ta farko bayan Zambia ta fara kamuwa da cutar.
Koriya ta Arewa ta ce, a ranar Lahadi, tana daya daga cikin kasashen da ba su da cutar coronavirus a duniya.
A Kenya, Hukumar Lafiya ta Duniya ta sanar da cewa an samu mutum 1,051,635 da suka kamu da cutar, tare da mutum 79,332 da suka kamu da cutar a cikin awanni ashirin da hudu kafin karfe 10 na yammacin ranar 4 ga Afrilu (0800 UTC).
A Amurka, an sami sama da mutane 244 da suka kamu da cutar coronavirus, tare da mutuwar akalla 5,900.
Wani rahoto daga CBS ya ce, bisa ga bayanan jami'ar Johns Hopkins, akwai yiwuwar sama da mutane 1,000 da suka mutu a ranar Laraba sakamakon cutar coronavirus a Amurka.
A duk duniya, kasashe sun ba da sanarwar matakan rigakafin cutar a kan rigakafin.
A ranar Alhamis, Sergei Sobyanin, shugaban Moscow, ya kara da cewa ya kamata a dakatar da shi daga barin gida a ranar 1 ga Mayu.
A bangaren kasa baki daya, Shugaba Vladimir Putin ya bayyana cewa 'yan kasar Rasha za su ci gaba da karbar kudaden shiga ko da kuwa sun tafi aiki a ranar 30 ga watan Afrilu.
Majalisar zartarwar Portugal ta amince da tsawaita dokar ta baci na kwanaki 15; an yi zaben ne da kuri'u 215 da suka ce a'a, 10 suka ce a'a, kuma daya ya ce a'a.
Saudiyya ta sake tsawaita dokar hana fita a garuruwan Makka da Madina a wannan rana; a baya, dokar ta fara daga karfe 3 na yamma zuwa karfe 6 na yamma.
Thailand ta shirya dakatar da tashin jirage daga karfe 10 na dare zuwa karfe 4 na dare.
Gwamnan Ohio, Mike DeWine, ya sanar da gwamnati cewa jihar ta sake dawo da dokar hana fita daga gida a ranar 1 ga Mayu.
Kasuwancin kasuwanci a Ostiraliya ya rage yawan kuɗin shiga cikin gida.
A ranar Litinin da Asabar, kamfanonin kasuwanci na Australia Woolworths da Coles sun rage takunkumin sayar da kayan kwalliyar gida zuwa biyu da kuma kunshin guda daya a cikin kowane kantin sayar da kayayyaki a duk fadin kasar.
ALDI kuma ya fitar da takardar sayan kaya guda daya, a altine.
An kuma sanar da wannan bayanin ne a shafin Facebook na hukumar.
An bukaci ma'aikata su dauki matakan kariya daga cutar COVID-19 yayin da kuma karfafawa mutane su zauna a gida.
A ranar Laraba, Woolworths ya kuma rage yawan motocin da aka yi a cikin gidaje inda mutane ba sa yin kaya a wuri guda.
Wannan yarjejeniya ta biyo bayan takunkumin da aka yi a kan fakitoci hudu da aka gabatar a ranar 4 da 5 ga watan Maris.
Coles, a cikin sanarwar da ta fitar a ranar 8 ga Maris, ta ce takunkumin sayar da kayayyaki guda hudu, "kasuwancin da ake yi yanzu yana ta yin ta'addanci a tsakanin abinci guda", yana kiran wannan aikin "ba daidai ba", yayin da ALDI, ta hanyar sanarwar Facebook a ranar Talata, ta kira shi "ba daidai ba".
Mai sayar da Woolworths ya ce tallace-tallace sun yi "wuya sosai" a makon da ya gabata.
Kamfanin Costco na Canberra ya rage shi zuwa fakitoci biyu a makon da ya gabata.
Don rage takunkumi, Coles ta nemi fakitin kayan kwalliya a Coles daga masu siyar da kayayyakin, Woolworths ta nemi ƙarin kayan kwalliya, yayin da ALDI ta yanke shawarar shirya kayan don siyarwa a ranar Laraba.
Russell Zimmerman, shugaban kungiyar 'yan kasuwar Australiya, ya ce masu sayar da kayayyaki sun yi kokarin kara farashin kayayyakin, amma takunkumin da kasar ta dauka kan sayar da kayayyakin a gida ya hana hakan.
Ya yi tunanin cewa ya kamata a ƙara yawan farashin samar da kayayyaki, don haka mutanen da ba su da shi za su iya samun kansu, tare da ƙananan kayayyaki.
A ranar Talata, ALDI ta sanar da cewa saboda matsalar samar da kayayyaki, wasu kamfanoni ba za su iya yin abin da aka ce a ranar Laraba ba.
A cikin rahoton News.com.au, Dr Gary Mortimer, masanin harkokin kasuwanci a Jami'ar Fasaha ta Queensland, ya ce kamfanoni suna yin ayyuka da dare.
Ya san cewa ƙarancin ɗakin gida yana da kyau, wanda ke rage kayan aiki a cikin shagon, kuma, idan ya ƙare, ya bar ɗakin da ba shi da komai, wanda ya haifar da tunanin rashin amfani.
Cooes da Woolworths sun yi imanin [cewa] idan akwai abubuwa da yawa a cikin shagon, idan abubuwa kamar kayan aikin wanka da kayan aikin tsabtace jiki za a iya [sanya su] a wuri, za ku yi tsammanin za ku ji tsoro, Russell Zimmerman ya gaya wa ABC News.
Wani mai ba da labari na Who Gives a Crap ya ce a ranar Laraba cewa duk kayan aikin sun ƙare.
Kimberly-Clark, wanda ke kera Kleenex Toilet Tissue, da Solaris Paper wanda ke kera Sorbent, sun ce suna aiki 24/7 saboda akwai kayan aiki, a cikin News.com.au.
Domain.com, wani shafin yanar gizon sayen gidaje da kuma dandamali, ya sanar da cewa masu sayen gidaje suna ba da kyauta a farkon lokacin sayen a Melbourne, a lokacin da farashin ya rage saboda masu sayen ba su da lokaci mai yawa don hutu na ranar Lahadi.
Labaran Alhamis NT News, wata jarida da aka kafa a Darwin, tare da haruffa shida da aka gyara don shiga cikin ɗakin.
Kasuwanci sun yi ta ta yin tawaye don kawo karshen takunkumin, a cikin rahoton ABC Australia a ranar 3 ga Maris cewa ba su da wata hanyar hana mutane yin takunkumi.
Russell Zimmerman ya kara da cewa mutane suna amfani da wasu abubuwa da yawa, kamar su kayan shafawa, kayan wanki, kayan aiki, kayan wanki, da kayan aiki.
A waje da Australia, a ranar Lahadi da yamma, kamfanin dillancin labarai na Burtaniya Ocado ya gano cewa ya rage farashin kayayyakin da aka sayar a gidan Andres zuwa 12 a cikin kwantena biyu.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba ta duniya.
A ranar Talata, Hukumar Lafiya ta Duniya (WHO) ta ce annobar COVID-19, wanda kwayar cutar SARS-CoV-2 ta haifar, ya zama annoba.
Kodayake kalmar "tazarar duniya" tana nufin yadda cutar ta yadu a ƙasa, ba don ta yi tsanani a wani yanki ba, WHO ta ba da shawarar cewa yana da mahimmanci a sanar da gwamnatoci game da yadda cutar ta yi tsanani a wani yanki, WHO ta ba da shawarar cewa gwamnatoci su yi aiki:
Dukkanin kasashe na iya canza yanayin cutar.
"Ya kamata kasashen su gano, kimanta, magance, daidaita, bincika da kuma sanar da al'ummarsu game da martani", in ji Tedros Adhanom Ghebreyesus, Babban Jami'in WHO.
Muna damuwa da yadda za a iya samun ci gaba mai zurfi da kuma rashin amfani da mutane.
A cewar Dr. Tom Frieden, wanda ya jagoranci Cibiyar Kula da Cututtuka ta Amurka, cutar ba ta da kyau.
Ya ce, a cikin wani jawabi ga CNN a watan Fabrairu, bayan wasu shekaru, babu wani sabon kwayar cutar numfashi da aka gano daga gaggawa a ci gaba da yaduwar cutar a cikin kasar".
Ghebreyesus ya yi magana iri ɗaya, yana cewa, "ba mu taɓa fuskantar annobar da coronavirus ta haifar ba".
Ya ci gaba da cewa, "ba mu taba fuskantar wata annoba da za mu iya magance ta ba a lokaci guda".
Wani sabon yanayi a lokacin annobar ya biyo bayan shawarar da WHO ta bayar a watan Janairu na ayyana cutar a matsayin gaggawa ta duniya.
Shugaban Cibiyar Kula da Allergy da Cututtuka ta Amurka, Dr. Anthony Fauci, ya yi magana game da cutar kamar, "yi magana da gaskiya, kada ku zama masu laifi".
Tun daga ranar Litinin, kamfanin dillancin labarai na Associated Press ya ruwaito cewa akwai akalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, inda suka yi sanadiyar mutuwar mutane 4,600.
Cutar coronavirus ta 2019-20 ita ce cutar ta coronavirus ta 2019 (COVID-19), wacce ta haifar da cutar sankarar bargo mai saurin yaduwa da ake kira coronavirus 2 (SARS-CoV-2).
Cutar ta bayyana a Wuhan, China, a watan Disamba na 2019, ta zama dokar ta baci ta Majalisar Dinkin Duniya a ranar 30 ga Janairu, 2020, kuma ta zama annoba ta duniya a ranar 11 ga Maris, 2020.
Tun daga ranar 10 ga Afrilu, 2020, an sami rahoton kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe da yankuna 210, inda suka yi sanadiyar mutuwar mutane 97,000.
Waɗanda suka ci kuwa sun kai dubu ɗari uku da sittin da huɗu.
Yawan mutuwar ya kai kashi 4 cikin 100 a kasar Sin, amma ya kai 13.04 a Aljeriya da 0.08 a New Zealand.
Alamun cutar sun hada da kumburi, kumburi da kuma numfashi kamar tashin hankali.
Abubuwan da ke iya zama matsala sun hada da pneumonia da kuma ciwon huhu.
Lokaci daga kamuwa da cutar zuwa bayyanar cututtuka ya kasance kwanaki shida, amma ya kasance tsakanin kwanaki shida da goma sha huɗu.
Babu wani rigakafi ko magani da aka sani da zai iya kashe wannan kwayar cutar.
Farkon maganin ya shafi bayyanar cututtuka da rashin cutar. Hanyoyi masu taimako na rigakafin cutar sune wanke hannu, rufe baki lokacin da kake yin magana, yin hulɗa da mutane, kulawa da kuma nisantar mutane da ake tsammanin suna da cutar.
Gwamnatoci a duk duniya sun amsa ta hanyar hana tafiye-tafiye, keɓewar mutane, dokar hana fita daga gida, gudanar da bincike kan ofisoshin ma'aikata, da rufe wuraren aiki.
Cutar ta shafi rayuwar jama'a da tattalin arziki, cin hanci da rashawa, shirye-shiryen yawon shakatawa, siyasa da wasanni, da kuma rage yawan abinci a cikin gida saboda tsoron cewa wasu za su iya kawar da su.
Makarantu da jami'o'i sun rufe a ko'ina cikin kasar ko kuma a yankuna a kasashe 193, wanda ya shafi kashi 99.4 na yawan daliban duniya.
Bayanai game da cutar sun bazu a sararin samaniya, kuma sun haifar da matsaloli da yawa da suka haɗa da cin zarafin ko kuma ƙin yarda da mutanen China, wasu ƙasashen Gabas ta Tsakiya da waɗanda suka yi ƙaura zuwa kudu maso gabashin Asiya, da sauransu ta hanyar yankunan da ke da ƙarancin cutar.
Saboda raguwar sufuri da rufe masana'antu, akwai raguwar iskar gas da kuma iskar carbon.
Jami'an kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun bayar da rahoton kamuwa da cutar sankarar huhu a ranar 31 ga Disamba, 2019, kuma an fara wani bincike a farkon Janairu, 2020.
Yawancin cututtukan sun faru ne ta hanyar Kasuwar Kayan Abinci na Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan K
Kwayar cutar ta haifar da cutar SARS-CoV-2, sabon kwayar cutar da aka gano wanda ya shafi kwayar cutar coronavirus, pangolin coronavirus, da SARS-CoV. An gano mutum na farko da ke da alamun cutar a ranar 1 ga Disamba, 2019, kuma wannan mutumin ya kasance mai sauƙin kamuwa da cutar a cikin dabbobi da kuma ido.
A farkon kararraki shida da aka ruwaito a watan Disamba na 2019, kashi biyu cikin uku sun kasance masu alaƙa da cutar sankara.
A ranar 13 ga Maris, 2020, wani rahoto da muka sani a South China Morning Post ya ce akwai wani sabon kamuwa da cutar da ya dawo a ranar 17 ga Nuwamba, 2019, wani mutum mai shekaru 55 a lardin Hubei, wanda zai iya zama na farko.A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, yayin da sabbin cututtuka suka ragu a China amma suka kara tsananta a Italiya, Iran, da Koriya ta Kudu, adadin wadanda suka kamu da cutar a wajen kasar Sin ya zarce adadin wadanda suka kamu da cutar a kasar Sin a karon farko.
Akwai wasu kungiyoyi da ba a bayyana su ba, musamman ma a cikin wadanda ke da alamun cutar.
A ranar 26 ga watan Fabrairu, an samu adadin wadanda suka kamu da cutar a tsakanin matasa masu shekaru 19 zuwa sama, wanda ya kai kashi 2.4% na wadanda suka kamu da cutar a duniya. Shugaban hukumar kula da ilimin ilimin dan adam ta Burtaniya, Patrick Vallance, ya yi hasashen cewa kashi 60% na jama'ar Ingila dole ne su kamu da cutar kafin a sami ingantacciyar kariya a cikin al'umma.
Masu cutar sune adadin mutanen da suka gwada tabbatacce na COVID-19, kuma waɗanda ba a rarraba su ba kamar yadda aka lissafa a cikin bayanan gwamnati.
A ranar 23 ga watan Maris, babu wata kasa da ta kamu da cutar da ta fi kashi 3 cikin 100 na yawan jama'arta, kuma kasashen sun cimma manufar gwamnati ta kamu da wadanda ke fama da cutar a wani lokaci, kamar Italiya, Netherlands, Spain, da Switzerland.
Rahoton da aka fitar a ranar 16 ga watan Maris ya gano cewa, a kasar Sin, a ranar 23 ga watan Janairu, kashi 86% na wadanda suka kamu da cutar COVID-19 sun kamu, kuma wadanda ba a samu ba sun kasance a matsayin masu kamuwa da cutar a kashi 79% na wadanda ba a samu ba.
Rahoton da aka fitar a ranar 30 ga watan Maris ya nuna cewa adadin wadanda suka kamu da cutar a Italiya ya fi na wadanda ba a sanar da su ba.
Sakamakon kimantawa na farko (R0) na COVID-19 shine 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka ta yi ya nuna cewa zai iya kaiwa 5.7.
Yawancin mutanen da ke da COVID-19 suna da rashin abinci.
A cikin masu shan nono, lokacin fara bayyanar cututtukan cutar yana tsakanin kwanaki 6 zuwa 41, kuma yawanci a cikin kwanaki 14.
Tun daga ranar 10 ga Afrilu 2020, kusan mutane 97,000 ne suka mutu sakamakon COVID-19.
A China, tun daga ranar 5 ga watan Fabrairu kusan kashi 80% na mutuwar sun shafi waɗanda shekarunsu suka wuce shekaru 6, kuma kashi 75% sun kasance daga wasu cututtuka kamar cututtukan zuciya da ciwon sukari. Rahoton gwamnati game da mutuwar COVID-19 ya ƙunshi yawancin mutanen da ba su da cutar COVID kamar yadda aka lissafa a cikin bayanan gwamnati.
Yawan mutuwar COVID-19 na iya zama ƙasa, musamman idan ba a haɗa da waɗanda ba su mutu ba tare da gwaji ba, misali, a gida, a asibiti, da sauransu.
Bayanai da aka fitar daga Italiya sun gano cewa adadin mutuwar da aka samu a lokacin annobar ya ninka na COVID-19 sau 4-5.
Wani mai ba da rahoto na Hukumar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ya lura cewa "Mun san cewa [adadin mutuwar da aka tabbatar] ya yi kasa", wasu rahotanni sun kuma bayyana cewa Amurka ta sami raguwa a cikin annobar cutar, kamar yadda cutar H1N1 ta yi a shekarar 2009.
An fara gano cutar a waje da China a ranar 1 ga Fabrairu a Philippines, kuma an sami mutuwar farko a waje da Asiya a Faransa a ranar 14 ga Fabrairu.
A ranar 28 ga watan Fabrairu, a wajen kasar Sin, an samu mutuwar fiye da goma sha biyu, duk wadanda aka samu a Iran, Koriya ta Kudu, da Italiya.
A ranar 13 ga watan Maris, sama da kasashe da yankuna arba'in sun sanar da cewa sun shiga kungiyar hadin gwiwa ta kasa da kasa a Antarctica.
Wadannan ƙididdigar sun bambanta da wuri da lokaci, da kuma yawan gwaje-gwaje, ingancin asibiti, yanayin jiyya, lokaci daga farkon bayyanar cutar, da kuma bambance-bambancen jama'a kamar shekaru, tsufa, da lafiyar jiki.
Dangane da bayanan Jami'ar Johns Hopkins, yawan mutuwar cutar a duniya ya kai 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu 2020.
Adadin ya bambanta da yankin.
A kasar Sin, yawan mutuwar mutum ya ragu daga 17.3% (ga wadanda suka fara kamuwa da cutar daga 1-10 ga Janairu 2020) zuwa 0.07% (ga wadanda suka fara kamuwa da cutar bayan 1 ga Fabrairu 2020).Sauran matakan sun hada da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka bincika sun mutu saboda wata cuta da kuma yawan mutuwar mutum (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (da kuma wadanda za a iya ganewa) da suka mutu saboda wata cuta.
Wadannan ƙididdigar suna tafiya tare da lokaci kuma suna biye da al'umma don cutar ta hanyar maganin cutar.
Yawancin masana sun yi ƙoƙarin rarraba waɗannan ƙididdigar a cikin al'umma.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta gano cewa yawan mutuwar da ake samu daga cutar ta duniya ya kai tsakanin 0.1% da 0.39%.
Abubuwan da ke ƙasa sun dace da sakamakon binciken farko na COVID-19 a Jamus, kuma nazarin ƙididdigar ya bincika tsarin ƙididdigar ƙididdigar CFR.
WHO ta ce za a iya dakatar da cutar a kasar.
Ba a iya tantance inda cutar ta kai ba kuma za ta iya bambanta da yankin.
Maciej Boni na Jami'ar Jihar Pen, ya ce, a wani bangare, cutar da ke haifar da cutar ta fi tsayi, kuma tana raguwa idan cutar ta ƙare tare da lalacewar da ke tattare da ita.
Amma fa, ba zai yiwu a yi sha'awar kome ba, sai dai a yi sha'awar mai-jinki".
Babban jami'in kula da lafiya na gwamnatin kasar Sin Zhong Nanshan ya ce "Zwing zai iya kawo karshen cutar" idan kasashen duniya suka yi aiki tare don bin shawarar WHO kan hanyoyin da za a iya hana yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Kiwon Lafiya da Magunguna ta London ya ce SARS-CoV-2 "zai iya zama sananne, mai ban mamaki a cikin shekaru ko biyu".
A cewar wani binciken da kwalejin Imperial ta gudanar wanda Neil Ferguson ya wallafa, haihuwar jama'a da kuma wasu hanyoyin da za a bi sun fara ne "a lokacin da aka samu rigakafin cutar (wannan ya kai watanni 18 ko sama da haka)".
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina tsammanin cewa wannan kwayar cutar, saboda za ta iya zama mai saurin kamuwa da cuta, ba za ta iya zama mai saurin kamuwa da cuta ba, kuma za ta iya zama mai saurin kamuwa da cuta a kowace shekara".
Rashin ƙarfin kwayar cutar zai dogara ne akan yiwuwar jiki tare da kwayar cutar da kuma sauye-sauyen ta.
Alamar COVID-19 na iya zama kamar haka kuma mutanen da ke kamuwa da cutar ba za su iya nuna alamun ba.
Abubuwa biyu da suka fi faruwa sune zazzabi (88%) da kuma jin zafi (68%).
Abubuwan da ba a saba gani ba sun hada da rashin ƙarfi, kumburi, rashin jin daɗi, rashin numfashi, ciwon jiki, ciwon hanci da ciwon kai, kumburi, kumburi, zubar da jini, kumburi, ko kuma cututtukan fata. WHO ta ce kusan mutum ɗaya a kowace shekara yana fama da ciwon kumburi da kuma wahalar numfashi.
Hukumar Kula da Cututtuka ta Amurka (CDC) ta lissafa alamun cutar kamar su ciwon huhu da kumburi, ciwon zuciya mai ci gaba ko kumburi, tari, ciwon zuciya da kumburi, fuska da hanci suna canzawa; ya kamata a sanar da likitocin likita idan akwai alamun cutar. Hakanan, cutar na iya kaiwa ga ciwon huhu, cututtukan numfashi, sepsis, cutar cututtukan jini da mutuwa.
Wasu daga cikin wadanda suka kamu da cutar na iya nuna alamun rashin lafiya da kuma sakamakon gwajin da ke tabbatar da cutar, kuma masu bincike sun nuna cewa wadanda suka saba da cutar ya kamata a kula da su kuma a gwada su don gano cutar.
China ta yi hasashen cewa yawan mutanen da ke nuna alamun cutar zai fara daga kashi 44 cikin dari.
Yawancin lokaci na rashin lafiya (lokacin tsakanin kamuwa da cutar da farawa) yana daga kwanaki 14 zuwa kwanaki 6; mafi yawan lokuta kwanaki shida.Dangane da sanarwa da aka bayar, yawan mutanen da ke da cutar COVID-19 da ba za a iya magance su ba ya kusan kashi 30% na farko kuma ya ragu zuwa 15% daga baya.
Har yanzu ba a samu wasu bayanai kan yadda cutar za ta yadu ba.
Cutar tana yaduwa ne da farko ta hanyar hulɗa da jijiyoyin da ke fitowa daga ihu, hanci, ko magana; kuma hulɗar tana kusan a cikin mita 1 zuwa 2 (ƙafafu 3 zuwa 6).
Bincike ya nuna cewa tsuntsayen da ke da tsayi suna iya yin tafiya mai nisa daga mita 4.5 (mita 15) zuwa mita 8.2 (mita 27).
Wasu sun ce za a iya yada kwayar cutar ta hanyar ƙananan ƙwayoyin cuta da ke cikin iska, wanda zai iya yin numfashi a lokacin da ake yin numfashi.
Za a iya samun saurin cutar ta bakin ko kuma ta hanci a cikin mutane da ba su da lafiya kuma za su iya kaiwa ga kowa.
Sauran hanyoyin kiwon lafiya kamar su watsawa da kuma numfashi na zuciya (CPR) na iya haifar da ruwa a cikin numfashi wanda zai iya shiga cikin iska kuma ya yada a sama.
Hakanan yana iya faruwa idan mutum ya taɓa wani dabba da ke da wannan cutar, kamar launin fata, wanda ya ɓoye idanu, hanci, ko bakin dabba.
A wasu lokuta, ana iya yada matsalolin ta hanyar hayaniya, amma wannan lokaci yana da yawa.
Gwamnatin kasar Sin ta yi watsi da cewa ana iya yada SARS-CoV-2 ta hanyar hanci da kuma baki. Kwayar cutar ta fi tsanani a cikin kwanaki uku na farko na bayyanar cututtuka, kodayake ana iya samun yaduwa kafin bayyanar cututtuka da kuma a ƙarshen yanayin cutar.
An gano mutanen da suka kamu da cutar kwanaki uku kafin bayyanar cututtuka wanda ke nufin cewa za su iya yaduwa kafin bayyanar cututtuka.
Kadan daga cikin cututtukan da aka gano a cikin lab sun nuna alamun cutar a cikin takardun su, amma an tabbatar da yaduwar cutar ba tare da alamun cutar ba a wasu ƙasashe ta hanyar bincike.
Hukumar Kula da Cututtuka ta Turai (ECDC) ta ce idan har ba a yi la'akari da yadda cutar ke yaduwa ba, mutum ɗaya na iya kamuwa da mutane biyu ko uku.
Mafi yawan lokuta, ana iya gano kwayar cutar a cikin kwanaki uku akan roba (polypropylene) da 304 mai laushi, a rana ɗaya akan takalma, kuma a cikin kwanaki huɗu akan azurfa.
Wannan, duk da haka, ya bambanta dangane da yanayin zafi da zafi. Wasu dabbobin gida da na daji sun kasance masu kamuwa da COVID-19.
Babu tabbacin cewa ana iya yada cutar ta hanyar nama, kodayake hukumomin Burtaniya sun ba da shawarar kada a yi amfani da ruwan da aka yi amfani da shi, kamar ta hanyar shan wasu shanun da ke da cutar.
Cutar cutar sankarar huhu ta coronavirus 2 (SARS-CoV-2) ita ce sabuwar kwayar cutar, wacce aka fara ganowa a cikin mutane uku da ke fama da cutar huhu da kuma wasu mutane shida da suka kamu da cutar sankarar huhu a Wuhan.
Sabbin cututtukan SARS-CoV-2 sun haifar da kwayar cutar coronavirus a cikin daji. A waje da jikin mutum, sabulu yana kashe kwayar cutar, wanda ke rufe jikin mutum. SARS-CoV-2 yayi kama da SARS-CoV na farko.
An yi imanin cewa ya samo asali ne daga dabbobi.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar ta Corona ta kasance mai kama da kwayar cutar Betacoronavirus, a cikin wani karamin rukuni na Sarbecovirus (B-type) da kuma kwayoyin da suka fito daga tsuntsaye biyu.
An gano shi a kashi 96% na kwayar cutar da kuma wasu kwayoyin cutar (BatCov RaTG13).
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambancin amino acid guda daya a tsakanin tsarin kwayoyin halittar dan adam da kuma na pangolin.
A halin yanzu, binciken da aka yi na kwayar halitta ya nuna cewa kashi 92% na kwayar halitta tana da alaƙa da kwayar cutar pangolin da SARS-CoV-2, wanda ya isa ya nuna cewa pangolin ne ke da matsakaicin ajiya.
Ana iya gano cutar ta hanyar kwayar cutar ta hanyar alamun, kodayake ana iya samun tabbacin ta hanyar nazarin maganin polymerase chain reaction (rRT-PCR) na ruwa.
Wani bincike da aka yi a Wuhan wanda ya gwada PCR da CT ya nuna cewa CT ya fi PCR tasiri, ko da yake a ƙasa, kuma yawancin alamun hoto suna wucewa ta hanyar cutar pneumonia da cututtuka.
Tun daga watan Maris na shekarar 2020, Kwalejin Kula da Maganin Maganin Amurka ta bukaci "a yi CT guda uku don gano ko kuma fara gano cutar COVID-19".
WHO ta fitar da takardu da dama na gwajin RNA don SARS-CoV-2, wanda na farko ya fito ne a ranar 17 ga Janairu.
Wannan gwajin yana aiki tare da nazarin polymerase chain reaction (rRT-PCR) daga baya.
Wannan cutar na iya yaduwa ta hanyar maganin huhu da jini.
Ana samun samfurori a cikin 'yan sa'o'i a rana.
Ana yin gwajin ne ta hanyar hanci ko kuma ta bakin baki. Yawancin cibiyoyin bincike da cibiyoyin kiwon lafiya suna gwagwarmaya don samar da kayan aikin gwajin jini, wanda ke nuna rigakafi.
Tun daga ranar 6 ga Afrilu, 2020, babu wani daga cikinsu da ya tabbatar da cewa zai iya amfani da shi a duk duniya.
A Amurka, Cellex ta samar da wani tsarin gwajin jini wanda aka amince da shi don amfani a dakunan gwaje-gwaje na zamani.
Hotunan rediyo da kuma CT (computed tomography) na mutanen da ke nuna alamun sun haɗa da canza yanayin yanayin yanayin yanayi a cikin duhu kuma ba tare da hasken rana mai yawa ba a cikin iska.
Kamfanin Radiological na Italiya yana tattara bayanai daga kasashe daban-daban kan batun ta hanyar daukar hoton marasa lafiya da suka kamu da cutar.
Saboda rashin daidaito kamar sauran cututtuka kamar adenovirus, hoto ba tare da gano PCR ba yana da iyakance don gano COVID-19.
Wani babban bincike a kasar Sin ya kwatanta sakamakon CT na zuciya da PCR kuma ya nuna cewa ko da yake ana iya gano cutar ta hanyar hanzari, amma ta hanyar hanzari da kuma gaggawa, wanda ya tabbatar da ingancinsa a matsayin kayan aikin bincike a wuraren da ake kamuwa da cutar.
An kirkiro wani tsari da ake kira convolutional neural networks don gano alamun hoto na kwayar cutar ta hanyar rediyo da CT.
Hanyoyi na hana yaduwar cutar sun hada da yin wanka, wanke hannu, hana taɓa idanu, hanci, ko baki da hannayen da ba su da kyau, da kuma yin taushi ko tausa a cikin takarda da kuma sanya takarda a cikin mai tsabta.
An shawarci mutanen da ke da cutar su sanya abin rufe fuska a cikin jama'a.
Ka'idojin haihuwa da na al'umma sun kuma bada shawara kan hana yaduwar cutar. Gwamnatoci sun rage ko kuma sun bada shawarar dakatar da zirga-zirga zuwa ko daga kasashen da ke fama da cutar.
Koyaya, kwayar cutar ta kai ga yaduwar jama'a a cikin yankuna da yawa na duniya.
A cewarsa, cutar tana yaduwa a cikin al'umma, kuma wasu mutane ba su san lokacin da kuma yadda aka kama su ba. Likitocin da ke kula da wanda ke da cutar sun shawarci yin amfani da matakan kariya, dabara, da rufe fuska. Binciken ganowa shine muhimmin mataki ga hukumomin kiwon lafiya don gano cutar da kuma hana ƙarin watsawa.
Yin amfani da bayanan wayar salula ta hanyar gwamnatoci don wannan aikin ya shafi batutuwan tsaro, tare da Amnesty International da wasu sama da 100.
Akwai aikace-aikacen wayar hannu da yawa da ake da su ko kuma aka ba da shawarar su don amfani da kai, kuma tun daga 7 ga Afrilu 2020, sama da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙ
Masu amfani suna cike da bayanai game da kasancewa tare da wani wanda ya kamu da cutar COVID-19. Sauran bayanan da suka shafi rigakafin cutar; misali, wanke baki da wanke baki da ruwan wanka ba su da tasiri.
Babu rigakafin COVID-19, kodayake ana aiki da yawa kan gano shi.
Wanke hannu yana da mahimmanci don hana yaduwar cutar.
CDC ta ba da shawarar cewa jama'a su wanke hannayensu da sabulu da ruwa na akalla sakan ashirin, musamman bayan sun shiga cikin gida ko kuma bayan wanke hannu; kafin shan nono; da kuma bayan sun kamu da cutar zazzaɓi, tari, ko tari.
Wannan saboda a waje da jikin mutum, sabulu yana kashe kwayar cutar, wanda ke rufe jikin mai cutar.
CDC ta kuma bada shawarar yin amfani da wanki mai wanki tare da akalla kashi 60% na barasa idan sabulu da ruwa sun kasance a wurin.
WHO ta ba da shawarar jama'a su guji taɓa idanu, hanci, baki da hannayen da ba su da tsabta.
Za a iya tsabtace farfajiyar ta hanyoyi daban-daban (a cikin minti daya idan an wuce kayan a kan farfajiyar abinci mai tsabta), kamar 62-72% ethanol, 50100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine.
Sauran hanyoyin, kamar su benzalkonium chloride da chrohexidine gluconate, ba su da ƙarfi sosai.
CDC ta ba da shawarar cewa idan wani yana da cutar COVID ko kuma yana da cutar a wani wuri kamar wurin aiki ko asibiti, duk wuraren kamar ofisoshi, wuraren shiga, wuraren shakatawa, umarni na rarraba, takardun shaida na gani, takardun shaida, telecommunications, da kuma umarni na ATM da mai cutar ke amfani da su ya kamata a kula da su.
Hukumomi sun ba da shawarar cewa mutane su rufe bakinsu da hancinsu da hannu ko kuma takalmin wanka lokacin yin gumi ko fitsari, kuma su cire duk wani takalmin da aka yi musu.
Ana ba da shawarar sanya abin rufe fuska ga mutanen da ke da cutar, saboda sanya abin rufe fuska na iya rage kumburi da rashin jin daɗi yayin yin hanci, magana, hanci, ko yin hanci.
WHO ta fitar da bayanai kan inda kuma yadda ake sanya abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin cutar a Jami'ar Leeds, "Samun abin rufe fuska na iya rage yiwuwar mutane su taba fuskokinsu, wanda shine farkon hanyar kamuwa da cutar ba tare da wanke su da kyau ba".
WHO ta ba da shawarar sanya abin rufe fuska ga mutanen da ba su kamu da cutar ba idan har za a iya gano cutar, kamar masu kula da wani wanda ke da cutar COVID-19, ko kuma idan an san cewa sanya abin rufe fuska na iya hana mutane taɓawa fuska.
Kasashe da dama sun fara sanya takunkumin rufe fuska a cikin jama'a.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska da aka yi da tufafi. China ta ba da shawarar sanya abin rufe fuska da aka yi da tufafi da aka yi da tufafi bayan an yi musu rauni, a lokacin da suke kusa da (mita 1 (ƙafafu 3) ko kusa) tare da wasu mutane.
Hong Kong ta ba da shawarar sanya abin rufe fuska a yayin da ake yin motoci tare da wasu mutane ko kuma a cikin motocin jama'a.
Hukumomin yaduwar cutar na Thailand suna ba da shawarar mutane su sanya abin rufe fuska a gida kuma wannan shine abin da ya faru.
Jamhuriyar Czech da Slovakia sun hana fita waje ba tare da sanya abin rufe fuska ba ko rufe baki da hanci.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa da kowa ya sanya abin rufe fuska yayin tafiya a cikin jama'a don kare kansa da sauran mutane.
Gwamnatin Austria ta bukaci duk wanda ya shiga shagon da ya saka abin rufe fuska.
Isra'ila ta umarci dukan jama'a su rufe fuskokinsu.
Taiwan, wacce ke samar da kayan rufe fuska miliyan 10 a tsakiyar watan Maris, ta bukaci masu sayar da motoci da motoci da ke zirga-zirgar birane su sanya kayan rufe fuska daga ranar 1 ga Afrilu.
Panama ta bukaci a sanya takunkumin rufe fuska a duk lokacin da mutum ya fita waje, kuma tana ba da shawarar yin takunkumin rufe fuska a gida ga wadanda ba za su iya sayen takunkumin rufe fuska ba.
Ana amfani da kayan rufewa a Zapong, Koriya ta Kudu, Malaysia, da Singapore.
Rashin rigakafin jama'a (wanda aka fi sani da rigakafin jiki) ya shafi tsarin rigakafin cutar don rage yaduwar cutar ta hanyar haɗuwa da mutane.
Matakan sun hada da keɓewa; dakatar da tafiye-tafiye; da rufe makarantu, ofisoshi, gidajen wasanni, gidajen wasan kwaikwayo, ko kantunan sayar da kayayyaki.
Mutane na iya amfani da hanyoyin yin wanka ta hanyar zama a gida, rage yawan tafiye-tafiye, guje wa wuraren da jama'a ke taruwa, yin wanka ba tare da yin wanka ba, da kuma yin wanka.
Yawancin hukumomi suna kira ko bayar da shawarar yin zaman lafiya a yankunan da cutar ta shafa.
Adadin mutanen da za su iya yin taro a cikin gida guda da hukumomin gwamnati da na Amurka suka tsara ya ragu daga mutane 250 (idan ba a yaduwar COVID-19) zuwa mutane 50, daga baya zuwa 10.
Jamus ta hana yin taro sama da mutane biyu bayan 22 ga Maris, 2020. Wadanda shekarunsu suka wuce shekaru biyu da waɗanda ke da wasu cututtuka kamar su ciwon sukari, cututtukan zuciya, cututtukan huhu, ciwon jini da hawan jini, tsarin rigakafi mara kyau suna da damar kamuwa da cutar da kuma rikice-rikice kuma CDC ta ba da shawarar su zauna a gida kamar yadda zai yiwu a wuraren taruwa na jama'a. A ƙarshen Maris, 2020, WHO da ma'aikatan kiwon lafiya daban-daban sun fara canza kalmar "ranar jama'a" zuwa "ranar jama'a", suna ba da shawarar cewa a rage haɗuwa da jima'i a cikin al'umma, ta hanyar umarni ko umarni.
Kalmar "mutanen gida" ta haifar da keɓancewa a cikin al'umma, maimakon ƙarfafa su su kasance tare da wasu ta wasu hanyoyi. Wasu hukumomi sun gabatar da wasu hanyoyin kiwon lafiya a cikin bincike a lokacin annobar.
Wannan ya hada da kuskuren kasancewa tare da wani wanda ba shi da kwayar cutar ko alamun cutar.
An ba da shawarar keɓewa da kuma kula da kai ga mutanen da ke da cutar COVID-19 da waɗanda ake tsammanin suna da cutar.
Cibiyoyin kiwon lafiya sun ba da shawarar keɓewa. Gwamnatoci sun ba da shawarar ko sun ba da shawarar keɓewa ga mutanen da ke cikin yankunan da cutar ta shafa.
Rahotanni na keɓewa sun fito ne daga ƙungiyoyin da ke da damar yin amfani da su.
Mutanen da suka kasance tare da wanda ke dauke da cutar ta COVID-19 da kuma waɗanda suka yi tafiya ta dogon lokaci a cikin ƙasa mai cutar ko yankin da ke yada cutar, dole ne a keɓe su na tsawon kwanaki 14 daga lokacin da suka kasance a wurin cutar.
Hanyoyin da za a iya hana cutar su ne warewa ko kuma ragewa, da kuma ragewa.
Hanyar da ta dace na keɓewa a farkon cutar ta ƙunshi gano waɗanda suka kamu da cutar da kuma samar da hanyoyin da za a iya sarrafa cutar da kuma allurar rigakafi don hana cutar daga yaduwa ga sauran al'umma.
Idan ba za a iya dakatar da yaduwar cutar ba, dole ne a mayar da matakan zuwa matakin ragewa: an dauki matakan don rage yaduwar cutar da rage tasirinsa a kan manufofin kiwon lafiya da zamantakewa.
Za a iya ɗaukar haɗin haɗin biyu na ƙarewa da raguwa a lokaci guda.
Rashin rigakafi ya kuma zama hanya mafi inganci don cimma nasarar rage cutar ta hanyar rage yawan cutar zuwa kashi 1%.
Wannan yana rage wahalar ma'aikatan kiwon lafiya kuma yana ba su ɗan gajeren lokaci don allurar rigakafi da magani.
Taimako na yau da kullun da ma'aikatan kiwon lafiya zasu iya yi game da cutar sun haɗa da matakan kariya na mutum, kamar wanke hannu, sanya abin rufe fuska, da kuma nisantar da kai; matakan zamantakewar jama'a kamar rufe makarantu da hana jama'a yin amfani da hanyoyin; ƙarfafa jama'a su guji shiga da yin amfani da waɗannan matakan; da kuma matakan kiyaye muhalli kamar tsabtace gidaje. Sauran matakai masu mahimmanci na hana yaduwar cutar sun kasance a cikin China a lokacin annobar, kamar su sanya birane a cikin layi da kuma hana zirga-zirgar jiragen sama.
Wasu jihohi sun dauki wasu matakai don rage yaduwar cutar a cikin birni.
Koriya ta Kudu ta kafa dokar hana yin gwajin jama'a da kuma ware mutane, kuma ta kafa matakan kiyayewa kan bayyanar da wadanda suka kamu da cutar.
Singapore ta samar da kudade don taimakawa wadanda suka kamu da cutar da kuma wadanda suka keɓe kansu da kuma taimakawa wadanda ba su yi hakan ba tare da wasu takunkumi.
Taiwan ta kara fitar da kayan rufe fuska da kuma hana adana kayan kiwon lafiya. Kwatantawar da aka yi tsakanin Burtaniya da Amurka ta nuna cewa rage (rage amma ba hana yaduwar cutar) da rage (hana yaduwar cutar) suna da matukar wahala.
Manufofin ragewa da kuma ingantawa na iya rage yawan masu kula da lafiya zuwa 2/3 da mutuwa a rabi, amma duk da haka dubban mutane suna shan magani ba tare da sun sami damar yin hakan ba.
Ya kamata a yi la'akari da cewa a lokacin da cutar ta bayyana a cikin al'umma (ko kuma lokacin da aka sami rigakafin, idan wannan shine farkon fitowar), ana iya mayar da cutar zuwa yankin.
Yin rigakafin cutar yana haifar da asarar kuɗi ga jama'a da ƙasa baki ɗaya.
Babu wani magani da aka sani da zai iya kashe COVID-19, amma akwai wasu hanyoyin da suka dogara da doka, wanda ya hada da gwajin magani da aka kammala.
Shan magungunan cutar zazzabin cizon sauro, shan giya, da hutawa na iya rage alamun cutar.
Idan an gano cutar, maganin ruwa, maganin jini, da taimakon numfashi na iya taimakawa.
Yin amfani da steroids na iya zama sakamako.
An bincika wasu abubuwa masu tasiri a cikin maganin wasu cututtukan ƙwayoyin cuta idan za su iya zama masu tasiri a cikin maganin COVID-19.
WHO ta ce akwai "magungunan gida da na gida wadanda za su iya rage alamun cutar SARS-CoV-19".
Kwayoyin kiwon lafiya na yau da kullun da aka tsara don taimakawa COVID-19 sun kasance a cikin wasu kungiyoyin WHO a matsayin hanyar amsa cutar.
ECDC da hukumomin yankin Turai da WHO sun gabatar da shawarwari ga asibitoci da cibiyoyin kiwon lafiya don samar da kayayyaki a wurare da yawa, tare da rage ƙarfin dakunan gwaje-gwaje ta hanyar gwajin COVID-19, daidaita tsarin zaɓin inda ya dace, rarraba da kuma kula da marasa lafiya da ke da cutar COVID-19 a cikin tsari, da inganta tsarin kiwon lafiya ta hanyar horar da ma'aikata da kuma ƙara yawan umarnin tsabtace iska da gado.
Akwai bayanai daban-daban game da inda mai cutar farko (wanda ya ce mai cutar farko) zai iya tashi.
An gano farkon cutar ta coronavirus a ranar 1 ga Disamba, 2019 a Wuhan, Hubei, China.
A cikin watan, adadin masu kamuwa da cutar coronavirus a Hubei ya ragu sosai.
An gano cutar ne a kasuwar abinci mai gina jiki ta Huan, wanda ya shafi naman alade da kuma naman ido, kuma wani bayani ya nuna cewa cutar ta samo asali ne daga daya daga cikin wadannan nau'o'in: , ko kuma a wasu kalmomi, ya kamata a ce, ta samo asali ne daga naman alade. An gano cutar a cikin fufu da aka yi amfani da ita a ranar 26 ga watan Disamba kuma ana kula da ita ne ta hanyar likita Zhang Jixian a Asibitin lardin Hubei, wanda CDC ta sanar a Wuhan Jianghan a ranar 27 ga watan Disamba.
A ranar 30 ga watan Disamba, wata kungiyar likitoci a Wuhan Central Hospital ta sanar da abokan aikinta game da "tsarin kwayar cutar SARS".
Wasu likitoci guda uku, Li Wenliang, sun zargi 'yan sanda da yin harbi, yayin da wani, Ai Fen, ya yi garkuwa da shi daga jami'an tsaro don kare hakkin jama'a.
Cibiyar Kiwon Lafiya ta lardin Wuhan daga baya ta fitar da sanarwar jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An gabatar da wasu cututtuka na cutar a Wuhan a matsayin farkon gwajin a farkon watan Janairu.A farkon cutar, adadin masu kamuwa da cutar ya ninka sau biyu bayan kwana bakwai da rabi.
A farkon da tsakiyar watan Janairu, kwayar cutar ta bazu zuwa wasu lardunan kasar Sin, tare da taimakon tafiye-tafiyen bikin Sabuwar Shekara a Wuhan wanda shine cibiyar tafiye-tafiye da hanyoyin kiwon lafiya a can.
A ranar 20 ga watan Janairu, kasar Sin ta bayar da rahoton sabbin mutane 140 a rana daya, mutane biyu a Beijing da daya a Shenzhen.
Sabbin bayanan gwamnati sun nuna cewa, mutane 6,174 ne suka kamu da cutar tun daga ranar 20 ga watan Janairun 2020.Tun daga ranar 26 ga watan Maris, Amurka ta zarce China da Italiya da yawan wadanda suka kamu da cutar a duniya.Tun daga ranar 9 ga Afrilu, 2020, sama da mutane miliyan 1.63 ne suka kamu da cutar a duniya; sama da mutane 97,000 suka mutu kuma sama da 364,000 suka kamu da cutar.
Kimanin kasashe 200 da yankuna sun sami akalla mutum daya da ya kamu da cutar.
Sakamakon annobar a Turai, kasashe da dama a yankin Schengen sun sami cikas saboda rashin daidaito kuma sun kafa matakan kiyaye kan iyakoki.
Manufofin ƙasa sun haɗa da ƙa'idodin keɓewa kamar su keɓewa (wanda aka sani da taron gida, taron hutu na gida, ko ƙuntatawa na fita waje) da ƙuntatawa.A ranar 2 ga Afrilu, mutane miliyan 300, ko kusan kashi 90% na yawan jama'a, suna cikin gida a Amurka, fiye da mutane miliyan 50 da aka hana su fita daga Philippines, kusan mutane miliyan 50 suna cikin gida a Afirka ta Kudu, kuma mutane biliyan 1.3 suna cikin gida a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya sun kasance a cikin gida, wanda ya karu zuwa biliyan 2.6 a cikin kwanaki biyu, wanda ya kai kusan kashi ɗaya bisa uku na yawan jama'ar ƙasar.
An gano mutum na farko da ya kamu da cutar COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; wani sanarwa da ba a samu ba ya nuna cewa an samu mutum na farko a ranar 17 ga Nuwamba.
Likita Zhang Jixian ya yi gwajin cutar pneumonia a ranar 26 ga watan Disamba, kuma asibitin ya sanar da CDC Wuhan Jianghan CDC a ranar 27 ga watan Disamba.
Gwajin farko na kwayar cutar a jikin mutumin da aka kama a ranar 29 ga Disamba, 2019 ya nuna cewa cutar SARS ce.
An fitar da sanarwar jama'a daga Hukumar Kiwon Lafiya ta lardin Wuhan a ranar 31 ga watan Disamba.
An sanar da WHO a ranar.
Lokacin da rahotanni suka bayyana, an sanar da likitocin Wuhan ta hanyar 'yan sanda don "tsayar da harin" kan cutar.
Jami'an lafiya na Ofishin Jakadancin China sun fara da cewa babu "tabbacin tabbaci" game da yaduwar mutum-zuwa-mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani mummunan shiri wanda daga bisani babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya yi amfani da shi a matsayin "tabbatar da jama'a" don dakile yaduwar cutar.
A cikin abin da ake kira "mafi girman rikici a tarihin ɗan adam", an sanar da dokar hana fita a ranar 23 ga Janairu, wanda ya hana zirga-zirga zuwa ciki ko waje na Wuhan, kuma an faɗaɗa shi zuwa wasu birane 15 a Hubei, wanda ya shafi haɗin kai na mutane miliyan 57.
Motarka ta kasance a cikin wani wuri mai ban mamaki.
Bukukuwan Sabuwar Shekarar Sin (25 ga Janairu) suna faruwa a wurare da yawa.
Jami'an gwamnati sun kuma sanar da gina asibitin da ya gabata, asibitin Huoshenshan, wanda aka kammala a cikin kwanaki 10.
Daga baya kuma an gina wani asibiti, asibitin Leishenshan, don karɓar wasu marasa lafiya.
A matsayin kari ga sabon asibitin da aka gina, kasar Sin ta sake gina wasu wurare 14 a Wuhan, wadanda suka hada da wuraren taruwa, dakunan motsa jiki, da kuma wuraren shakatawa.A ranar 26 ga watan Janairu, gwamnati ta gabatar da wasu matakai don shawo kan cutar ta COVID-19, kamar su sauƙaƙe wa'azi ga masu yawon bude ido da kuma jinkirta bikin bazara.
Jami'o'i da makarantu a duk fadin kasar za su bude.
Yankunan Hong Kong da Macau sun gabatar da wasu shawarwari, musamman game da makarantun sakandare da jami'o'i.
An kuma yi amfani da tsarin aiki daga gida a wasu sassan kasar Sin.
An tsaurara dokar hana zirga-zirga a ciki da wajen Hubei.
An yi zaben zaben 'yan kasa, kuma an rufe dukkan gidajen tarihi a kasar Sin.
An yi zanga-zangar jama'a a birane da dama, kuma kimanin mutane miliyan 760 (fiye da yawan jama'a) sun kasance a gida.Bayan barkewar cutar a duniya a watan Maris, gwamnatin kasar Sin ta dauki matakan da suka dace don hana cutar "tsallakewa" daga wasu ƙasashe.
Misali, Beijing ta ba da umarnin keɓewa na kwanaki 14 ga duk wanda ya yi balaguro zuwa ƙasashen waje kuma yana son shiga birnin.A ranar 23 ga Maris, babban yankin China ya sami mutum ɗaya da ya kamu da cutar a cikin gida, bayan ya yi kwanaki shida, ta hanyar wani da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Ministan kasar Sin Li Keqiang ya sanar da cewa yaduwar cutar a cikin birni ta tsaya kuma cutar ta kare a kasar Sin.
Tafiya a wannan rana ta ƙare, kuma a Wuhan, kwanaki biyu bayan dokar hana fita ta bayyana.Ma'aikatar Kula da Lafiya ta China ta sanar a ranar 26 ga Maris 2020 cewa ba za a dakatar da takardar izinin shiga ko izinin zama ba, daga ranar 28 ga Maris, kuma za ta ba da ƙarin bayani game da kammalawar.
Wadanda ke son shiga kasar Sin dole ne su nemi takardar izinin shiga daga ofisoshin jakadancin kasar Sin a kasashen waje.
Gwamnatin kasar Sin ta hana bude masana'antu da masana'antu a ranar 30 ga watan Maris, tare da bayar da tallafin farfadowa ga masana'antu. Ma'aikatar Harkokin Wajen kasar ta sanar da cewa za a fara gudanar da zanga-zangar ta tsawon minti uku a hankali a karfe 10:00 na yamma a ranar 4 ga watan Afrilu, wanda kuma ya yi daidai da bikin Qingming, duk da cewa gwamnatin tsakiya ta bukaci a yi karin bincike don tabbatar da cewa an samu karuwar masu cutar da kuma bukatar a yi gwajin rigakafi domin hana barkewar cutar COVID-19.
COVID-19 ya bayyana a matsayin wanda ya yadu a Koriya ta Kudu a ranar 20 ga Janairu, 2020 daga China.
Hukumar lafiya ta kasar ta sanar da cewa adadin wadanda suka kamu da cutar ya karu a ranar 20 ga watan Fabrairu, yayin da mutane suka yi ta tahowa da yawa a Daegu domin halartar sabon bikin da aka sani da Shincheonji Church of Jesus.
Yan Shincheonji da ke da alaka da Daegu daga Wuhan ne suka yi rahoton cutar.
A ranar 22 ga Fabrairu, daga cikin mutane 9,336 da suka kamu da cutar, 1,261 ko 13% na su sun nuna alamun cutar.
A ranar 28 ga watan Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, wanda ya kai 3,150 a ranar 29 ga watan Fabrairu.
An killace dukkan sojojin Koriya ta Kudu bayan da aka gano cewa sojoji uku sun kamu da cutar.
Shirin jirgin ya kasance mai tsauri kuma ya canza.Koriya ta Kudu ta kafa abin da ake ganin shine mafi girma da kuma mafi girma a duniya don yin rigakafin cutar, tare da keɓe waɗanda suka kamu da cutar da kuma bincika da kuma kiyaye waɗanda suka kamu da cutar.
Dabarar gwajin ta hada da bayar da rahoton kai tsaye game da cutar ga mutanen da suka dawo daga kasashen waje ta hanyar aikace-aikacen wayar hannu, gwajin kwayar cutar da kuma sakamakon da zai bayyana a cikin kwanaki masu zuwa, da kuma inganta tsarin gwajin don samun damar yin gwajin cutar ga mutane 20,000.
Shirin na Koriya ta Kudu ya kasance wani gagarumin mataki na magance cutar ko da kuwa ana iya samun birane masu magana da harshen korea.
Yawancin 'yan Koriya sun sanya hannu kan takarda don nazarin cutar Moon saboda suna tsammanin gwamnati za ta iya magance cutar, ko kuma muna tsammanin amsar ta.
A ranar 23 ga watan Maris, an bayar da rahoton cewa Koriya ta Kudu ta sami mafi ƙarancin adadin kwanaki a cikin makonni huɗu.
A ranar 29 ga watan Maris aka sanar da cewa daga ranar 1 ga watan Afrilu, duk wanda ya shiga kasar zai yi zaman kansa na tsawon makonni biyu.
A cewar rahotanni da aka bayar a ranar 1 ga Afrilu, Koriya ta Kudu ta karbi buƙatun don tallafawa gwajin cutar a kasashe 121.
Iran ta sanar da kamuwa da cutar SARS-CoV-2 a ranar 19 ga watan Fabrairu a Qom, inda, a cewar Ministan Lafiya da Jami'ar Lafiya, mutane biyu suka mutu a baya a wannan rana.
Matakan farko da gwamnati ta bayar sun hada da dakatar da bukukuwa da sauran ayyukan wasan kwaikwayo, ayyukan wasanni, da kuma rufe ranar Lahadi, da kuma rufe jami'o'i, dakunan karatu, da makarantu.
Iran ta fitar da rigakafin rigakafin cutar na tiriliyan shida.
Shugaban kasar Hassan Rouhani ya bayyana a ranar 26 ga watan Fabrairun 2020 cewa babu wani shiri na kebe wuraren da cutar ta addabi, kuma za a kebe mutane ne kawai.
An sanar da tsare-tsaren rage zirga-zirgar jiragen sama tsakanin birane a watan Maris, duk da cewa akwai karin zirga-zirga tsakanin birane kafin bikin Sabuwar Shekarar Farisa.
An bude wuraren shakatawa na Shia a Qom ga 'yan bindiga tun 16 ga watan Maris na shekarar 2020.
A cikin wani shiri na dakile yaduwar cutar a Iran, sama da kasashe 10 sun dawo da rahoton wadanda suka kamu da cutar a Iran a ranar 28 ga watan Fabrairu, inda suka ce cutar ta fi yawan wadanda suka kamu da cutar 388 da gwamnatin Iran ta sanar a yanzu.
An rufe harin na 'yan tawayen Iran, kuma an samu mutane 23 daga cikin 290 da suka kamu da cutar a ranar 3 ga watan Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta yi kira ga hukumomin kare hakkin bil adama na Iran da su saki wadanda suka kare wani wanda aka kama da laifi da kuma sakin duk wani dan bindiga da bai yi laifi ba.
An bayar da rahoton cewa lokacin yaduwar kwayar cutar ya fi muni a wuraren da aka rufe kamar gidajen haihuwa, waɗanda ba su da ingantaccen tsarin kiwon lafiya.
A ranar 15 ga watan Maris, gwamnatin Iran ta sanar da mutuwar mutane 100 a rana daya, wanda shine mafi girma tun farkon barkewar cutar.
An kashe 'yan siyasa da jami'an gwamnati na yanzu da na baya a Iran sakamakon cutar a ranar 17 ga watan Maris.
Har zuwa ranar 23 ga watan Maris, Iran na samun sabbin mutane 50 a kowace rana da kuma mutuwa daya a kowane minti 10 saboda cutar coronavirus.
A cewar wani jami'in WHO, adadin wadanda suka kamu da cutar ya ninka na Iran sau biyar.
Ya ce matakin da Amurka ta dauka kan Iran na iya shafar kudaden shiga na kasar saboda yadda za a iya magance cutar.
Babban Kwamishinan 'Yancin Dan Adam na Majalisar Dinkin Duniya ya lura da raguwar tattalin arziki a kasashen da cutar ta yi tasiri sosai.
Cutar ta kai Italiya ranar 31 ga watan Janairu, lokacin da aka gwada wa wasu 'yan kasar Sin biyu da cutar SARS-CoV-2 a Rome.
An samu karuwar masu kamuwa da cutar, wanda ya sa gwamnatin Italiya ta dakatar da duk wani zirga-zirga da jiragen sama zuwa ko daga China kuma ta ayyana dokar ta baci.
An samu karin mutane 16 da suka kamu da cutar COVID-19 a Lombardi a ranar 21 ga watan Fabrairu. A ranar 22 ga watan Fabrairu, hukumomi sun sanar da sabon tsari na hana yaduwar cutar, tare da sanya mutane sama da 50,000 a keɓe a larduna 11 na arewacin Italiya.
Ministan harkokin wajen kasar Giuseppe Conte ya ce, "A lokacin annobar, babu shiga ko fita.
An dakatar da ayyukan wasan kwaikwayo da wasan kwaikwayo a yankunan. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da shawarar rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar yayin da Italiya ta yi addu'ar mutuwar mutane 100 da suka mutu.
Yawancin wasannin kwallon kafa, kamar wasan kwallon kafa na Serie A, ya kamata a yi a cikin wani wuri da aka rufe a watan Afrilu, amma a ranar 9 ga Maris, an dakatar da wasannin kwallon kafa na akalla wata daya.
A ranar 11 ga watan Maris, Ministan Conte ya ba da shawarar dakatar da yawancin kantunan sayar da kayan kwalliya da kantin sayar da magunguna.A ranar 6 ga watan Maris, Kwalejin Kula da Magunguna, Anaesthesia, Resuscitation and Intensive Care (SIAARTI) ta ba da shawarar da za a yi amfani da ita don kula da lafiyar jiki.
A ranar 19 ga watan Maris, Italiya ta zarce China a yawan mutanen da suka mutu sakamakon cutar coronavirus a duniya bayan da ta samu mutuwar mutane 3,405 sakamakon annobar.
A ranar 22 ga watan Maris, an bayar da rahoton cewa Rasha ta tura jiragen sama na soja hudu dauke da magunguna zuwa Italiya.
Tun daga ranar 5 ga watan Afrilu, an samu mutum 128,948 da suka kamu da cutar, 15,887 sun mutu, kuma 21,815 suna jinya a Italiya, kuma mafi yawan wadanda suka kamu da cutar sun kasance a yankin Lombardy.
Wani rahoton CNN ya ce rashin daidaiton da Italiya ta yi na tsawon lokaci da kuma rashin samun damar kula da wadanda ke dauke da cutar a yanzu na iya kara yawan mutuwar.
Amsar da Burtaniya ta bayar game da cutar ta bayyana a matsayin daya daga cikin mafi munin rikice-rikice tsakanin kasashe, kuma a ranar 18 ga Maris, 2020, Burtaniya za ta gabatar da wani tsari na zaman kanta ko kuma ware kai tsaye daga jama'a.
A wani bangare kuma, an dauki matakin da ya dace na gudanar da aikin da ya shafi cutar da kuma amsa matsalolin da jama'a ke fuskanta. A ranar 16 ga watan Maris, Firayim Minista Boris Johnson ya ba da sanarwar bayar da shawarar hana tafiye-tafiye inda ake samun karin amfani da abinci da kuma sadarwa tare da jama'a, tare da ba da shawarar cewa jama'a su yi aiki daga gida idan ya yiwu kuma su yi watsi da wuraren shakatawa kamar mashaya, gidajen cin abinci, da gidajen wasan kwaikwayo.
A ranar 20 ga watan Maris, gwamnati ta sanar da cewa duk wuraren shakatawa kamar mashaya da wuraren shakatawa za su rufe, suna cewa za su biya kashi 80% na ma'aikatan su amma a kalla £2,500 a wata daya saboda mutane uku sun rasa ayyukansu a lokacin rikicin.A ranar 23 ga watan Maris, Ministan ya sanar da matakan dokar hana fita, dakatar da taron jama'a a cikin makonni biyu da kuma rage zirga-zirga da aiki a waje a wuraren da suka fi dacewa.
Ya bambanta da tsarin ƙetare, ƙuntatawa, 'yan sanda suna sa mutane suyi amfani da su ta hanyar yin amfani da su ta hanyar yin amfani da su ta hanyar watsa labarai.
Kasuwanci galibi suna rufewa saboda irin wannan taron, amma kasuwancin da ake ɗauka "mahimmanci", kamar shagunan kayan masarufi, kantin sayar da magunguna, shagunan ajiya, masana'antun kayan masarufi, kantin sayar da mai, da kantin sayar da motoci.
A ranar 20 ga watan Janairu, an gano mutum na farko da ya kamu da cutar COVID-19 a jihar Pacific ta Arewa maso Yammacin Washington a jikin wani mutum da ya dawo Wuhan a ranar 15 ga watan Janairu.
Za a fitar da Kwamitin White House na Coronavirus a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci, tare da hana shigar da mutanen kasar Sin.
A ranar 28 ga Janairu, 2020, Hukumar Kula da Cututtuka, babbar hukumar kula da lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa ta gabatar da sakamakon gwajin.
Duk da haka, Amurka ta yi jinkirin gudanar da bincike, wanda ya rage yawan cutar a kan lokaci.
Binciken ya gano cewa akwai matsala game da ingancin kayan aikin gwaji da gwamnatin tarayya ta fitar a watan Fabrairu, saboda gwamnatin tarayya za ta amince da kayan aikin gwaji na gwamnati (daga jami'o'i, dakunan bincike da asibitoci) a karshen watan Fabrairu, tare da rage hanyoyin samun damar yin gwajin a farkon watan Maris (bayan da aka sami yarjejeniyar likita).
A ranar 27 ga watan Fabrairu, jaridar The Washington Post ta ruwaito cewa za a yi gwajin gwaji sama da 4,000 a Amurka.
A ranar 13 ga watan Maris, The Atlantic ta ruwaito cewa za a yi gwajin 14,000.
A ranar 22 ga Maris, kamfanin dillancin labarai na Associated Press ya ruwaito cewa: "Yawancin mutanen da ke da alamun cutar sun jira kwanaki ko kwanaki kafin a yi musu bincike".Bayan an samu mutuwar farko a Amurka a Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, wanda wasu jihohi suka bi bayan haka.
Makarantu a yankin Seattle sun dakatar da karatunsu a ranar 3 ga Maris, kuma a tsakiyar Maris, makarantu a duk faɗin ƙasar sun rufe gidajensu.A ranar 6 ga Maris, an ba da shawarar Amurka game da yiwuwar sabon kwayar cutar coronavirus a cikin ƙasa ta hanyar ƙungiyar masu ilimin cututtuka a Kwalejin Imperial ta London.
A wannan ranar ne Shugaba Trump ya gabatar da Dokar Shirye-shiryen Coronavirus da Amsa Supplemental Appropriations Act, wanda ya samar da dala biliyan 8.3 a cikin tallafin gaggawa ga hukumomin jihohi don magance cutar.
Kamfanoni sun sanya takunkumin hana zirga-zirga ga ma'aikatansu, sun dakatar da sadarwa, kuma sun tura ma'aikata su yi aiki daga gida.
An dakatar da ayyukan jiragen sama da jiragen sama. A ranar 11 ga watan Maris, Trump ya sanar da dakatar da zirga-zirgar jiragen sama zuwa mafi yawan kasashen Turai, da kuma Birtaniya, na tsawon kwanaki 30, daga ranar 13 ga watan Maris.
A rana mai zuwa, ya fadada wannan dokar ta hana shiga Birtaniya da Ireland.
A ranar 13 ga watan Maris, ta ayyana dokar ta baci, wanda ya haifar da fitar da kudade daga asusun tallafi don amsa cutar.
Tun daga ranar 15 ga watan Maris, kamfanoni da dama sun rufe ko kuma rage wuraren da suke aiki a Amurka a kokarin rage yaduwar cutar.
A ranar 17 ga watan Maris, an samu rahoton cutar a jihohi 50 da kuma a cikin Gundumar Columbia. A ranar 23 ga watan Maris, an bayar da rahoton cewa Birnin New York yana da mutane 10,700 da suka kamu da cutar coronavirus, wanda ya fi adadin wadanda suka kamu da cutar a Koriya ta Kudu.
A ranar 5 ga Maris, gwamnati ta ce dokar hana fita ta yi tasiri, yayin da adadin masu kamuwa da cutar ya ragu daga kwanaki 2.0 zuwa 4.7.
Tun daga ranar 28 ga watan Maris, an samu mutum 32,308 da suka kamu da cutar a birnin New York, kuma mutane 672 sun mutu sakamakon cutar. A ranar 26 ga watan Maris, Amurka ta bayyana cewa tana da adadin mutane da suka kamu da cutar coronavirus fiye da kowace kasa a duniya, ciki har da China da Italiya. Tun daga ranar 8 ga watan Afrilu, an samu mutum 400,335 da suka kamu da cutar a Amurka, kuma mutane 12,841 sun mutu.
A cewar wani rahoto da aka fitar a ranar 30 ga watan Maris, Shugaba Trump na Amurka ya shirya tsawaita ranar haihuwar jama'a zuwa ranar 30 ga watan Afrilu.
A cikin wannan yanayin, USNS Comfort, asibitin asibiti mai kama da gado 1000, ya kasance a New York.
A ranar 3 ga Afrilu, Amurka ta yi rahoton mutuwar mutane 884 sakamakon cutar coronavirus a cikin kwanaki 24.
A jihar New York, adadin wadanda suka kamu da cutar ya wuce 100,000 a ranar 3 ga Afrilu. Fadar White House ta gano cewa ta yi watsi da cutar kuma ta sanya ido kan bayanai ta hanyar tura jami'an kiwon lafiya da masana don kare bayanan jama'a da kuma abubuwan da suka shafi cutar a cikin sanarwar shugaban kasa Mike Pence.
Dukkanin dabarun da Trump ya dauka na magance cutar sun bayyana a bangarori daban-daban.
Wasu jami'an Amurka da masana sun amince da ra'ayin Amurka game da kayayyakin da ba su da inganci a kasashen waje, kamar su magunguna na farko, a kasar Sin.
Wani bincike kan yadda ake daukar iska don ragewa da kuma tantance yadda ake yaduwar cutar ya bayyana a cikin Journal of Travel Medicine a tsakiyar watan Janairun 2020.
Dangane da bayanan 2018 na Kungiyar Kula da Sufurin Jiragen Sama ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei suna da yawan mutanen da ba sa tafiya daga Wuhan.
Dubai, Sydney, da Melbourne sun kuma bayyana a matsayin wuraren da mazauna Wuhan ke tafiya.
Bali an bayyana shi a matsayin mafi ƙarancin sanannen wurin shakatawa a cikin biranen 20 mafi yawan masu ba da izinin tafiya a cikin tsarin tsarawa, yayin da wasu biranen Australiya ke da mafi yawan shirye-shirye.Australia ta fitar da Sabon Tsarin Amsar Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Akwai ƙarin bayanai da za a samu game da COVID-19, kuma Australia na buƙatar ƙara yawan matakan tsaro da bayanai a cikin maganin cutar.
A ranar 21 ga watan Maris, an sanar da dokar ta baci a Australia.
Don kawar da mutanen da suka yi tafiya tare da tsarin kula da jama'a a Wuhan da Hubei, kasashe da dama sun shirya fitar da 'yan kasarsu da kungiyoyin tsaro daga yankin, da farko ta hanyar jirgin da kasar ta shirya, tare da goyon bayan gwamnatin kasar Sin.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand na daga cikin kasashen da suka fara shirin kwashe 'yan kasar.
Pakistan ta ce ba za ta fitar da 'yan kasarta daga kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta fitar da 'yan Brazil 34 da suka yi gudun hijira, ban da 'yan Pole hudu, da wani dan kasar Sin, da kuma wani dan kasar Sin.
Masu yawon shakatawa daga Poland, China, da Indiya sun sauka a Poland, inda jirgin ya tsaya kafin ya bi sahunsa zuwa Brazil.
An kuma kebe 'yan Brazil da suka je Wuhan daga cikin sansanin soja da ke Brasilia.
A wannan rana, 'yan Kanada 215 (176 a cikin jirgin farko, da 39 a cikin jirgin na biyu da gwamnatin Amurka ta yi garkuwa da su) sun tashi daga Wuhan zuwa CFB Trenton don samun damar shiga cikin jirage biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama mai dauke da 'yan Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Gwamnatin Australia ta kwashe mutane 277 a ranar 3 da 4 ga watan Fabrairu a tsibirin Kirsimeti, wanda aka yi la'akari da shi a matsayin yanki na keɓewa, kuma sun kasance a can tsawon kwanaki 14.
Taron farko na New Zealand ya isa Auckland a ranar 5 ga Fabrairu; masu tserewa (da sauran masu zuwa daga Australiya da Pacific) sun zauna a cikin sansanin sojan ruwa na Whangaparoa, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta ba da 'yancin zama dan kasar Amurka ta hanyar daukar nauyin Diamond Princess.
A ranar 21 ga watan Fabrairu, wani jirgin saman jirgin sama mai dauke da mutanen Kanada 129 da ya tashi daga jirgin Diamond Princess ya fadi a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara dawo da 'yan kasarta daga Iran. A ranar 14 ga watan Maris wani jirgin saman kamfanin South African Airways da gwamnatin Afirka ta Kudu ta shirya ya dawo da 'yan kasarta daga Afirka ta Kudu 112.
Ana gudanar da bincike na likita kafin a yi allurar rigakafi, kuma ana iya samun wasu mutane hudu a Afirka ta Kudu da ke nuna alamun cutar coronavirus a baya don rage cutar.
Mutanen Afirka ta Kudu da suka yi gwajin lafiya sun zama 'yan kasa.
Binciken ya nuna cewa duk 'yan Afirka ta Kudu, da kamfanonin jiragen sama, masu sufuri, kamfanonin otal,' yan sanda da sojoji masu ba da agaji ga jama'a, a matsayin tsarin kare hakkin bil'adama, sun kasance a cikin kulawar da ke keɓewa na tsawon kwanaki 14 a Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga kasar Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, jami'an harkokin wajen kasar Sin sun sanar da cewa kasashe 21 (kamar Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika da taimako ga kasar Sin.
Wasu daliban Sinawa a jami'o'in Amurka sun yi ta neman agaji a yankunan da cutar ta shafa na kasar Sin, tare da wasu kungiyoyi a yankin Chicago da suka yi ta gwagwarmaya don isar da takunkumin rufe fuska N95 50,000 zuwa asibitocin lardin Hubei a ranar 30 ga Janairu. Kungiyar agaji ta Direct Relief, tare da hadin gwiwar FedEx, ta aika da takunkumin rufe fuska 200,000 da sauran kayayyakin kariya, kamar kayan rufe hannu da kayan aiki, ta hanyar jirgin gaggawa zuwa asibitin Wuhan Union a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da tallafin dala miliyan 100 ga WHO don gudanar da bincike kan allurar rigakafi da hanyoyin magani da kuma kula da "al'ummomin Afirka da Kudancin Asiya da ke fama da cutar".
Interaction ta ruwaito cewa gwamnatin kasar Sin ta ba da kayan rufe fuska 200,000 ga 'yan kasar Philippines a ranar 6 ga watan Fabrairu, bayan da Sanata Richard Gordon ya aika da kayan rufe fuska miliyan 3.16 a Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura dala miliyan 2.26 a matsayin tallafi ga kasar Sin.
Japan ta ba da takunkumin rufe fuska a Wuhan, Turkiyya ta rarraba kayan aikin kiwon lafiya, Rasha ta tura sama da tan 13 na magunguna da kayan aikin kiwon lafiya a Wuhan, Malaysia ta sanar da bayar da kayan aikin rufe hannu miliyan 18 zuwa China, Jamus ta ba da kayan aikin kiwon lafiya iri-iri da kayan aikin Hazmat 10,000, kuma Amurka ta ba da tan 17.8 na magunguna da kayan aikin kiwon lafiya zuwa China kuma ta yi alkawarin ba da tallafi da kudade sama da dala miliyan 100 ga kasashen da cutar ta shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayan kiwon lafiya da likitoci don taimakawa Italiya a yaki da cutar coronavirus.
Shugaban kasa Jack Ma ya ba da umarnin samfurori miliyan 1.1, da kayan rufe fuska miliyan 6, da kuma kayan shafawa 60,000 a Addis Ababa, Habasha don rarraba su ta hanyar Tarayyar Afirka.
Daga baya ya aika da kayan gwaji 5,000, kayan rufe fuska 100,000 da umarnin tsabtace iska 5 zuwa Panama.
Har ila yau, ta taimaka wa Kanada tare da kayan aikin kiwon lafiya. Netherlands, Spain, Turkey, Georgia, da Jamhuriyar Czech sun nuna damuwa game da kayan aikin rufe fuska da aka yi a China da kayan aikin gwaji.
Misali, Spain ta fitar da kayan gwajin da aka yi a China 58,000 wanda ya nuna ingancin kashi 30%, yayin da Netherlands ta fitar da takardar shaidar rufe idanun kasar Sin 600,000 da ke dauke da cutar.
Belgium ta samar da takunkumin rufe fuska na 100,000 bayan an gano shi a Colombia.
A wani lokaci, taimakon kasar Sin ya kasance abin karɓa a wasu sassan Latin Amurka da Afirka. A ranar 2 ga Afrilu, Majalisar Dinkin Duniya ta fara ayyukan agaji na gaggawa a kasashen da ke fama da cutar.
WHO ta yi tsokaci kan kokarin gwamnatin China na shawo kan cutar.
WHO ta lura da bambanci tsakanin barkewar cutar SARS ta 2002-2004, inda aka yi zargin cewa gwamnatin China ta yi watsi da matakan da aka dauka na rigakafi da hanawa, da kuma barkewar cutar da gwamnatin tsakiya ta "ba da rahoton ta ga mutane uku kafin bikin Sabuwar Shekara ta Mayu".
A ranar 23 ga watan Janairu, a mayar da martani ga shawarar da gwamnatin tsakiya ta bayar na dakatar da takunkumin da aka yi wa hanyoyin yaduwar cutar a Wuhan, mai ba da shawara kan WHO Gauden Galea ya lura cewa "ba a jin cewa WHO ta yi hakan", "da akwai bukatar gaggawa don dakatar da cutar a kan wani mummunan yanayi" kuma ya kira shi "ba a taɓa ganin irinsa ba a tarihin kiwon lafiya". A ranar 30 ga watan Janairu, bayan tabbatar da yaduwar mutum zuwa mutum daga China da kuma karuwar adadin wadanda suka kamu da cutar a wasu ƙasashe, WHO ta sanar da cutar a matsayin gaggawa ta Hukumar Lafiya ta Duniya (PHEIC), a matsayin ta farko da ta fara aiwatar da PHEIC tun lokacin da aka fara aiwatar da cutar a cikin shekarar 2009.
Babban Daraktan WHO Tedros Adhanom ya ce PHEIC na iya "yaɗuwa a duk duniya, musamman a ƙasashe masu ƙarancin tattalin arziki da marasa lafiya waɗanda ba su da ingantaccen tsarin kiwon lafiya.
A cikin martani game da raguwar zirga-zirgar jiragen sama, Tedros ya ce "babu wani mataki da zai hana zirga-zirgar jiragen sama na kasashen waje da kasuwanci" kuma "WHO ta ba da shawarar rage kasuwanci ko rashin lafiya".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su shirya shirin samar da tallafin dala miliyan 675 ga kasashe masu tasowa, ta hanyar ba da agajin gaggawa ga kasashen da "ba su da hanyoyin magance cutar, ko da kuwa ta yaya ta faru".
Tedros ya kara da cewa "mu masu karfi ne kamar jikinmu mai rauni" kuma ya yi kira ga al'ummar duniya da su "yi kokarin magance kansu yanzu ko kuma su yi kokarin magance su a nan gaba".A ranar 11 ga watan Fabrairu, WHO a wani taron manema labarai ta sanya COVID-19 a matsayin cutar da ta riga ta samu.
A wannan ranar, Tedros ya ce Babban Sakataren Majalisar Dinkin Duniya António Guterres ya amince da bayar da "duk wani hadin gwiwar siyasa na Majalisar Dinkin Duniya a cikin martani".
Wasu kungiyoyin kula da cutar na Majalisar Dinkin Duniya suna aiki a matsayin masu amsawa, wadanda ke ba da amsa ga duk wani hadin gwiwar Majalisar Dinkin Duniya, wanda WHO ta ce za a ba su damar "samar da amsa ga lafiyar jiki a lokaci guda kuma sauran kungiyoyi za su iya amfani da ilimin su don yin aiki tare da matsalolin cutar a cikin al'umma, da kuma dukiyarmu. "
A ranar 14 ga watan Fabrairu, an kafa kungiyar hadin gwiwa da kasar Sin don samar da kwararrun kasashen waje da WHO a kasar Sin don taimakawa wajen hanawa da kuma tantance "taron cutar da yaduwar cutar" a cikin kasar tare da hada kai da manyan dakunan bincike da kuma kasashen waje don magance "aikin da ya kamata a yi a larduna da garuruwa, da birane da garuruwa". A ranar 25 ga watan Fabrairu, WHO ta ce "ya kamata duniya ta yi shirye-shirye don yiwuwar barkewar cutar coronavirus", kuma ta ce a halin yanzu, a matsayin ci gaba da yaduwar cutar, kasar tana cikin "farkon matakin tsarawa".
A sakamakon annobar da ta barke a Iran, WHO ta aika da wani kwamitin aiki na musamman don bincika abin da ke faruwa a can.A ranar 28 ga Fabrairu, jami'an WHO sun ce za a fara gwajin cutar coronavirus a duk fadin duniya daga "baƙi" zuwa "ƙananan masu cutar", wanda shine babban matakin ci gaba da gwajin cutar.
Mike Ryan, babban jami'in kula da ayyukan gaggawa na WHO, ya bayyana a cikin wani rahoto cewa "Wannan kamar gwajin gwaji ne ga kowace gwamnati a duniya: Bari muyi imani.
"Wannan kwayar cutar na iya zama a kan kanta kuma dole ne a hana ta", ta hanyar samar da hanyoyin da za su iya haifar da cutar da za ta iya haifar da "mummunan yanayi a duniya".
Ryan ya kara da cewa bayanan na yanzu zai ba da tabbaci ga hukumomin kiwon lafiya game da cutar, yana mai cewa wannan bayanin yana nufin "mun yarda da cewa kusan kowane mutum a duniya zai iya kamuwa da cutar".
A watan Maris, WHO ta ayyana cutar coronavirus a matsayin annoba.
Shugaban ya ce WHO ta "yi matukar damuwa da yadda ake yaduwar cutar, da kuma yadda ake gudanar da ayyukan tsaro". WHO na iya yin la'akari da muhimman abubuwan da suka shafi kula da cutar, da kuma bayanan da suka shafi gaggawa na kiwon lafiya da kuma shigar da kwayar cutar a cikin rukunin annoba.
Wannan kuma ya shafi bukatar da aka yi wa tsohon shugaban WHO Tedros Adhanom na sanya hannu kan takardar janyewar da mutane 733,000 suka sanya hannu a ranar 6 ga watan Afrilu.
A ranar 26 ga Maris, 2020, masana ilimin lissafi na Majalisar Dinkin Duniya za su gudanar da taron tattaunawa kan yadda za a yi nazarin ilimin lissafi na yau da kullun yayin annobar COVID-19.
Kungiyar ta amince cewa duk wani abu yana da alaka da yanke shawara game da cin zarafin mutum, kuma gwamnati tana da ikon yin hakan.
Kungiyar ta ce rashin kulawa ko kulawar lafiya ba zai iya zama wani nau'i na nuna bambanci ga al'umma ba.
Masana sun kuma lura cewa duk wanda ke da tasiri a kan kiwon lafiya, ya hada da mutanen da ke da cutar daga haihuwa, wadanda ke cikin kungiyoyi masu zaman kansu, tsofaffi, mutanen da suka canza yanayin rayuwarsu a cikin al'umma, marasa gida, mutanen da ke zaune a cikin mafi munin yanayi, fursunoni, da kuma jami'an tsaro da sauran kungiyoyin tallafi na gwamnati.
Hukumomin duniya suna gwagwarmaya don magance matsalolin da ke tattare da kashe kuɗi da kuma zamantakewar da cutar ta COVID-19 ta haifar.
Hukumar Tsaro ta Duniya ta samar da dandamali na samar da cikakken bayani game da manufofin siyasa a duk fadin duniya, da kuma duk wani tunani da kuma bambance-bambance.
Daga manufofi don daidaita tsarin kiwon lafiya da kiyayewa na duniya zuwa rage matsalar zama a gida da rage tafiye-tafiye, cibiyar ayyukan ta hada da Binciken Manufofin Kasa, wanda ke da nufin taimakawa kasashen da ke koyon yadda ake magance matsalar cutar ta coronavirus a duniya.
Gwamnatin kasar Sin ta amince da shawarar Amurka, Shugaban ofishin majalisar ministocin Burtaniya Michael Gove, da kuma Shugaban Brazil Jair Bolsonaro da kuma Eduardo Bolsonaro na shawo kan annobar, wacce ta barke a lardin Hubei na kasar Sin.
Wasu hukumomin lardin da jam'iyyar kwaminis ta kasar Sin (CPC) ta kafa za su shiga don su iya yin la'akari da yadda ake samun 'yan gudun hijira a yankin tsakiyar kasar Sin, da yadda ake samun sauyi da kuma yadda ake daukar matakan siyasa kan annobar a yankunan da ake fama da ita.
Wasu masana sun yi imanin cewa wannan matakin ya dace don kare tsohon shugaban jam'iyyar kwaminis ta kasar Sin Xi Jinping daga rikicin jama'a game da cutar coronavirus.
Wasu shugabannin kasar Sin, kamar Zhao Lijan sun yi watsi da tabbacin farko na bayyanar cutar coronavirus da ta fara a Wuhan, bisa la'akari da yadda ake samun labarin cutar COVID-19 da ta samo asali a Amurka ko Italiya.
Gwamnatin Amurka Donald Trump ta kira kwayar cutar "kwayar cutar Sin" ko kuma "kwayar cutar Wuhan" kuma ta ce China "ta bayyana wani kwayar cutar da ta zama annoba ta duniya", wanda wasu masu sharhi suka yi watsi da shi ta hanyar cewa ya kasance mai karkatar da asali da kuma "saurin zargi ga hukumomin kasar wajen hana barkewar cutar".
Jaridar Daily Beast ta samu wata takarda daga gwamnatin Amurka da ke nuna wani shiri na tsaro da aka yi ta hanyar Feel the Nation, wanda take cewa "Duk abin ya shafi China.
An yi mana alkawarin cewa za mu yi kokarin ganin an samu irin wannan tallafi a wasu bangarori, tare da hada kan kafofin watsa labarai da kuma kallon talabijin".Masu tallata labarai kamar Politico, Foreign Policy, da Bloomberg sun nuna cewa duk wani yunkurin da China ke yi na neman tallafi ga kasar Sin na nuna kasa da kasa.
Wani dan siyasar kasar Josep Borrell ya bayyana cewa akwai "tsarin zaman lafiya da kuma siyasa da aka tsara a baya a matsayin hanyar da za a iya girmamawa ta hanyar zabe da kuma "tsarin tallafi".
Borrell ya kara da cewa "China ta yi watsi da wannan bayanin da karfi, kuma kamar Amurka, ita ce mai daraja da amintacciyar abokiyar hulda".
China ta kuma bukaci Amurka da ta janye takunkumin da ta kafa kan Syria, Venezuela da Iran, kuma tana tura taimakon agaji ga kasashen biyu da aka ambata.
Za a dakatar da Jack Ma da kuma rufe fuska 100,000 a Cuba saboda takunkumin Amurka a ranar 3 ga Afrilu.
Gwamnatin Amurka ta yi watsi da taimakon da aka yi wa wasu kasashe a kasar.
Akwai wasu al'amuran da aka ruwaito game da rufe fuska a wasu ƙasashe, kamar Jamus, Austria, Switzerland; da Czech Republic da Italiya.
Bugu da kari, Turkiyya ta sanya umarni don samar da iska mai iska a kan jiragen ruwa da aka tura zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta yi tir da Tarayyar Turai saboda rashin samun damar bayar da tallafi ga Italiya da ke fama da cutar coronavirus.
Maurizio Massari, mai ba da shawara kan Italiya a EU, ya ce "Sunan China ya kasance mai amsawa ne a bangarorin biyu.
Hakika, wannan zai zama misali mai kyau ga ikilisiyar Turai".
A ranar 22 ga watan Maris, bayan tattaunawar wayar tarho da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya gana da sojojin Rasha don sayen kayan aikin soja, motocin wanki na musamman, da sauran umarni na kayan magani a Italiya.
Jaridar La Stampa ta Italiya ta ba da rahoton "ƙwarewar siyasa mai mahimmanci" amma ba ta bayyana cewa 80% na taimakon Rasha ya kasance "mai ƙarancin gaske ko kuma ba shi da amfani sosai ga Italiya".
Wannan takarda ta ce Rasha ta shiga cikin rikici "na siyasa da na addini" da kasashen waje.
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Waje Luigi Di Maio sun yi watsi da labaran da suka nuna rashin amincewarsu.
Rasha ta kuma tura jiragen ruwa masu jigilar kayayyaki da taimakon kiwon lafiya zuwa Amurka.
Wakilin Kremlin Dmitry Peskov ya ce "a lokacin da yake ba da tallafi ga abokan huldar Amurka, [Putin] ya yi imanin cewa idan masana'antun likitancin Amurka sun sami ƙarfi, za su iya samun damar yin hakan idan sun sami damar yin hakan".
Shirin makarantar sojin NATO "Defender 2020" a Jamus, Poland da ƙasashen Baltic, mafi girman makarantar sojan NATO tun ƙarshen Yakin Farin Ciki, ya kasance mai ƙanƙanta.
Babban jami'in kula da harkokin waje Kate Hudson ta amince da shirin Defender 2020: "A halin yanzu, cutar ta shafi sojoji da ke aiki a Amurka da sauran kasashen Turai da kuma al'ummomin kasashen da ake kai hare-hare a kasar. "Kasar Iran ta kamu da cutar, kuma sama da 'yan adawa biyu da dama da suka kamu da cutar sun kamu da cutar da kuma wasu 'yan siyasa na yanzu ko na baya.
Shugaban kasar Iran Hassan Rouhani ya rubuta wata wasika a bude ga shugabannin duniya inda ya nemi taimako a ranar 14 ga watan Maris na shekarar 2020, inda ya ce kasarsa na fama da matsalar cutar saboda rashin samun damar shiga kasashen duniya saboda takunkumin da Amurka ta dauka kan Iran. Cutar ta janyo kira ga Amurka da ta rage manufofin da ke hana a samu ci gaba a kasashe masu arziki, da kuma samar da kiwon lafiya na kasa da kasa, da kula da yara, da kuma samar da gidaje masu tsada, da kuma samar da tallafin kiwon lafiya da kudi da kuma hanyoyin da za a bi.
Masu ba da shawara kan harkokin siyasa sun ce ana iya yin watsi da takarar Donald Trump a zaben shugaban kasa na 2020.
Koriya ta Kudu ta amince da "matakan keɓewa na yau da kullun" bayan Japan ta sanar da cewa duk wanda ya tashi daga Koriya ta Kudu dole ne ya kasance cikin keɓewa na makonni biyu a cikin shirin gwamnati.
Jama'ar Koriya ta Kudu sun rarrabu kan yadda Shugaba Moon Jae-In ya amsa wannan annobar.
Koriya ta Kudu ta sanya hannu kan wata sanarwa da ta tabbatar da cewa Moon ya ce gwamnati za ta iya hana cutar ko kuma ta yi kokarin magance ta.
Wasu masana sun yi tunanin cewa zai iya ba da damar gwamnatoci su ɓoye ikonsu a cikin ƙura.
A Hungary, majalisar ministocin ta yanke shawarar ba da takardar shaida ga Firayim Minista Viktor Orbán, don dakatar da wannan lamari, dakatar da majalisar ministocin da zaben da kuma hana wadanda ba a san su ba da bayanan da ba su dace ba game da kwayar cutar da kuma rashin nasarar gwamnati wajen magance matsalar.
Cutar coronavirus ta haifar da hadari mai yawa kamar cibiyoyin kashe gobara, saboda cibiyoyin kiwon lafiya suna aiki tare da gobara mai yawa don magance cutar a duniya, tsoron rashin lafiya, rufe masana'antu da zirga-zirga.
Hukumar Kula da Magunguna ta Amurka ta fitar da rahoto don yin la'akari da takardun shaida da umarnin kiwon lafiya saboda yawan buƙatun da aka yi da kuma ƙarancin masana'antun.
A wurare da dama kuma, iyalan sun ji tsoron rashin abinci wanda ya sa suka rasa kayayyakin da suka dace kamar abinci, kayan gida, da ruwan sha, wanda ya sa suka daina samun abinci.
Hanyar fasaha ta fi dacewa da ƙwarewa a cikin jigilar kayayyaki kamar umarni.
A cewar Babban Daraktan WHO Tedros Adhanom, bukatar kayan shafawa ya karu da kashi 100.
Wannan aikin ya samar da abinci ga noggas kuma ya samar da kayan aiki ga magunguna a cikin nau'i hudu zuwa shida.
Har ila yau, kayan masks a duniya suna da wuyar samu, kuma WHO ta yi gargadin cewa hakan na iya shafar lafiyar ma'aikata.
A Ostiraliya, annobar ta ba da dama ga 'yan kasuwa masu siyar da kayayyakin Australiya a China.
Wannan aikin ya sa aka samu kayayyakin yara a kantunan kayan kwalliya kuma gwamnatin Australia ta dakatar da shi.Duk da yawan adadin masu kamuwa da cutar COVID-19 a arewacin Italiya da yankin Wuhan, da kuma garkuwa da mutane saboda kayayyakin abinci da dama, duk yankunan biyu ba su da matsalar abinci.
Manufofin da China da Italiya suka yi na hada kayayyaki da cinikin kayayyakin da ba a iya ganowa ba suna ci gaba, wanda ke haifar da raguwar cin abinci da aka samu a Turai da Arewacin Amurka.
Arewacin Italiya da kuma noma mai kyau sun ga raguwar yawan amfanin gona, amma farashin ya karu a cikin masu adawa.
An samu karancin abinci a wani lokaci, musamman a birnin Wuhan, inda jami'an gwamnatin kasar Sin suka kaddamar da wani shiri na samar da abinci ga jama'a.
Irin wannan tsari yana cikin Italiya wanda ke ba da izinin masu samar da kayan abinci na gaggawa.
An ba da rahoton tashin hankali a cikin duniya a China: a cewar wani rahoto na wasu kafofin watsa labarai a ranar 16 ga Maris, an yi matukar tasiri a cikin kasashe biyu na farko na shekarar 2020 saboda matakan da gwamnati ta dauka na dakile yaduwar cutar, kuma cinikin kananan kayayyaki ya ragu da kashi 20.5%.
Kamar yadda kasar Sin ta kasance cibiyar samar da kayayyaki da kuma samar da kayayyaki, bayyanar cutar ta shafi ci gaban samar da kayayyaki a duniya.
Agathe Demarais na Economist Intelligence Unit ya ce, "Ya kamata a yi amfani da lokaci kadan kafin a iya ganin ingancin abin da ke ciki".
A watan Janairun 2020, wasu masana sun yi hasashen cewa sakamakon cutar zai kasance mafi girma fiye da abin da cutar SARS ta 2002-2004 ta haifar.
Wani masani a jami'ar Washington da ke St. Louis ya ce za a kashe sama da dala biliyan 300 a cikin tsarin rigakafin cutar a cikin shekaru biyu masu zuwa.
Kungiyar Kasashen Da Ke Fitar Da Man Fetur (OPEC) ta ce "ta yi kasala" bayan da farashin man fetur ya yi kasa saboda kasar Sin ta dakatar da sayen.
Kasuwannin duniya sun yi sanyi a ranar 24 ga Fabrairu saboda karuwar adadin masu kamuwa da cutar COVID-19 a wajen kasar Sin.
A ranar 27 ga Fabrairu, saboda damuwa game da cutar coronavirus, wasu alamun kasuwancin Amurka da suka hada da NASDAQ-100, S&P 500 Index, da Dow Jones Industrial Average sun ci karo da mafi girman farashin su tun 2007-08.
Dukkanin lambobi uku sun kammala mako da sama da kashi 10%.
A ranar 28 ga Fabrairu, Scope Ratings GmbH ta gabatar da lissafin China, amma ta bar shi a matsayin Sanarwar Sanarwa.
Kasuwanci sun sake faɗuwa saboda tsoron coronavirus, wanda ya faru a ranar 16 ga Maris.
Mutane da yawa suna tsammanin cewa za a iya samun raguwa.
Mai ba da rahoto Mohamed El-Erian ya gode wa ayyukan gaggawa na ma'aikatar tsakiya da na kasa da kasa da suka isa kan lokaci.
Kamfanonin ajiya na tsakiya suna da alhakin abin da suka yi a cikin kudaden shiga na 2008.
Yawon shakatawa wani yanki ne da ke fama da matsalar hana zirga-zirga, rufe tashoshin jama'a da zirga-zirgar jiragen sama, da kuma rashin amincewar gwamnatoci uku kan batun zirga-zirgar jiragen sama a duniya.
A sakamakon haka, an dakatar da jiragen sama da yawa da masu jigilar kaya, kamar su British Airways, China Eastern Airlines, da Qantas, yayin da kamfanin jirgin sama na yankin na Burtaniya Flybe ya yi watsi da shi.
Tafiya tare da masu hankali kuma san addu'o'in da ba a taɓa yin watsi da su ba.
An rufe kofofin jirgin ruwa da na jirgin ruwa.
Cutar ta shafi Chunyun, lokacin tafiyar da tsuntsaye da bikin Sabuwar Shekara ta kasar Sin.
Yawancin ayyukan da aka gudanar da jama'a sun dakatar da su ta hanyar gwamnatocin jihohi da hukumomi, da kuma bukukuwan Sabuwar Shekara, da kuma haɗin gwiwar rufe wuraren shakatawa na gida da na masu zaman kansu kamar Hong Kong Disneyland da Shanghai Disneyland.
Ayyukan Sabuwar Shekara da abubuwan da suka faru sun kasance a rufe ga mutane uku masu ban sha'awa, tare da Forbidden City a Beijing da kuma wuraren shakatawa na gidajen tarihi.
A larduna 24 da 31 na kasar Sin, birane da yankuna, hukumomi sun yi watsi da bikin Sabuwar Shekara a ranar 10 ga watan Fabrairu, kuma sun bukaci cibiyoyi da dama da su bude idan lokaci ya yi.
Wadannan yankuna suna samar da kusan 80% na GDP da 90% na fitarwa.
Hong Kong ta kara tsaurara matakin da take dauka na magance cutar a cikin wata sanarwa da ta fitar, inda ta rufe makarantu a watan Maris, ta dakatar da bukukuwan Sabuwar Shekara.
Rashin kananan shinkafa a Turai da Latin Amurka ya kai kashi 40%.
Ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Hakan kuma ya haifar da raguwar sawu da ƙafa a cikin shaguna da kashi 33-43% a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da kasuwancin duniya sun kara wasu matakai, kamar su inganta kulawar lafiya, samar da kayayyakin rigakafi don magance matsalar lafiyar masu amfani, da kuma dakatar da kayayyaki. Hukumar Tattalin Arzikin Majalisar Dinkin Duniya ta Latin Amurka ta kiyasta cewa cutar da ta haifar da raguwar kayayyaki na iya barin tsakanin mutane miliyan 14 zuwa 22 a cikin Latin Amurka a cikin yanayin da ba a cikin cutar ba.
A watan Janairu da Fabrairu na shekarar 2020, lokacin da cutar ta barke a Wuhan, mutane miliyan 5 a kasar Sin sun rasa ayyukansu.
Ma'aikatan kasar Sin da suka yi hijira sun kai miliyan 300 da ke zaune a gida a lardin ko kuma a lardin Hubei.A watan Maris na shekarar 2020, sama da Amurkawa miliyan 5 a kasar Sin sun rasa ayyukansu, a cewar tallafin gwamnati.
Cutar coronavirus na iya asarar ayyuka miliyan 47 a Amurka kuma rashin aikin yi na iya kaiwa kashi 32%, a cewar wani kimantawa na Bankin Tarayya na St Louis. Rashin aiki a gida a Indiya ya bar ma'aikata 'yan kasashen waje miliyan goma a India (wanda ake biyan su daidai gwargwado). Wani bincike a Cibiyar Angus Reid ya gano cewa kashi 44% na Kanada sun yi irin wannan rashin aikin yi. Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da aka fara koyar da su zama a gida a tsakiyar Maris 2020.
A cikin watan Maris na biyu, ma'aikata miliyan 4 na Faransa sun nemi taimako kafin su sami damar yin aiki kuma ma'aikata miliyan 1 na Burtaniya sun nemi su yi aiki gaba ɗaya. Kusan rabin miliyan masana'antu a Jamus sun tura ma'aikatansu a cikin wani shiri na gwamnati na ɗan gajeren lokaci wanda aka sani da Kurzarbeit.
An kuma dauki gudunmawar aikin a cikin ɗan gajeren lokaci a Jamus ta Faransa da Ingila.
Yanayi kamar haihuwa da hannu ko tarihin gida sun yi tasiri sosai ga cutar, wanda hakan ya shafi tsarin aiki da kuma al'umma, duka ma'aikata da kuma na yau da kullun, a duniya.
Hukumomi kamar su kayan kwalliya ko tarihin gida sun yi kokarin sake gina ayyukan su (wanda galibi gwamnati ke tallafawa) don buɗe gidan kayan gargajiya ga jama'a, kiyaye lafiyar ma'aikatansu da na jama'a, da kuma yin balaguro a inda ya dace.
A watan Maris na shekarar 2020, a duk fadin duniya da kuma a matakai daban-daban, gidajen tarihi, makarantu, wuraren baje kolin wasan kwaikwayo, da sauran gidajen jama'a sun rufe kofofin su kuma an dakatar da baje kolin, ayyuka da kuma ayyukan su.
A sakamakon haka, an yi wasu matakai na kai wasu ƙauyuka ta hanyar yin oda. Wani abin da cutar ta yi shi ne dakatar da ayyukan coci, wasanni, da sauran ayyukan jama'a, kamar bukukuwan kiɗa da rawa, tarurruka na fasaha, da kuma bikin jana'iza.
Gidan watsa labaran ya kuma sanar da dakatarwar. Vatican ta sanar da cewa za a dakatar da sake dawo da ranar Alhamis a Rome, wanda ke faruwa a karshen mako wanda ke nuna rashin jin daɗi ga mutanen Allah.
Yawancin gidaje sun ba da izinin tsofaffi su zauna a gidajensu don su halarci bukukuwan Haikali da kuma na Altar; wasu kuma sun yi amfani da rediyo, na'urar mai magana da yawun jama'a, ko kuma na'urar talabijin, wasu kuma sun yi amfani da motoci.
Cocin Roman Katolika na Roma ya rufe majami'u da wuraren ibada a Babila na St. Peter ba tare da masu bautar Masarawa ba, wasu al'ummomi sun dakatar da ibada kuma sun rage yawan jama'a a wuraren bautar Masarawa, wuraren bautar Musulunci, wuraren ibada da gurduras.
Jami'an Iran sun sanar da dakatar da gudanar da ayyukan a ranar Juma'a a yankunan da cutar ta shafa sannan kuma a rufe ofisoshin gwamnati, yayin da Saudiyya ta dakatar da shiga masu yawon bude ido na kasashen waje da na gida a makwabta makwabta Makka da Madina.
Cutar ta dakatar da abubuwa da yawa a cikin tsarin wasanni na duniya tun bayan yakin duniya na biyu.
Yawancin wasannin wasannin kwallon kafa za a dakatar da su ko kuma a soke su, kamar 2019-20 UEFA Champions League, 2019-20 Premier League, UEFA Euro 2020, lokacin NBA 2019-20 da kuma lokacin NHL 2019-20 NHL.
Cutar ta dakatar da shirye-shiryen gasar Olympics ta 2020 na bazara, wanda ya shirya a farkon watan Janairu; Kwamitin Olympic na Duniya ya sanar a ranar 24 ga Maris cewa za a gudanar da ayyukan "a farkon 2020 amma ba a kai ga tsakiyar 2021 ba".
Wannan ya sa masu wasan kwaikwayo suka yi tsalle a kan dandalin, kuma manyan wuraren wasan kwaikwayon sun ba da rahoton karuwar yawan masu halarta.
Yawancin gidajen wasan kwaikwayo kamar waɗanda ke kan Broadway sun dakatar da duk ayyukan su.
Wasu masu yin fim suna neman hanyoyin da za su iya yin aiki da kuma rarraba aikinsu a duniya kamar yadda wasu ke yi a fili, kamar yin waƙa a gaban jama'a ko kuma yin "tallace-tallace" a duniya, rarraba, da kuma nuna aikinsu.
A bangaren al'umma, wasu kasashe da ke da cutar coronavirus sun yi ta yaduwa kuma wasu sun bayyana hakan a matsayin rikici da kuma rikici a tsakiyar rikicin.
Tun bayan barkewar cutar COVID-19, nuna wariya, wariyar launin fata, da nuna bambanci sun kasance a tsakanin Sinawa da 'yan asalin Gabashin Asiya, da kuma wadanda suka fito daga yankunan da cutar ta shafa a Turai, Amurka da sauran ƙasashe.
A cikin ƙasashe da yawa muna magana ne game da ƙirar, kulawa, da kuma ƙabilu musamman a Turai, Gabashin Asiya, Arewacin Amurka, da yankin Asiya-Pacific.
Wasikun da aka wallafa a watan Fabrairu (lokacin da mafi yawan masu kamuwa da cutar suka keɓe kansu a kasar Sin) sun nuna cewa akwai wasu al'ummomin kasar Sin da ke da alhakin yadda cutar ta kai su ko kuma yadda suka kamu da ita.
Sauran kasashen Afirka ma sun nuna kishin kasar Sin ta hanyar kallon mutane da ido.
Mutane da yawa a Wuhan da Hubei sun ba da rahoton yin zaɓin jinsi.
Al'ummar kasar Sin sun sami kariya, ta hanyar sadarwa ta baki da kuma wuraren da cutar ta kamu da ita.
Saboda ci gaba da yaduwar cutar a kasashe masu fama da cutar, mutane daga Italiya, kasar Turai ta farko da ta sanar da cutar COVID-19, na iya zama abin zargi ko kuma a yi musu watsi da su. Ƙungiyoyin ƙasashe kamar Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun fara sanya hannu kan takardu da ke neman hana shigowar jama'ar kasar Sin zuwa ƙasashensu don hana cutar.
A Japan, hashtag #ChineseDontComeToJapan ya yi ta yawo a shafin Twitter.
Al'ummomin Sinawa da Asians a Burtaniya da Amurka sun ba da rahoton karuwar damuwa game da asalin, da sauran matsaloli.
Shugaban Amurka Donald Trump ya yi kasa a gwiwa saboda kiran kwayar cutar "kwayar cutar Sin", wata kalma da ta zama abin tsoro da abin mamaki a idanun masu sauraro.
Masu zanga-zangar Ukraine sun dakatar da motocin da ke dauke da 'yan kasar Ukraine da' yan kasashen waje daga Wuhan zuwa Novy Sanzhary.
Daliban da suka dawo daga Arewa maso gabashin Indiya, wanda ke da iyaka da China, kuma suna karatu a yawancin biranen Indiya an ba da rahoton cewa sun sami matsala saboda cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata Party na jihar Bengal Dilip Ghosh ya ce kasar Sin ita ce duniya kuma "Allah ya ba su damar yin hakan".
Wani mai ba da shawara kan al'ummar kasar Sin a Kolkata ya yi watsi da wannan lamarin, inda ya kira shi "rashin adalci".A kasar Sin, wariyar launin fata da nuna bambanci ga al'ummar da ba 'yan kasar Sin ba sun karu tare da annobar, kuma an kira baƙi "kayan hadaya na gargajiya" wanda dole ne a "kashe".
An cire wasu sakonni da kuma bayanan sirri saboda wasu ko kuma duk bayanan da suka shafi cutar coronavirus.
Masu bincike a cikin kafofin watsa labarai sun yi magana game da cutar ba tare da yin la'akari da komai ba.
Wasu masu bincike sun zaɓi su rarraba bayanan su a cikin tsari kafin a buga su a cikin takardu kamar bioRxiv.
Cutar da ta faru a baya, cuta ce da ke kamuwa da sabon kwayar cuta, galibi saboda bayyanar cutar ko kuma hanyar watsawa.
Duniya da annoba - ganowa da yaduwar cutar a duniya
Lissafin kamuwa da cuta da annoba - Lissafin mutuwar cututtuka marasa yaduwa
Dabbobi masu haɗari da cututtuka masu haɗari - Dalilan kiwon lafiya da ba su da alaƙa da cinikin dabbobi da suka fito daga ƙasashen waje.
Binciken kwayar cutar coronavirus na 2019 (COVID-19) a cikin dakin gwaje-gwaje tare da kwayar cutar da ba ta dace da SARS-CoV-2 ya shafi hanyoyin da za a iya gano cutar da kuma wadanda za a iya ganowa a matsayin maganin cutar.
An gano kwayar cutar a cikin kwayoyin ta hanyar RT-PCR, wanda ke nuna RNA na kwayar cutar.
Wannan gwajin na musamman ne kuma ya shafi kwayar cutar SARS-CoV-2 RNA.
Yana da amfani wajen gano sababbin cututtuka ko kuma cututtuka masu aiki.
Yin amfani da kwayar cutar (samfurin jini) na iya zama da amfani ga bincike da kuma kula da al'umma.
Binciken rigakafi yana nuna mutane da ke da cutar, kamar waɗanda alamun cutar ba su da yawa don gano ko bayyana yadda suke.
Za a iya sanin yawan mutuwar da aka samu ta hanyar gwajin da aka yi.
Saboda rashin cikakken bincike, a watan Maris na shekarar 2020 babu wata kasa da ke da cikakken bayani game da cutar a cikin al'umma.
Ya zuwa ranar 23 ga watan Maris, babu wata kasa da ta yi gwajin fiye da kashi 3% na yawan jama'arta, kuma akwai wasu maganganu da yawa game da yadda gwajin ya faru a cikin jihohi.
Wannan yanayin yana shafar yawan mutuwar da aka ruwaito, wanda galibi ana yada shi ta baki a wasu ƙasashe.
Yin amfani da gwajin nazarin polymerase chain reaction (rRT-PCR) na iya haifar da cututtukan huhu da aka kama ta hanyoyi daban-daban, kamar cutar sankarar bargo ko cutar sankarar bargo.
Sau da yawa ana yin maganin a cikin 'yan sa'o'i ko a cikin kwanaki 2.
Sakamakon RT-PCR na kwayoyin cutar da aka gano a cikin kwayar cutar zai iya zama abin dogaro ne kawai a cikin makon farko na cutar.
Bayan haka, kwayar cutar za ta iya zama a cikin hanci yayin da take yaduwa a cikin huhu.
A cikin mutanen da aka gano a mako na biyu, ana iya ɗaukar wasu kayan aikin numfashi ta hanyar numfashi ta hanyar yin amfani da katheter ko na'urar jiyya (na'urar jiyya).
An gudanar da gwajin PCR na farko a Charité a Berlin a ranar 20 ga Janairu 2020 ta hanyar amfani da nazarin polymerase chain reaction (rRT-PCR) na baya da na lokaci, kuma an samar da kayayyaki 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
Birtaniya ta gabatar da tsarin gwajin ne a ranar 23 ga watan Janairun 2020.Kwamitin kimiyyar Kogenebiotech na Koriya ta Kudu ya fitar da kayan aikin gwajin SARS-CoV-2 na PCR (PowerChek Coronavirus) ga ma'aikatan asibiti a ranar 28 ga watan Janairun 2020.
Yana bincika kwayar "E" da kowane kwayar cutar beta coronavirus ke da ita, da kuma kwayar RdRp wacce ta bambanta da SARS-CoV-2. A China, BGI Group na ɗaya daga cikin manyan dakunan gwaje-gwaje don karɓar kwangilar gaggawa daga Hukumar Kula da Kayan Kiwon Lafiya ta China don kayan aikin bincike na SARS-CoV-2 bisa PCR. A Amurka, Cibiyar Kula da Cututtuka da Cututtuka (CDC) tana rarraba sabon tsarin gwajin kwayar cutar coronavirus ta 2019 (2019-nCoV) RT-PCR a lokaci guda ga dakunan gwaje-gwaje na gwamnati ta hanyar International Reagent Resource.
Wani daga cikin gwaje-gwajen kwayoyin guda uku a cikin tsarin gwajin na baya-bayan nan ya nuna alamun rashin inganci ga masu cutarwa, tare da wahalar bincike a CDC a Atlanta; wannan ya ba da damar yin amfani da ƙananan ƙwayoyin cuta har zuwa 100 a cikin kwanakin da aka gwada da kyau a cikin watan Fabrairu 2020.
Gwaje-gwaje da kayan aiki guda biyu za su nuna tabbataccen sakamako a ranar 28 ga Janairu, 2020, kuma daga baya hukumomi da cibiyoyin bincike na ƙasa za su sami damar fara gwajin.
An amince da gwajin ne daga Hukumar Abinci da Magunguna a karkashin izinin Amfani da Gaggawa. Cibiyoyin bincike na kasuwanci sun fara gwajin a farkon Maris 2020.
Tun daga ranar 5 ga Maris, 2020, LabCorp ya sanar a fili cewa za a iya yin gwajin COVID-19 ta hanyar RT-PCR.
Quest Diagnostics ya kuma sanar a duk fadin kasar cewa ana samun gwajin COVID-19 tun daga 9 ga Maris, 2020.
Babu cikakken bayani game da adadin da aka bayar; an gudanar da bincike kan cutar da kuma kimantawa ta hanyar CDC.
A Rasha, an gano kuma an kirkiro gwajin COVID-19 ta Cibiyar Nazarin Kiwon Lafiya ta Jiha ta Virology da Biotechnology VECTOR.
A ranar 11 ga Fabrairu, 2020, an amince da gwajin ta hanyar Hukumar Kula da Kiwon Lafiya ta Tarayya. A ranar 12 ga Maris, 2020, Mayo Clinic ta ba da rahoton cewa ta fitar da gwajin gano cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta amince da FDA don wani gwajin da za a iya gudanarwa a cikin awanni 3.5 na yamma, wanda ke ba da izinin yin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin gaggawa na aiki (EUA) ga Abbott Laboratories don yin nazarin tsarin Abbott m2000; FDA ta ba da izinin irin wannan ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta ba da izinin EUA ga FDA don gwajin da zai ɗauki kimanin minti 45.
FDA ta amince da wani gwaji na amfani da fasahar isothermal nucleic acid amplification a bangaren PCR.
Don fahimtar canje-canje a cikin zafin jiki da zafi, wannan tsarin zai iya ɗaukar sakamako mai kyau a cikin minti shida da sakamako mara kyau a cikin minti 13.
A halin yanzu akwai umarni 18,000 a Amurka kuma Abbott yana da niyyar haɓaka wannan ƙaddamarwa don yin gwaje-gwaje 50,000 a rana. Ana amfani da gwajin rigakafi na mutum guda wanda ke da alaƙa da kwayar nucleocapsid (N protein) na sabon kwayar cutar coronavirus a Taiwan, tare da fatan samar da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin cutar.
Wani bincike da aka yi a watan Maris ya nuna cewa "ra'ayoyin jijiyoyin jiki suna da ƙananan ƙididdigar bincike a farkon matakan, amma sakamakon CT [hoto da kuma sauti] na iya kasancewa kafin farkon bayyanar.
Sauran alamun CT sun hada da bilateral multilobar ground-glass opacificities da kuma cututtuka a cikin baki, baya da kuma gaba.
Bugu da ƙari, yawancin yaduwar cutar a cikin kumburi, haɗuwa da kuma ɓoyewa suna haɗuwa yayin da cutar ke ci gaba.
Wani bincike da aka yi a Wuhan wanda ya yi amfani da PCR da CT a farkon annobar ya nuna cewa CT ya fi PCR tasiri, kodayake ya fi aminci, kuma sakamakon hotunan na iya bambanta da wasu cututtukan huhu da kuma yanayin cutar.
A watan Maris na 2020, Kwalejin Kula da Magunguna ta Amurka ta ba da shawarar cewa "Ba za a yi amfani da CT ba don bincike ko kuma a matsayin hanyar farko don gano COVID-19".
A matsayin tushen amsawar rigakafi shine samar da kwayar cutar ta hanyar rigakafi kamar IgM da IgG.
Ana iya amfani da su don gano cutar a cikin mutane tun daga farkon kwanaki 7 ko makamancin haka bayan bayyanar cututtuka, don tabbatar da lafiyar jiki, da kuma a cikin kulawar jama'a. Ana iya yin gwajin a cikin cibiyar bincike ta tsakiya (CLT) ko ta hanyar gwajin asibiti (PoCT).
Tsarin gwaji na yanayi a yawancin dakunan gwaje-gwaje na iya wuce waɗannan sakamakon amma kasancewar su ya dogara da yawan fitar da kowane tsari.
A cikin CLT, an fi ɗaukar jini na jini, ko da yake ana iya ɗaukar jini na gaba don amsawa ta hanyar rigakafi.
An yi amfani da PoCT a cikin ƙwayoyin jini guda ɗaya da aka yi amfani da su ta hanyar yin amfani da maganin rigakafi.
Ba kamar tsarin PCR ba, ana amfani da izinin fitarwa kafin a yi bincike. A ranar 26 ga Maris, 2020, FDA ta lissafa kayayyakin 29 da ke ba da bayanan asibiti a matsayin marasa lafiya kuma suna iya ba da gwajin rigakafi.
A ranar 7 ga Afrilu, 2020, FDA ta amince da gwajin guda ɗaya don dakatar da aikin gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami
Yawan gwajin zai yi gwajin kwayar cutar a cikin ƙwayoyin cuta kuma ya fi ƙarfin gwajin PCR na RNA na kwayar cutar da aka sani.
Ana iya gano rigakafin bayan kwanaki 14 daga farkon cutar. A farkon watan Afrilu, Burtaniya ta gano cewa ɗayan kayan aikin gwajin rigakafin da ta sayi ya zama dole a yi amfani da shi.
Hong Kong ta gabatar da wani shiri na musamman wanda ake ganin mai cutar zai zauna a gida, "masu kula da gaggawa za su ba da rigakafin cutar ga mai cutar", su yi masa allurar rigakafi, su yi masa jinya kuma su gano sakamakon daga baya. NHS Ingila ta ce tana gudanar da aikin gwajin marasa lafiya a gida, wanda ke kawar da yiwuwar kamuwa da cutar daga wasu mutane idan suka zo asibiti, ko kuma tsabtace motoci don kula da marasa lafiya. A cikin gwajin motar marasa lafiya na COVID-19, mai kula da lafiya yana ɗaukar rigakafin lafiya da kulawa.
Gidajen gwajin motoci sun taimaka wa Koriya ta Kudu wajen inganta gwajin, tare da fadada shi zuwa kowace kasa. A Jamus, Kungiyar Likitocin Kula da Kiwon Lafiya ta Kasa ta sanar a ranar 2 ga watan Maris cewa, ana sa ran gudanar da gwajin 12,000 a duk wuraren da za a iya daukar motar kuma an gudanar da gwajin 10 700 a farkon mako.
Mai ba da inshora ba zai biya kuɗin gwajin ba idan likita ya tsara shi.
A cewar daraktan cibiyar Robert Koch, Jamus na iya daukar nauyin mutane 160,000 a mako.
A ranar 19 ga watan Maris, an gudanar da bincike kan motoci a birane da dama.
A ranar 26 ga Maris 2020 adadin dukkan gwaje-gwajen da aka yi a Jamus ya ragu, saboda an ba da rahoton sakamakon cutar kawai.
Binciken farko na dakin gwaje-gwaje ya nuna cewa tun daga ranar 12 ga watan Disamba na shekarar 2020 an gwada akalla kwayoyi 483,295 kuma a ranar 12 ga watan Disamba na shekarar 2020 an samu kwayoyi 33,491 (6.9%) da suka tabbatar da kamuwa da cutar SARS-CoV-2.[1] A Isra'ila, masu bincike a asibitin Technion da Rambam sun kirkiro da kuma inganta tsarin gwajin kwayoyi guda 64 a kowane mako, ta hanyar rarraba magunguna a cikin tsari guda daya da kuma gano ko akwai cakuda da ke dauke da cutar. A Wuhan, wani asibitin gano cutar gaggawa mai tsawon mita 2000 mai suna "Huo-Yan" (Sinanci: 火眼, ko "Ido na Yasu") ya buɗe a ranar 5 ga Fabrairu 2020 ta hanyar BGI, wanda ya yi gwajin gwajin na tsawon kwanaki 10,000.
Tare da gina ginin wanda shugaban BGGI Wang Jian ya gudanar kuma zai dauki kwanaki 5, sakamakon ya nuna cewa yawan masu kamuwa da cutar a Hubei zai iya kaiwa kashi 47% kuma farashin kulawar rigakafin zai iya ninka idan ba a samu adadin gwaje-gwaje ba.
Wuhan Laboratory ya biyo bayan dakunan gwaje-gwaje na Huo-Yan a Shenzhen, Tianjin, Beijing, da Shanghai, da kuma wasu birane 12 a kasar Sin.
A watan Maris na shekarar 2020 adadin gwajin ya kai 50,000 a rana. A cikin tsarin budewa, an samar da wasu nau'ikan gwajin Origami wanda zai iya magance cutar COVID 1122 tare da gwajin 93 kawai. Ana iya isar da waɗannan gwaje-gwajen a cikin ƙananan dakunan gwaje-gwaje ba tare da ma'aikatan da ke amfani da ruwan robotic ba.
A watan Maris, adadin maganin ya ƙare kuma ya kasance mai ƙarancin ƙalubale don gwaji mai yawa a cikin EU da Ingila da Amurka.
Wannan ya sa wasu masu bincike suka fara nazarin hanyoyin samar da magani wanda ya hada da sanya magunguna a 98 °C (208 °F) na tsawon minti 5 don fitar da kwayoyin RNA don wasu dalilai.A ranar 31 ga Maris, an ba da rahoton a cikin Hadaddiyar Daular Larabawa cewa suna gudanar da gwajin cutar ta coronavirus a cikin al'umma daban-daban, kuma yana kan hanyar isar da gwajin zuwa al'umma.
Wannan ya faru ne ta hanyar hada tsarin gwajin cikin mota, samar da dakunan gwaje-gwaje masu karfin gaske a Group 42 da BGI (bisa ga dakunan gwaje-gwajen "Huo Yan" na kasar Sin).
An gina shi cikin kwanaki 14, dakin gwaje-gwaje zai iya daukar dubun dubatan gwajin RT-PCR a rana kuma zai kasance na farko da irin wannan a wajen kasar Sin.
An fara gudanar da gwaje-gwaje daban-daban da suka shafi tsarin kwayar cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar lafiya ta duniya WHO ta amince da shirin Jamus na fitar da kayayyakin da aka shigo da su a kasashen da ba su da karfin samar da kayayyakin da ba su da karfin fitarwa.
An fitar da shawarar Jamus a ranar 17 ga Janairu, 2020; shawarar da Hukumar Kula da Lafiya ta Amurka ta bayar ba ta bayyana ba kafin 28 ga Janairu, wanda ke nufin cewa an kammala gwajin da ake da shi a Amurka. Kasashen Sin da Amurka suna da shakku game da amincin kayan aikin gwajin a farkon barkewar cutar, yayin da ƙasashe kamar Australia ba su da ikon samar da kayan aikin gwajin da zai iya amsa tambayoyin da kuma ra'ayoyin masana kiwon lafiya.
A wani lokaci, masana sun ce gwajin da aka yi a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon coronavirus.
Tsarin gwaji, musamman a cikin dakunan gwaje-gwaje na kasuwanci, an gabatar da shi shekaru da yawa da suka gabata ta gwamnatin Koriya ta Kudu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira da a inganta tsarin gwajin a matsayin muhimmin mataki na rage yaduwar cutar COVID-19.Matsayin gwajin da ya dace da yaduwar kwayar cutar ya hana gwajin inji a dakunan gwaje-gwaje na kasuwanci a Amurka, kuma kayan aikin samar da kwayoyin cuta da reagents sun yi rauni.
A watan Maris na shekarar 2020 Cayni ta sanar da cewa akwai wasu matsaloli game da amincin kayan aikinta.
A Amurka, kayan aikin gwajin da kasar Sin ta bayar ta hanyar CDC suna da "ƙwarewa", kuma gwamnati ta ba da takunkumin hana gwajin ta wasu dakunan gwaje-gwaje na gwamnati. Spain ta sayi kayan aikin gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na kasar Sin, amma ta gano cewa sakamakon ba shi da tabbaci.
Kotun ta ce sakamakon da ba daidai ba na iya haifar da rikici a cikin maganin magani ko rashin amfani da kayan aikin gwaji.
Kungiyar ta Spain ta ce za ta sake samar da kayan aikin da suka nuna cewa ba su da inganci, kuma za ta maye gurbinsa da wasu kayan aikin da Shenzhen Bioeasy ta samar. 80% na kayan aikin da Jamhuriyar Czech ta shigo da su China sun samar da kayan aikin da ba su da inganci. Slovakia ta shigo da kayan aikin gwaji miliyan 1.2 zuwa China wanda aka gano ba su da inganci.
Shugaban gwamnatin kasar Matovič ya ba da shawarar cewa ya kamata a tura shi cikin ruwan tekun Danube. Ateş Kara na Hukumar Kula da Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta shigo da su China suna da "babban adadin cutar" kuma "ba za a iya jurewa ba". "Ingila ta shigo da kayan gwajin miliyan 3.5 zuwa China amma a farkon watan Afrilu ta sanar da cewa ba su da inganci.
Binciken, wanda ya biyo bayan ware mutanen da suka kamu da cutar daga sauran mutane da kuma binciken wadanda suka yi hulɗa da masu kamuwa da cutar SARS-CoV-2, ya nuna cewa yana da tasiri.
Masu bincike da ke aiki a garin Viterbo na Italiya, wanda shine farkon lokacin da aka gano COVID-19 a Italiya, sun gudanar da gwajin mutane 3,400 a cikin kwanaki 10.
Kusan rabin wadanda aka gano ba su da wata matsala, kuma duk wadanda aka gano sun kasance a cikin yanayi mai kyau.
Tare da hana zirga-zirgar ababen hawa a cikin birni, wannan ya hana sabbin kamuwa da cuta.
Tare da hana mutane shiga, dakatar da balaguron baƙi, gwaji, keɓewa, annobar cutar coronavirus ta 2020 a Singapore ta kasance mai saurin yaduwa da sauri fiye da sauran ƙasashe masu haɗari, amma ba tare da takunkumi masu mahimmanci ba kamar rufe gidajen abinci da kantuna.
An dakatar da ayyuka da yawa, kuma Singapore ta fara jin daɗin zama a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a cikin lokaci bayan ranar 23 ga Maris.
Yawancin sauran ƙasashe sun magance cutar ta hanyar keɓewa da kuma kula da marasa lafiya, ƙuntatawa kan balaguron shiga, gwaji, da kuma keɓewa, amma tare da ƙa'idodin keɓewa masu sauƙi kamar Iceland da Koriya.
Nazarin ilimin lissafi ya nuna cewa ƙasashe da yawa, dangane da yawan mutuwar, suna da ƙananan ƙimar mutuwa, saboda ƙasashe sun fi dacewa da fahimtar abubuwan da ke faruwa a cikin lokaci ko kuma ba su da kyau.
WHO ta ba da shawarar cewa ƙasashe marasa ƙarancin gwaji da kuma cibiyoyin bincike na ƙasa waɗanda ba su da cikakken bayani game da COVID-19 su gabatar da magunguna shida da suka tabbatar da cutar ta COVID-19 da magunguna goma da suka tabbatar da cutar ta COVID-19 a ɗaya daga cikin cibiyoyin bincike 16 na WHO a matsayin takaddun shaida don tabbatar da gwajin.
Daga cikin wadannan dakunan gwaje-gwaje 16, 7 suna Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amurka da 1 a Australia.
A cikin tebur na gaba, rukunin "Yawan kashi na bincike" ya shafi manufofin bincike na ƙasa.
Kasashen da ke yin gwajin asibiti kawai suna da yawan kamuwa da cutar fiye da kashi ɗaya cikin dari na kasashe da ke yin gwajin al'ummarsu, ko da kuwa suna nuna ko ba su nuna alamun cutar ba, wasu abubuwa suna da kyau.
Wanke hannu, wanda aka fi sani da wanke hannu, yana nufin wanke hannayenka don cire datti, man fetur, ƙura, ko wasu abubuwa marasa amfani.
Yin amfani da sabulu a "a kai a kai" a rana yana hana yaduwar cututtuka da dama, kamar su tari da kuma cutar kwalara, wanda ke yadawa ta hanyar hanci da hanci.
Mutane na iya kamuwa da cututtukan huhu kamar zazzabin cizon sauro ko kuma mura, idan sun wanke hannayensu kafin su taɓa idanunsu, hanci ko bakinsu (misali, idan sun taɓa naman alade mai sanyi).
Akwai lokuta shida na yau da kullum da ya kamata a wanke hannaye da sabulu: kafin da bayan wanka, bayan wanke jariri ko canza kwalban, kafin da bayan wanke abinci ko taɓa kayan abinci, kifi, ko kayan abinci.
Idan ba a sami sabulu da ruwa ba, kana iya wanke hannunka da wanki.
Kafin, a lokacin, da kuma bayan cin abinci.
Kafin da kuma bayan kula da mai haƙuri.
Bayan canza kwalban ko wanke jariri.
Bayan ka hura ƙwai, sai ka yanke ko kuma ka yi sanyi.
Bayan ka shayar da dabba, ka shayar da dabba, ko kuma ka shayar da naman dabba.
Wanke hannu ya ƙunshi tsarin kula da lafiya.
Wanke hannu kafin a ba da magani ko kula da mai cutar na iya hana ko rage yaduwar cutar.
Wanke hannu yana da mahimmanci saboda yana wanke hannaye ta hanyar kawar da cututtukan cututtukan cututtuka (kwayoyin cuta, ƙwayoyin cuta, ko ƙwayoyin cuta masu cutarwa) da sauran abubuwa waɗanda zasu iya cutarwa ko haifar da cuta.
Wannan yana da mahimmanci ga mutanen da ba su taɓa cin abinci ba ko kuma suna aiki a cikin kiwon lafiya, amma kuma yana da mahimmanci ga jama'a.
Wanke hannu yana da fa'idodi da yawa, kamar hana yaduwar cutar sankara, kwayar cutar coronavirus, da sauran cututtukan da ke yaduwa; hana kamuwa da cutar sankara; rage cututtukan huhu;
da rage yawan mutuwar jarirai da ake haifa a gida.
Wani bincike na 2013 ya nuna cewa wanka da wanke hannu na iya haifar da sakamako mai kyau a cikin lafiyar yara har zuwa shekaru shida.
A cikin ƙasashe masu tasowa, ana iya rage yawan mutuwar yara daga cututtukan huhu da cututtukan zuciya ta hanyar gabatar da canje-canje na halayyar, kamar wanke hannu da sabulu.
Wannan matakin zai iya rage yawan mutuwar cutar da kashi 50%.
Matakan da suka rage wanke hannu na iya rage yawan masu cutar ta hanyar kashi uku, wanda ya zama mummunan kamar samar da ruwan sha mai tsabta a cikin wuraren wanka.
48% na raguwar tari da tari na iya danganta da wanke hannu da sabulu. Wanke hannu da sabulu shine mafi inganci da mafi ƙarancin inganci don hana kamuwa da cutar tari da cutar huhu (ARI), kamar yadda muke yi a gida, makarantu, da al'ummomi a duk duniya.
Cutar huhu, cutar ARI ta farko, ita ce babbar hanyar mutuwar yara 'yan kasa da shekaru shida, wanda ke kashe kusan yara miliyan 1.8 a kowace shekara.
Cutar kumburi da kuma ciwon huhu suna kashe yara miliyan 3.5 a kowace shekara.
A cewar UNICEF, sanya wanke hannu da sabulu kafin shan magani ko bayan fitowar gida a cikin al'adarmu na iya ceton rayuka da yawa ta hanyar allurar rigakafi ko magani, rage mutuwar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktuktuktukan cututtuktuktuktuktuktuktuktuktuktuktuktuk
Wanke hannuwanmu sau da yawa yana tare da wasu shirye-shiryen kiwon lafiya kamar su ruwa, tsabtace jiki da kuma tsabtace jiki (WASH).
Rashin hannu yana da haɗari saboda tarzagire wanda ya wuce ta hanyar jiki.
Wani abin damuwa kuma shi ne cewa wanke hannu akai-akai na iya ɓoye ɓoyayyen jiki saboda rashin jin daɗi.
Wani binciken Danish na 2012 ya nuna cewa yawan wanke hannu na iya haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk da cututtuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttuttutt
Yin wasa da hannu yana da alaƙa da rikicewar damuwa (OCD).
Akwai lokuta shida masu mahimmanci don wanke hannu da sabulu don rage yaduwar cututtukan daga hanci zuwa baki: bayan barin gida (kayan wanka, sutura), bayan wanke jariri (kayan wanka), kafin nono, kafin / bayan shayar da abinci ko taɓa kayan wanka mara kyau, kayan wanka ko kayan wanka.
Sauran lokutan da wanke hannu zai zama dole don hana yaduwar wasu cututtuka sun hada da kafin ko bayan kulawar cuta; bayan yin fitsari, yin iyo, ko yin hanci; bayan taɓa muryar dabbobi ko dabbobi masu shayarwa; da kuma bayan taɓa kayan abinci.
A ƙasashe da yawa, yawan mutanen da suke wanke hannuwansu da sabulu ya ragu.
Wani bincike na wanke hannu a kasashe 54 a shekarar 2015 ya nuna cewa, kashi 38.7% na matasa suna wanke hannayensu da sabulu. Wani bincike na 2014 ya nuna cewa Saudi Arabia tana da mafi girma a kashi 97%; Amurka tana kusa da tsakiyar kashi 77%; China tana da kashi 23% na ƙasa. An inganta dabarun canza halayyar zamani don ɗaukar halayyar wanke hannu da sabulu a wasu lokuta da suka zama dole.
Shirin Kula da Lafiya na Muhimmanci da Hukumar Ilimi ta Philippines ta gabatar ya nuna cewa ana ba da fifiko ga lafiyar jiki da ilimin yara.
Yin wanka sau biyu a shekara tare da sabulu, wanke turare wanda yafi amfani da fluoride, yana kan gaba a cikin ajandar ƙasa.
An kuma yi amfani da shi sosai a Indonesia.
Ana cire ƙwayoyin cuta daga jiki ta hanyar ƙara sabulu ko ruwa mai tsabta.
Aikin farko na sabulu da ruwa mai tsabta yana da kyau don rage yawan kayan aiki, yana ƙara yawan ƙonewa.
Wasu ruwa suna da ƙarancin ƙarfi a cikin jiki saboda ƙwayoyin cuta da sunadarai, abubuwa ne masu tasowa, waɗanda ba za a iya cire su ba tare da ruwa ba.
Dole ne a wanke wanka da ruwa mai laushi.
Sabulu mai laushi, saboda ana iya sake amfani dashi, na iya samun kwayoyin da ke rayuwa a ciki yayin da aka yi amfani da shi.
Wasu ƙananan nazarin da suka yi nazarin kwayar cutar daga sabulu da aka yi amfani da shi sun nuna cewa ba za a iya yin kwayar cutar ba saboda kwayoyin sun rabu da numfashi.
CDC ta kuma ce "sabon ruwa mai ruwa wanda ba a taɓa shi da hannu ba yana iya yaduwa".
Ana ba da shawarar sabulu mai kashe ƙwayoyin cuta ga jama'a waɗanda ke da damuwa game da lafiyarsu.
A halin yanzu, babu wata hujja da ta nuna cewa amfani da maganin antiseptics ko maganin kashe ƙwayoyin cuta yana haifar da ƙarancin maganin rigakafi.
Duk da haka, sabulu masu kashe kwayoyin cuta suna da kayan aikin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin COCHACA
Bugu da ƙari, ko da yake maganin rigakafi na rigakafi yana da kyau a cikin sabulu na antibacterial, ba zai iya zama mai tsanani kamar yadda aka bayyana a cikin takarda ba.
A cikin ƙari ga surfactants da kayan aikin kariya na fata, haɗuwa da kayan aiki na iya haɗuwa da acid mai ƙanshi (acetic acid, ascorbic acid, lactic acid) kamar mai hana PH, benzoic acid wanda ke kashe ƙwayoyin cuta da kayan aikin rigakafi (aloe vera, bitamin, menthol, maganin rigakafi). Nazarin da aka gudanar a Jami'ar Oregon School of Public Health ya nuna cewa sabulu mara kyau yana ƙarfafa masu amfani da sabulu masu ƙarancin ƙarfi waɗanda ke da maganin rigakafi wanda ke dauke da triclosan don kawar da cututtuka da kuma kawar da ƙwayoyin cuta daga hannu.
Ruwan zafi da aka yi amfani da shi don wanke hannu zai iya kashe kwayoyin cuta.
Kwayoyin sun fi dacewa da zafin jiki (37 °C).
Duk da haka, ruwan zafi da sabulu sun fi ruwan sanyi tasiri wajen kawar da man fetur da ke dauke da kwayoyin cuta.
Sabanin yadda mutane suke tsammani, binciken masana ya nuna cewa wanke hannu da ruwan sanyi ko sanyi yana taimakawa wajen rage jin zafi a hannu.
Sanitizer ko kuma maganin kashe wuka na hannu shine kayan wanke hannu amma ba kamar ruwa ba.
A ƙarshen 1990s da farkon karni na 21, kayan aikin wanke hannu na giya da na ruwa (wanda ake kira kayan wanke hannu na giya, kayan aikin wanke hannu na antiseptic, ko kayan aikin wanke hannu) sun fara bayyana sosai.
Yawanci yana dogara ne akan isopropyl alcohol ko ethanol wanda aka haɗa tare da kayan aiki kamar Carbomer (polymer acrylic acid) a kan gel, ko kayan aiki kamar glycerin a kan ruwa, ko kuma karfi don samun aiki tare da shi ba tare da wahala ba tare da ragewa ko kuma kamar giya yana motsa hannu.
Ƙara yawan hydrogen-peroxide yana ƙara aikin kashe ƙwayoyin cuta. Sanitizer na hannu wanda ke da kashi 60 zuwa 95% na barasa yana da amfani sosai don kashe ƙwayoyin cuta.
Maganin wanke hannu na giya yana kashe kwayoyin cuta, kwayoyin cuta masu cutarwa (MRSA da VRE), cututtukan hanta, da wasu ƙwayoyin cuta (kamar HIV, herpes, RSV, coronavirus, vaccinia, zazzabin cizon sauro, da cutar zazzabin cizon sauro) da fungi.
Kayan aikin wanke hannu tare da giya mai kashi 70% na giya yana kashe kashi 99.97% (rage log 3.5, kamar raguwar decibel 35) na kwayoyin halittar hannu a cikin sakan 30 bayan wanka da kashi 99.99 zuwa 99.999% (rage log 4 a 5) na kwayoyin halittar hannu a cikin minti 1 bayan wanka.
Maganin wanke hannu da barasa ba shi da tasiri sosai a kan kwayar cutar cuta (ko Norwalk), wanda aka fi sani da cutar ta huhu. Maganin wanke hannu da antiseptic ko kuma barasa ya kamata ya isa ya wanke hannu da hannu biyu.
Kafin da bayan da kuma tsakanin da kuma kammala dukan al'ada kamata a tsoma a cikin ruwa, iska ko gel na tsawon 30 seconds.
Dole ne a wanke dukkan kayan aikin hannu sosai, ta hanyar wanke su da hannu biyu. Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar wanke hannu fiye da kayan aikin wanke hannu, musamman idan hannayen suna kama da tufafi.
Yin amfani da wannan kayan aiki yana da matukar damuwa saboda amfani da shi yana kashe ƙwayoyin cuta; duk da haka, ba zai iya zama mai tsabta ba idan ba tare da sabulu da ruwa ba.
Yin amfani da kayan aikin wanke hannu na yau da kullun tare da barasa na iya rage tasirin jikin mutum yayin da abubuwa masu guba suka karu a cikin mahaɗin.
Za a iya rage ko dakatar da maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin.
Binciken da aka yi a cikin dakin gwaje-gwaje ya nuna cewa kayan aikin wanke hannu suna da kayan aiki na wucin gadi wanda ba a taɓa hannayenka da sabulu ko kayan wanka ba.
Allergic contact dermatitis, contact urticaria ko kuma halayyar shan giya ko kuma abubuwan da ke cikin kayan aikin wanke hannu da kuma giya suna iya zama masu saurin faruwa.
Hanyar rage yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
Ko da yake waɗannan abubuwa suna da ƙarfi, ba sa bukatar wanke hannuwa a kan tufafi, amma suna lalata ƙazanta.
Saboda haka, wanke hannu ba shi da amfani fiye da sabulu da ruwa don hana yaduwar cututtuka da yawa, saboda cututtuka suna cikin hannayen.
Ƙarfafa kayan aikin wanke hannu ba tare da barasa ba bisa ga abin da ke ciki, kuma tarihi ya nuna mana cewa zai iya rinjayar kayan aikin wankewa da barasa.
Duk da haka, wani samfurin da ke dauke da benzalkonium chloride ya nuna cewa yana da tasiri mai tasiri da kuma haɗuwa bayan amfani da shi, ba kamar barasa ba, wanda ya nuna raguwa a cikin ƙarfinsa bayan ci gaba da amfani da shi don amsawa ga jiki.
Mutane da yawa a cikin al'ummomin da ke fama da cutar ba su da damar samun sabulu kuma suna aiki a cikin ƙura da ƙasa.
Ƙasa ko ƙasa na iya zama mai kyau fiye da sauran ruwa, amma zai iya zama mai kyau ga yashi.
Wani matsala kuma shine cewa yanayin yanayi ko ƙasa mai ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin.
Kamar sabulu, inuwa ita ce kayan aikin da ke kashe tsuntsaye domin idan ta haɗu da ruwa, tana zama kamar ƙura.
WHO ta ba da shawarar a yi amfani da kayan ado kamar sabulu ko ruwa.
Tsarin wanke hannu na Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ya ba da shawarar wadannan hanyoyin:
Wanke hannuwanka da ruwan sanyi ko ruwan sanyi.
Ana bada shawarar ruwa mai tsabta saboda mai ɗaukar ruwa zai iya samun cutar, kuma ruwa mai tsabta ba zai canza wani abu ba.
Da farko, ka wanke hannuwanka da sabulu, don numfashi yǎ fito daga hannunka da ƙafafunka da kuma daga ɓurɓurwarka duka.
Sabulu yana kawar da ƙwayoyin cuta daga jiki, kuma nazarin ya nuna cewa mutane sun daina wanke hannayensu idan sabulu ya kasance a kan ruwa mai dafa abinci.
Yi aiki a cikin akalla 20 seconds.
Yin tausa yana haɗa hannuwan, wanda ke kawar da jijiyoyin jiki da kuma yawan tausa yana haifar da yawan raunuka.
Yi wanka da ruwan zãfi.
Yin tafiya a cikin ruwa zai iya sa hannayenka suyi aiki a cikin kullun.
Yi wanka da tufafi masu tsabta ko kuma tare da iska.
Hannun da aka yi wa wanka kuma za su iya zama masu laushi. Wuraren da mutane suke yin wanka da kyau su ne a kan kafa, a kan hannayensu, a tsakanin kafafunsu, da kuma a cikin ƙuƙumma.
Tsuntsaye da aka yi wa wanka ko kuma aka yi wa wanka za su iya zama masu haɗari.
Ana ba da shawarar yin amfani da man shafawa sau uku; yin amfani da kayan shafawa na jiki na iya zama wani mataki na iya haifar da kamuwa da cuta.
Sauran hanyoyin da ba su da sauƙi na wanke hannu a wuraren da ruwa da/ko sabulu suke da yawa, kamar su wanke ruwa a cikin wanka ko kuma a cikin ruwa ta hanyar matosai da/ko kuma shan ruwa a inda ya dace kamar a ƙasashe masu tsabta. A lokutan da ruwa ba shi da yawa (kamar a makarantu ko gidajen abinci a ƙasashe masu tsabta), akwai hanyoyin da za a iya kiyaye ruwa, kamar "tippy-taps" da sauran hanyoyin da ba su da sauƙi.
Tippy tap wani zaɓi ne wanda ke sanya takarda a kan tukunyar tukunyar da sauran kayan da za a iya cirewa daga ƙasa don yin wanka a hannaye da ƙananan sabulu.
Wanke hannu yana da mahimmanci a cikin tsarin tsabtace hannu, amma akwai wasu ra'ayoyi game da yadda ake wanke hannu a cikin ɗakin jama'a.
Yawancin bincike na gaba sun bada shawarar sanya takalma a cikin ɗakin bayan gida maimakon a cikin ɗakin bayan gida.
A shekara ta 2008, an gudanar da wani bincike a Jami'ar Westminster, London, tare da taimakon Tissue Symposium na Turai, don gwada tasirin tsabtace kayan aiki na kayan aiki, da kuma kayan aikin hannu da kuma kayan aikin hannu.
Bayan wanke hannu da kuma wanke hannu, duk kwayoyin da aka gano sun kasance a kan kayan wanka da kashi 194% da kuma a kan hannu da kashi 254%.
Yin wanka da iska mai iska ya nuna raguwar kwayoyin cuta a kan kayan ado na 42% da kuma a kan hannuwan hannu 15%.
Bayan wanke hannu da wanke takarda, yawan kwayoyin sun ragu da kashi 76% a kan kayan wanka da kuma kashi 77% a kan hannu. Masana sun yi nazarin gwajin don gano ko cutar za ta iya yaduwa daga wasu ma'aikata da kuma wasu wurare na dakin kamar yadda aka nuna a kowane tsarin wankewa.
Tsarin iska mai iska, wanda ke motsa iska a cikin 180m/s (650 km/h; 400 mph), zai iya hura iska daga hannayensu zuwa gawarwakin kuma zai iya shafar mutane a cikin ɗakin da ke kusa da ɗakin a cikin mita 2.
Yi aiki tare da umarnin saurin hannu don yada kayan aiki zuwa mita 0.25 tare da umarnin saurin.
A cikin gida, ana iya gano yaduwar ƙwayoyin cuta. A shekara ta 2005, a wani binciken da TÜV Pordukt und Umwelt ya gudanar, an gano hanyoyin da za a iya yin amfani da su.
Ga wasu bayanai kan yawan kwayoyin bayan wanke hannu:
Akwai masu yin allurar rigakafi daban-daban, da kuma allurar rigakafi a kan takardun gida.
Wanke hannu da kayan wanki shine madadin lokacin tafiya ba tare da sabulu da ruwa ba.
Dole ne kayan aikin wanke hannu na giya su kasance aƙalla kashi 60% na giya.
Wanke hannu ya zama dole har sai da likitan Hungary Ignaz Semmelweis ya gano amfaninsa (a 1846) don hana kamuwa da cuta a wani sashin asibiti.
Akwai umarni da ke tunatar da ma'aikatan asibiti su wanke hannayensu bayan sun yi sallah.
Wani bincike ya nuna cewa ana iya rage yawan kamuwa da cutar idan aka yi amfani da shi.
Wanke hannuwanka na tsawon dakika 15, tare da sabulu da ruwa ko gel don samun iska mai kyau.
Sai ya yi kuka, yana kuka, yana kuka, yana kuka.
Idan akwai tufafi a cikin takalma, ana iya amfani da su don yin tufafi.
Tun da yake ana iya samun ƙwayoyin cuta a hannu, yana da muhimmanci a wanke hannuwan da tsabta kuma a rufe su da tufafi masu tsabta.
Bayan barci, ya kamata a ɗauki takalma don rufe ɗakin (kuma a buɗe kofa idan akwai).
Don kiyaye hannunka daga ɗaukar kaya kuma.
Amfanin wanke hannu a wuraren da ake samun lafiya a jiki shine don kawar da ƙwayoyin cuta ("ƙwayoyin cuta") da kuma hana yaduwar su ga wasu mutane.
The New England Journal of Medicine ta lura cewa rashin wanke hannu ya zama ruwan dare a yawancin fannonin kiwon lafiya, kuma likitoci da masu kula da marasa lafiya suna wanke hannu kafin su taɓa marasa lafiya, wanda ke haifar da yaduwar cututtuka ga wasu.
Wani bincike ya nuna cewa wanke hannu da kuma wasu takardun shaida na iya rage kamuwa da cutar ta hanyar catheter ta hanyar kashi 66% na cutar.
An samo takardar shaidar tsabtace hannu ta hanyar yanar gizon yanar gizon don amfanin jama'a.
Wani muhimmin bincike ya wuce ta hanyar Whitby et al.
Umurnin kasuwanci na iya gwadawa da karɓar tsabtace jiki, idan akwai alamun da ke nuna cewa umarnin ya ci gaba.
Hukumar Lafiya ta Duniya ta kafa "Ranar Jehovah" don wanke hannu:
bayan taɓawa da jini/jinsi
kafin aikin kula da marasa lafiya, da
Bayan kulawar mai haƙuri. Ƙara kayan aikin kashe ƙwayoyin cuta a cikin sabulu (sabulu "na asibiti" ko "mai kashe ƙwayoyin cuta") yana ƙarfafa kashewa a cikin kayan aikin wanke hannu.
Irin wannan aikin na kashewa zai iya zama da amfani kafin a kama mutum ko kuma a wurin da aka samu cututtukan da ke da cutar. Don 'yanke' hannayen a wurin da aka kama, yana da muhimmanci a sami ruwa mai tsabta wanda mutum zai iya buɗewa ko rufewa ba tare da taɓa hannu ba, wanke tare da chlorhexidine ko iodine, takalma da ba a taɓa amfani da su ba, da kuma goga mai tsabta da kayan tsabta don tsabtace ƙwayoyin cuta.
Sai ku kawar da dukan ƙazanta.
Wannan tsari yana buƙatar wanke hannu daga ƙasa zuwa ƙasa, yawanci a cikin minti 2-6.
Yin barci mai yawa a kan kuka (minti 10) ba shi da amfani.
A lokacin wanka, ana zubar da ruwa uku a hannayenka.
Bayan an gama wanke hannayensu, sai a wanke hannayensu da tufafi masu tsabta kuma a sanya suturar mai tsabta.
Don rage yaduwar cututtukan cututtuka, yana da muhimmanci a wanke hannu ko kayan aikin wanke hannu kafin da kuma bayan kula da marasa lafiya.
Don hana kamuwa da cutar staphylococcus a asibitoci, an nuna cewa yawan riba a cikin wanke hannu ya kai kashi 20% na farkon wankewar, tare da ƙaramin ƙaruwa da ya faru yayin da yawan wanke hannu ya ƙaru zuwa 35%.
Wanke hannu da sabulu ya ninka sau uku yawan kamuwa da kwayoyin cuta da ke yaduwa a cikin abinci fiye da wanke hannu da sabulu mai kashe kwayoyin cuta. Kwatanta wanke hannu da kayan maye da sabulu mai kashe kwayoyin cuta a cikin sakan 30 daban-daban ya nuna cewa wanke hannu da kayan maye ya rage yaduwar kwayoyin cuta da kashi 26% fiye da wanda aka yi da sabulu mai kashe kwayoyin cuta.
Amma sabulu da ruwa sun fi amfani da kayan aikin wanke hannu da ke dauke da barasa wajen rage kamuwa da kwayar cutar H1N1 A da kuma Clostridium difficile spores a hannu. Hanyoyin da za a inganta yawan wanke hannu a wuraren kiwon lafiya na iya hada da wayar da kan ma'aikata game da wanke hannu, wanda ke kara wadatar kayan aikin wanke hannu da ke dauke da barasa, da kuma yin amfani da su a rubuce da kuma a baka ga ma'aikata.
Akwai buƙatar ƙarin bincike wanda waɗannan hanyoyin zasu iya zama mahimmanci a wasu fannoni na kiwon lafiya.
A cikin ƙasashe masu yawan gurɓataccen abinci, wanke hannu da sabulu an san shi da tsabta, hanya ce mai mahimmanci don kiwon lafiya, da kuma abinci mai gina jiki.
Koyaya, rashin isasshen ruwa, sabulu ko wuraren wanka a gidajen jama'a, makarantu da ofisoshi an bayyana su a matsayin matsala ga halayen wanke hannu.
Misali, a yawancin kasashen Afirka, akwai matsala wajen samun isasshen ruwan wanka a cikin gidajen wanka na mutum ko na jama'a, duk da cewa akwai damar gina wuraren wanka na yau da kullun.
Koyaya, ana iya samun ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin.
Ji da kuma bayyanar da wanke hannu da sabulu na iya shafar manufofin al'ada, bayyana fa'idodin wanke hannu da kuma canza halayyar jama'a a nan gaba.
Don tabbatar da cewa tsarin yana aiki da kyau, kulawa da gwaji suna da mahimmanci.
Binciken binciken 70 ya nuna cewa dabarun canza al'umma suna da mahimmanci don rage wanke hannu a LMIC, yayin da wasu lokuta kuma ke haifar da kuskuren al'umma don sayen kayan abinci ga yara. Wani tabbaci na jin daɗin wanke hannu a makarantu shine tsarin da UNICEF ta kira "Taro na Uku" wanda ke ba da shawarar makarantu su ɗauki matakan da suka dace don tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu, a tsakanin sauran hanyoyin tsabtace jiki.
Idan an yi taron farko, za a iya samun maki uku.
Gina wuraren wanka na iya shiga cikin tsarin da ake kira na wanke hannu da gaggawa don rage cututtukan cututtuka da mutuwar yara.
Ranar Rashin Goge Hannun Duniya wata alama ce ta kare hakkin dan adam wanda ya haifar da sauyin hali.Dangane da cutar coronavirus ta 2019-20, UNICEF ta ba da shawarar karɓar wanke hannu.
Karamin bincike ya yi lissafin yawan kudin da wanke hannu zai iya kaiwa ga kasashe masu tsabta kamar yadda DALY ta ruwaito.
Koyaya, akwai wasu bincike da ke nuna cewa wanke hannu da sabulu ya fi dacewa da wanke ruwa ko wasu hanyoyin kiwon lafiya.
Amfanin wanke hannu a rayuwar mutum, musamman ga al'umma da ke cikin wasu yanayi kamar su marasa lafiya ko sojojin da ke cikin asibiti, ya bayyana a tsakiyar 1900s ta hanyar masu fafutukar tsabtace jiki: Ka yi la'akari da ɗan Hungary Ignaz Semmelweis wanda ya yi aiki a Vienna, Austria da Florence Nightingale, "mahaifiyar likitan" Ingila.
A lokacin da yawancin mutane suka yi tunanin cewa cutar ta haifar da cututtuka masu yawa da ake kira miasma.
A cikin shekarun 1980, cutar da ke yaduwa ta hanyar abinci da kuma cututtukan kiwon lafiya sun sa Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ba da shawarar tsabtace hannu a matsayin muhimmin mataki na hana yaduwar cutar.
Bayyanar cutar sankara ta 2009 da cutar COVID-19 ta 2020 sun kara karfafa gwiwa a kasashe da dama kan muhimmancin wanke hannu da sabulu wajen kare kai daga cututtuka.
Misali, hotuna da "mahimman shawarwarin wanke hannu" suna kan allon wanke hannu a cikin ɗakunan jama'a da kuma ɗakunan ajiya da tashar jirgin sama a Jamus.
Kalmar nan "wanke hannuwanka" tana nufin cewa kana son ka shiga cikin wani abu ko kuma ka zama mai taimako.
Ya fara ne da labarin Matta cewa Bilatus Babunti ya sa hannunsa a kan Yesu Kristi, amma wannan labarin ya zama sananne ga Ikilisiyar Ingila.
A Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta don ta nemi gafarar wani laifi da ke cikin zuciyarta, wanda ya nuna mata laifin kisan da ta sa mijinta ya shiga cikinta.
An kuma gano cewa mutane, bayan yin wanka ko yin tunani game da abubuwa masu ban sha'awa, suna wanke hannayensu a kai a kai fiye da wasu mutane, kuma suna da daraja ga kayan wanke hannu.
Bugu da ƙari, mutanen da ke da alhakin wanke hannu bayan irin waɗannan ayyuka suna shirye su shirya ayyukan "tsabtacewa" a matsayin taimako.
Dinanci suna ba da shawarar wanke hannu don hanyar wankewa da bayyanuwa. Wanke hannu, tare da ruwa ba tare da sabulu ba, ya zama sananne a cikin yawancin addinan addinai, kamar su Bahá'í Din, Hindu, tevilah da netilat yadayim a cikin addinin Yahudanci, Lavabo a cikin Masallaci, da Buddha a cikin Musulunci.
Addinin Hindu, addinin Yahudanci da Musulunci sun saba da wanke hannu a bayan gida.
A gaskiya ma, Hindu, Buddha, Sikhism, Judaism da Musulunci sun bada shawarar wanke hannu kafin da kuma bayan kowane abinci.
Hanyoyin haɗarin aiki na COVID-19
Binciken haɗarin aiki na COVID-19 shine ingantaccen tsarin aiki na muhalli da kiwon lafiya don hana cutar coronavirus 2019 (COVID-19).
Matsayin haɗarin a wurin aiki ya bambanta dangane da wurin aiki da nau'in aikin, dangane da kimanta haɗarin haɗuwa, yaduwar cuta a cikin al'umma, da abubuwan da ke iya hana ma'aikata masu yuwuwar kamuwa da COVID-19.
Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA) ta ce, irin wannan aiki na gida ba shi da haɗari sosai don haɗuwa da jama'a ko ma'aikata, wanda matakan rigakafin farko suka ba da shawarar, kamar wanke hannu, sanya ma'aikata kaɗan a gida idan sun kamu da cutar, tsabtace numfashi, da tsabtace wuraren aiki.
Ayyukan da ke da haɗarin kamuwa da cutar sun haɗa da waɗanda ke da alaƙa da waɗanda ba a san ko ba a san su ba tare da cutar COVID-19, amma waɗanda za su iya kamuwa da cutar ta hanyar watsa jama'a na yanzu ko ta hanyar tafiya zuwa wata ƙasa.
Wannan ya hada da ma'aikata masu iyawa da kuma zamantakewa kamar a makarantu, wuraren aiki masu yawan jama'a, wuraren da aka sanya kayan tallace-tallace masu yawa.
Abubuwan da ke haifar da wannan rukunin haɗarin, ban da matakan rigakafin farko, sun haɗa da iska ta hanyar umarnin hana yaduwar ƙwayoyin cuta, suturar da ke rufe ƙwayoyin cuta, da kuma sanya tufafin kariya na mutum a wurin da za a iya saduwa da wanda ke da COVID-19.
OSHA tana lissafin ma'aikatan kiwon lafiya da ma'aikatan kiwon lafiya da suka mutu kamar yadda suka gano kansu ko wani wanda ke da cutar COVID-19 a matsayin mai haɗarin kamuwa da cutar, wanda ke ƙara haɗarin haɗari idan ma'aikata suka yi abubuwan da ke fitar da aerosol akan, ko kuma suyi magana, ko kuma su taɓa magunguna, wani wanda ke da cutar ko kuma wanda ke da cutar COVID-19.
Abubuwan da ke da mahimmanci ga masu amfani da wannan nau'in sun hada da ingantattun kayan aikin injiniya kamar su ɗakunan iska, da kayan aikin da suka dace da aikin.
Cutar COVID-19 na iya haifar da haɗari a wuraren aiki.
Ma'aikata na iya hana su zuwa aiki saboda kamuwa da cutar, don kula da wasu, ko kuma saboda tsoron kamuwa da cutar.
Hanyoyin kasuwanci na iya bambanta, duka dangane da kayan da ake amfani da su, da kuma hanyoyin da za a iya samun kayan (misali, ta hanyar yin amfani da su a lokacin da kayan ke da wuya, ko ta hanyar masu gyara a gida ko a cikin motoci.
A ƙarshe, ana iya dakatar da shigo da kayayyaki daga yankunan da COVID-19 ke da tasiri sosai. Shirye-shiryen rigakafi ko amsawa na iya zama dole don kiyaye ayyukan.
Shirye-shiryen sun rage haɗarin haɗari da ke tattare da wuraren aiki da irin waɗannan ayyukan, kamar su kai tsaye, abubuwan da ke haifar da haɗari a cikin gida da kuma cikin al'umma, da abubuwan da ke haifar da haɗarin haɗarin haɗarin haɗari ga masu amfani da kai kamar su haɗari ko kuma wasu cututtuka masu zuwa.
Sun kuma kafa matakan kariya don rage irin wannan hadarin, tare da tsara jadawalin keɓewa don abubuwan da zasu iya faruwa a matsayin alamun kamuwa da cuta.
Shirye-shiryen da shirye-shiryen amsawa ga cutar na iya zama na kasa ko lardin.
Dabaru na amsa cutar sun hada da hana yaduwar cutar ga ma'aikata, masu kula da mutane da sauran mutane masu saurin kamuwa da cutar, ci gaba da kasuwanci, da kuma rage wasu hadari a wani bangare na tafiyarsu.
Cutar ta shafi al'ummomin da kasuwancin ke gudana kuma yana shafar hanyoyin da aka tsara.
Gudanar da haɗari shine tsarin da ake amfani dashi a cikin kiwon lafiya da kuma kiwon lafiya don samar da tsaro da kuma ƙungiya tare da amfanin su.
A cikin yanayin da ba za a iya kawar da haɗarin COVID-19 ba, mahimman matakan kiyayewa sune kulawar injiniya, biye da kulawar aiki, kuma a ƙarshe kayan aikin rufewa.
Ingantaccen bincike ya shafi ma'aikata da haɗarin aiki ba tare da la'akari da halayyar ma'aikaci ba, kuma yana iya zama mafi inganci.
Canjin aiki shine canji a cikin manufofin aiki ko ƙa'idodi waɗanda ke buƙatar haƙƙin ma'aikaci ko mai sarrafawa.
Kayan kariya na jiki (PPE) ba su da tasiri sosai a kan aikin injiniya da aikin aiki, amma suna iya zama da amfani ga sauran matakan kariya.
Kowane PPE dole ne a zaɓa bisa ga haɗarin mai amfani, wanda ya dace (kamar umarnin fashewa), an saka shi da kyau kuma an tsabtace shi, an bincika, an tsabtace shi, kuma an canza shi idan ya dace da lokaci, cire shi da kyau, cire shi, ko kuma a yi amfani da shi don haɗuwa da wasu.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ba su da tabbaci ba na iya zama da illa ga jama'a ko kuma wasu ma'aikata.
Matakan rigakafin cutar da aka ba da shawarar a cikin wuraren aiki sun haɗa da wanke hannu sosai da kuma a kai a kai, ƙarfafa ma'aikata su zauna a gida idan sun kamu da cutar, tsabtace numfashi ta hanyar rufe sutura da kayan shafawa, samar da takalma da mai tsabtace tufafi, shirya don sauya yanayin rayuwa ko ƙaura idan ya cancanta, hana ma'aikata uku suyi aiki tare da kayan aiki ko umarnin wasu, da kuma tsabtace da kuma tsabtace wurin aiki.
Sanin lafiya da kuma ware mutanen da ke da cutar wani muhimmin mataki ne na kare ma'aikata, abokan ciniki, masu ba da izini, da sauransu a wurin aiki.
Hukumar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta ba da shawarar cewa ma'aikata da ke da alamun cututtukan huhu na yau da kullun su zauna a gida har sai sun sake yin fitsari, alamun rashin lafiya, ko kuma alamun rashin lafiya bayan awanni 24 ba tare da shan maganin hana kumburi ko kuma wasu alamun cutar ba, kuma cewa su yi watsi da cutar, ba da izinin ma'aikata su zauna a gida don kula da dangin su da ke da cutar a gida, kuma masu karɓar wannan manufar sun yarda.
A OSHA, ayyukan da ke da hadari sun hada da wadanda ke son yin hulɗa da mutane a cikin nisan kafa shida (1.8 m) wanda aka sani ko kuma wanda ke da cutar COVID-19, amma wanda zai iya kamuwa da cutar SARS-CoV-2 ta hanyar watsa jama'a a cikin wuraren kasuwanci, ko kuma ta hanyar wani wanda ya yi balaguro kwanan nan zuwa wata ƙasa tare da watsa COVID-19.
Wannan ya hada da ma'aikata da ke tare da jama'a kamar makarantu, wuraren aiki masu cunkoso, da wuraren cin kasuwa inda abubuwa suka yi yawa. Binciken injiniyoyi na kanjamau da kungiyoyin da ke da matukar hadarin kamuwa da cutar sun hada da sanya kayan aikin tsabtace iska, kara iska, sarrafa abubuwa kamar yumbu, da kuma sanya takunkumi a kan motocin cin kasuwa. Binciken gaggawa da kungiyoyin da ke da hadarin kamuwa da cutar sun hada da sanya ma'aikata da ke da cutar a gida, canza yanayin da ke cikin gida ko kuma a cikin gida, hana abokan ciniki shiga cikin gida, samar da ayyuka na gaggawa da kariya kamar su kare lafiyar COVID-19, samar da hanyoyin da za a iya magance cutar, samar da ingantaccen tsarin kula da lafiyar jiki, samar da ayyukan kare lafiyar jiki, samar da ingantaccen tsarin kula da lafiyar jiki, samar da ingantaccen tsarin kula da lafiyar jiki, samar da ayyukan kare lafiyar jiki, da kuma samar da hanyoyin kare lafiyar COVID-19.
Ma'aikata a cikin wannan rukuni suna buƙatar umarni na farawa.
Idan mutum ya kamu da cutar a cikin jirgin sama, matakan kariya na musamman ga ma'aikata da sauran ma'aikatan sun hada da ware mai cutar daga sauran mutane, kasancewa a kusa da kafa shida, sanya wani mutum a cikin kulawar mai cutar, da kuma sanya takunkumi a kan mai cutar ko kuma koya wa mai cutar ya rufe bakinsa da hanci da takalma yayin yin hanci ko fitsari.
Ma'aikatan Kabin dole ne su sanya kayan kariya na hannu bayan kula da mai haƙuri wanda ke tafiya ko taɓa ƙwayoyin cuta ko ƙafafun da aka shafa, idan ya cancanta tare da wasu kayan kariya idan mai haƙuri yana da ciwon jiki, ciwon huhu mai ɗorewa ko matsalar numfashi.
Dole ne a ajiye kayan rufe hannu a cikin ɗakin da ake riƙe da irin waɗannan kayan, kuma ya kamata a tsabtace ƙafafun da ke da cutar kuma a tsabtace su. Baya ga hana fitar da kayayyakin kasuwanci, kamar jiragen sama da sauran wuraren da ba a kula da su ba, rigakafin cutar ya hada da hana tafiya idan mutum ya kamu da cutar, kasancewa a gefe da kuma sanar da ma'aikatan kiwon lafiya idan kun ji zafi.
A wani bangare, ana iya samun kulawa a cikin ɗaki mai nisa. Game da makarantu da makarantun yara, CDC ta ba da shawarar rufewa na ɗan lokaci don yin wanka ko wanka idan mutum mai kamuwa da cutar yana cikin ɗakin makaranta ba tare da la'akari da yaduwar jama'a ba.
Idan akwai ƙarancin yaduwar cutar a cikin al'umma, tsarin keɓewa na iya zama mai tasiri kamar dakatar da tafiye-tafiye, tsare-tsare, da kuma abubuwan da suka shafi zamantakewar jama'a kamar yin gasa, yin waƙa ko cin abinci a cikin gidajen abinci, ƙara ƙuƙwalwa a tsakanin gidajen abinci, rage lokacin isowa da fita, hana baƙi zuwa ko amfani, hana asibiti don wasu yara waɗanda ke da alamun cutar.
Idan akwai kamuwa da cuta a cikin al'ummar yankin, bayan da aka fara aiwatar da matakan hana jama'a, za a iya tsawaita lokacin rufe makarantun.Dangane da yawan mutanen da ke kula da cutar ko kuma abin da ya faru, CDC ta ɗauki haɗarin lafiya na yau da kullun.
An shawarci mutanen da ke tare da mutanen da ke da ko kuma za su iya kamuwa da cutar COVID-19 su bi ka'idodin da ma'aikatan kiwon lafiya ke bi, kamar su sanya kayan kariya.
Idan aka yi aiki a lokacin da aka kama, ma'aikata su tsabtace kayan aikin su da kayan aikin su kafin amfani da su kuma suyi amfani da kayan aikin tsabtace gida ko tsabtace gida, kuma su bi ka'idodin aiki na musamman wanda ya haɗa da adanawa da kuma samar da PPE da kuma sanyawa ko sutura.
OSHA tana daukar ma'aikatan kiwon lafiya da na gaggawa a lokacin da aka kai ga gaggawa ko kuma hadarin gaske.
Ayyukan da ke da haɗari sun haɗa da ma'aikatan kiwon lafiya, masu ba da agaji, masu bincike, da kuma kula da lafiyar jiki waɗanda ke tare da marasa lafiya waɗanda ke da ko kuma waɗanda ke da cutar COVID-19.
Akwai haɗari sosai idan ma'aikata suka yi aiki tare da masu kula da iska, ko kuma suka yi amfani da ko kuma suka taɓa takunkumi a kan mutanen da aka sani ko kuma waɗanda ke da cutar COVID-19.
Hanyoyin yin amfani da aerosol sun hada da watsa abubuwa ta hanyar baki, hanyoyin motsa jiki, bronchoscopies, tsarawa da sauran gwaje-gwaje na jijiyoyin jiki, ko kuma yin gyaran fata.
Ayyukan masu haɗarin aiki na gawawwakin sun haɗa da tsara haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗ
Aikin iska mai iska mai iska yana iya zama da amfani a wasu fannoni na kiwon lafiya da kuma kulawar waje.
Dole ne a bi matakan tsaro na matakin 3 na kiwon lafiya.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa masu shiga su keɓe kansu a wuraren da za a iya samun cutar COVID-19. Baya ga PPE, OSHA ta ba da shawarar umarnin yin allurar rigakafi ga mutanen da ke aiki a kusa da waɗanda ke da cutar SARS-CoV-2, da kuma waɗanda ke gudanar da ayyukan aerosol.
A Amurka, takardar shaidar N95 da NIOSH ta amince da ita ko kuma mafi girma dole ne ta yi aiki tare da takardar shaidar rigakafin numfashi, wanda aka tsara azaman bincike, nazari, da kuma bincike.
Wasu umarni na numfashi na iya ba da ƙarin kariya da kuma kare mai amfani. WHO ta ba da shawarar suturar rufewa ta jiki saboda COVID-19 cuta ce ta huhu da ake ɗauka ana yaduwa ta hanyar kwayar halitta.
WHO ta ba da shawarar sanya takunkumin rufe fuska ga ma'aikatan asibiti.
Wadanda ba su kula da cutar ba, ko kuma ba su kula da cutar ba.
Idan ana amfani da tsarin aerosol, ana maye gurbin murfin fuskar mai binciken da N95 ko FFP2.
Saboda rashin wadatar kayan aikin PPE a duniya, WHO ta ba da shawarar rage bukatar PPE ta hanyar gwajin yau da kullun, matakan kamar ƙofofi da shinge, wanda ke ba da damar samun damar shiga cikin masu kula da COVID-19, amfani da kayan aikin PPE a inda ake aiki, amfani da umarnin da kuke da shi ba tare da cire shi ba yayin kula da marasa lafiya daban-daban waɗanda ke da irin wannan gwajin, kiyayewa da kiyaye masu sayen PPE, hana
DAGA: Katherine Maher, Shugaba na Gidauniyar Wikimedia
HA: Dukkanin kungiyoyin Wikimedia Foundation
TAMBAYA: [Covid-19] rigakafin cutar da tsara makomar
LOKACI/SAKON SHAGA: 14 ga Maris, 2020, 00:24 UTC
Licensing: CC0: Babu haƙƙoƙi
Mun sami kanmu a cikin wannan matsala ta wata.
Cutar COVID-19 wani lamari ne da ya sa rayuwarmu ta ɗan adam ta kasance cikin matsala yayin da muke fuskantar matsalolin yau da kullun.
Ba mu da tabbaci game da hakan, amma mun san cewa amsoshinmu masu mahimmanci sun dogara ne akan jinƙai da rashin jin daɗi, aiki, da kuma aiki a cikin al'umma wanda yake tsakiyar rayuwar.
Tausayi da kulawa ga al'umma da muke hulɗa da abokanmu ta hanyar imel, kira, da saƙonni muhimmin aiki ne wanda ɗan adam yana da damar yin amfani da shi.
Ba zan ƙara gode muku ba, domin kun sa ni in yi wa waɗansu laifi.
A makon da ya gabata, wani ya raba ni da aikinmu.
Ya tunatar da ni yadda yake da muhimmanci a duniya a canza ta hanyar Wikipedia a yanzu, kuma yana da matukar muhimmanci cewa wannan tsari ya kasance mai mahimmanci kuma kowa zai iya samun dama.
Ayyukan da kuke yi na iya zama mai ban sha'awa, ko dai ta hanyar kula da shafukan yanar gizo ko abokan ciniki ko kuma al'ummomin zamantakewa.
Duniya na bukatar bayanan da Wikipedia ke bayarwa, yanzu fiye da kowane lokaci.
Wannan lokaci ne na ƙarshe ba kawai abin da muke yi ba, amma yadda muke yi, zai kawo rarrabuwa a duniya.
Saboda darajar wannan aikin da abin da za ku iya yi a ciki, za mu sake nazarin hanyoyinmu na yadda za mu yi aiki, farawa a mako mai zuwa.
Bayani game da ayyukanmu da kuma tsarinmu
Kamar yadda Robyn ta bayyana a takaice, c-team din sun hadu ne domin su daidaita tsarin da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A cikin wannan hira, mun yi la'akari da abin da muke tsammanin zai zama muhimmiyar amsa ga abin da muke gani a yanzu da kuma yadda za a inganta al'umma a wannan lokacin.
Ba ma so mu yi ta gunaguni, sai dai mu yi aiki tuƙuru don mu sami abin da muke bukata.
Idan kana so ka dawo, ka yi hakan.
A cikin dukan ƙungiyoyi, mai ba da aiki, da kuma ma'aikata:
aikinmu wanda zamu iya yin duk abin da aka rubuta shine a karfe 4 na yamma a rana, ko 20 na yamma a mako don ƙarin bayani.
Za mu sanar da ku cewa idan kuna iya aiki a cikin wasu ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Amma, a wannan duniyar da babu wanda zai iya sanin abin da zai faru a nan gaba, ko kana son ka kula da ƙaunataccenka, ko kana son ka sayi kaya, ko kuma ka je wurin likita, lafiyar jikinka tana da muhimmanci a gare mu.
Bari mu ji abin da kuka yi da lokacin da kuka mutu.
Idan kana da rashin lafiya, yi aiki.
Ba ma bukatar mu yi musu magana, amma muna yi musu magana.
Idan akwai wata matsala ko PTO da za a iya warwarewa, sanar da shugabanka kuma taimaka wa ƙungiyarka ta tsara jadawalin don sanin ko an rufe wuraren da ake buƙata.
(Idan ka yi gwajin COVID-19, ka yi amfani da bayanan Bryau a cikin T&C Ops don tabbatar da cewa kana da lafiya kuma ka bi ka'idodin da aka tsara game da kai).
Waɗanda suka yi aiki a kan ƙarfe, sun sami albashinsu.
Mun gama, mun shirya mu ba da lissafinmu ga masu ba mu aiki da kuma abokan aikinmu a cikin jirgin ruwa.
Duk wanda ya yi wasa, zai sami albashinsa daidai da na waɗanda suka yi wasa a dā.
Ko da yake ba za ka iya aiki ba idan kana rashin lafiya.
Idan kana son yin aiki, za mu taimake ka.
Mutane da yawa suna ganin aiki a matsayin hanyar da za su iya bayyana ra'ayinsu a cikin duniyar yau.
Amma abin da muke yi yana da amfani, musamman ma a wannan lokaci.
Ƙari ga haka, yana nufin kula da kanka da kuma kanka.
Muna fata za ku iya sa shi ya yi magana da ku, don kada ku yi shakka a cikin abin da ya faru, amma ku yi magana da mu a kan abin da ya faru.
Sauran aikin ya zama dole.
Akwai wasu abubuwa da za a ci gaba da yi.
SRE, HR Ops, Trust & Safety, da kuma Ƙungiyoyin Taimako (a tsakanin wasu) suna yin aiki mai mahimmanci wanda zai iya buƙatar ƙarin taimako.
Mun fara tattaunawa da dukkan kungiyoyi don muyi la'akari da hanyoyin da muke bi yanzu da kuma daidaita ayyukanmu zuwa ga abubuwan da suka fi dacewa da aikinmu.
Akwai aiki mai yawa a cikin waɗannan abubuwa, amma bari mu zaɓi abubuwa mafi muhimmanci.
Gama wahala ta yau za ta zama wahala ta gobe.
Muna fatan "ku ninka lokacinku na yin sulhu" bayan barkewar cutar.
Ba za ku bukaci ƙarin kayan aiki don ku daidaita abin da muke yi yanzu ba.
Mun san cewa abubuwa suna canzawa, kuma muna aiki don daidaita dabarunmu da shirye-shiryenmu zuwa inda ya dace.
Menene ke faruwa da APP (Abubuwan da ke faruwa)?
Don daidaita aikinmu na yanzu da kuma abin da za mu iya yi a yau, muna so mu daidaita lokacin da za mu gabatar da shirinmu na 2020-2021.
A cikin tunaninmu muna son muyi amfani da jadawalin 2019-2020 wanda ke ba da lokaci mai yawa don tara kuɗi don ba da izinin ma'aikata masu aiki, kula da kansu, da kula da ƙaunatattun su yayin da muke ɗaukar waɗanda ke son shiga ko waɗanda ke son rage jadawalin su a cikin makonni masu zuwa.
Wannan lokaci ya rage yawan ayyukan gaggawa a cikin al'umma.
Za mu gabatar da shirinmu ga shugaban kasa a mako mai zuwa kuma mu sanar da 'yan adawa da kungiyoyi a taron da ke tafe idan muka samu wannan amsa.
Muna godiya ga kungiyar APP saboda goyon bayan da kuka bayar.
Samun daidaito, nunawa da kuma tsabtace
A makon da ya gabata, mun sami labarin cewa wani danginmu da ke SF ya kamu da cutar COVID-19.
Amma, a kan dukkan alhakinmu, mun dauki wasu kungiyoyi don kula da tsabtace da kuma kawar da duk wani abu da ke dauke da kwayar cutar a yankin San Francisco.
Ƙungiyar ta yi amfani da tsarin rigakafin cutar da ake amfani da shi a asibiti don tsabtace ɗakunan, da kuma shigarwa, da kuma kayan aikin gyaran jiki a cikin ɗakin.
Ginin yana amfani da tsarin tsabtace jiki kuma yana amfani da kayan aikin tsaro.
Muna aiki tuƙuru don mu sami aikin da zai sa mu yi tunani sosai game da abin da za mu yi.
Wani dan kungiyarmu na DC a WeWork, wanda ya raba mana da tsarin COVID-19 tare da wani dan kungiyar DC.
A makon da ya gabata, ofishin mu na DC ya koma wani yanki mai matukar zafi wanda ke bin tsarin da aka raba tare da San Francisco.
Kamar abokanmu da ke NYC, mun kuma tattauna batun sayen wani gida a Brooklyn.
Wadannan abubuwan suna ci gaba amma suna iya yin barci.
Wasu 'yan'uwanmu suna aiki tun suna yara a karo na farko.
Abokanmu da suka iya aiki tun da wuri sun san cewa za a iya yin gwaji, suna so su ba ku wasu shawarwari:
Rage yawan tarurruka a cikin taron zuwa daya ko biyu.
Idan akwai bukatar ƙarin tattaunawa, duba yadda za mu iya samun su a cikin kwanaki da yawa.
Ka ba da gudummawa ga taron, ko kuma ba za mu iya ba, kuma aika da kayan karatu a kan lokaci
Yi bidiyo na ƙarshe, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe aiki tare da haɗin kai.
Masu sauraro suna kula da taron, wani zai iya tsara bayanan don tattaunawa da kuma kula da adadin masu magana, da kuma wani don taimakawa wajen rubuta lissafin (ko aiki da rubutu).
Aika imel zuwa goyon bayan fasaha idan kana buƙatar kayan aiki mai kyau.
Ka yi addu'a ga Allah don abinci.
Shiga tashar #remoties a Slack don tattaunawa da abokanka game da aikin da aka yi watsi da shi
Ƙungiyar HR ta shiga cikin shirin gabatar da shi a cikin yanar gizo don taimakawa tare da aikin da aka rarraba a cikin Gidauniyar.
A makon da ya gabata mun sanar da masu sauraronmu game da ayyukan zamantakewar da Wikimedia ke tallafawa, kamar su edithons, yayin da WHO ta ayyana cutar a matsayin annoba.
Mun gaya musu cewa mun fahimci cewa tattaunawarmu game da takardun shaida da takunkumi na iya haifar da rashin iya kammala ayyukan da aka tsara da kuma rashin iya barin kowa saboda rashin aiki ko canjin yanayi.
A cikin makonni masu zuwa muna fatan ci gaba da gabatar da Wikimania tare da sadarwa da kuma al'amuran al'umma a wasu yankuna.
Ra'ayin jama'a a cikin al'ummar kasar ya kasance kamar yadda ake kira don dakatar da shi amma a hankali don yin la'akari da shi da kuma tattauna shi a kan al'ummomin su, Wikimedia da sauransu.
A ci gaba, CRT tana aiki don samar da wani shafi na Meta-Wiki don samar da dandamali ga al'umma don kare wannan tasiri da kuma ci gaba da hulɗa da su.
Yin magana game da COVID-19.
Za mu aika da takardun shaida a kan jadawalin da aka tsara a ranar Litinin, 14:00 UTC/07:00 PT don taron rukuni na musamman.
Za mu yi amfani da wannan lokacin don raba wasu bincike, amsa tambayoyinku kuma ku ciyar da ɗan lokaci don yin magana da a'a.
Muna cikinsa, muna shirye mu taimake shi.
A wasu lokuta, zaku iya ci gaba da samun sabuntawa don imel ɗin da sauran mahimman bayanai game da COVID-19, a kan Office Wiki.
CRT za ta bincika waɗannan takardu da bayanan a cikin wani shafi.
Muna kuma aiki tare da kungiyoyi masu zaman kansu a cikin kasashe masu tasowa a halin yanzu.
Idan kuna da tambaya game da tafiya, aiki, aiki mai mahimmanci, ko batun haɗin kai, ko wani abu da kuke buƙatarsa, yi la'akari da yin bayani da aiki tare da CRT.
Muna nan don taimakawa da kuma tara mutane a inda ake bukata.
Idan kana da wasu bayanai masu mahimmanci ko kuma masu dacewa, aika imel zuwa Bryan Judan - HR Manager International Global Operations.
Babu wani daga cikin waɗannan canje-canjen da zai zama kamar ya dace da aikinmu ko ayyukanmu.
Duk da haka, yana da mahimmanci cewa a wannan lokacin, aikinmu da ayyukanmu dole ne a bincika su kamar yadda muke tsammani.
Waɗannan su ne matakan da muke tsammanin za su taimaka mana mu ci gaba da aiki, mu daidaita yanayinmu da bukatunmu, da kuma duniya da ayyukan da suke samarwa.
Ayyukanmu da muka tsara za su kasance a cikin al'ummarmu a lokacin.
Yanzu, lokaci ya yi da za a taimaka wa juna da kuma samun damar yin aiki mai mahimmanci a cikin makonni masu zuwa da kuma hunturu na gaba.
Ba wai muna bukatar ku biya mana bukata kawai ba, amma muna bukatar ku biya mana bukata, domin mu sami zaman lafiya a wurinku.
Saboda haka, ka yi haƙuri, ka wanke hannunka, ka kuma sa ɗan'uwanka a fuska.
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran Ƙungiyoyin Gudanarwa (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
bAngiotensin-converting enzyme 2 (ACE2) wani sinadarin da ke da muhimmanci a waje da jikin (kwayoyin) kwayoyin halitta a cikin huhu, jini, zuciya, jijiya, da kuma jijiyoyin jini.
ACE2 yana hana aikin aikin angiotensin-converting enzyme (ACE) ta hanyar rage haɓakar angiotensin-II da haɓaka Ang ((1-7)), wanda ya sa ya zama magani mai yuwuwa don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin ƙofa a cikin wasu ƙwayoyin cuta na coronavirus.
Kwayar cutar mutum tana da alaƙa da hACE2.
Angiotensin-converting protein 2 shine zinc-containing metalloenzyme kuma yana kan endothelial da sauran kwayoyin halitta.
Kwayar ACE2 tana da N-terminal peptidase M2 domain da kuma C-terminal collectrin renal amino acid transporter domain.
ACE2 shine mai shigar da kwayar halitta mai nau'in nau'in I, wanda ke dauke da sinadarin aiki kuma yana da tasiri a kan kwayoyin halitta a cikin huhu da sauran kwayoyin.
An haɗa yankin ACE2 na waje da kwayar halitta zuwa yankin transmembrane ta wani sinadarin da ake kira sheddase, kuma an sanya wannan furotin a cikin jini kuma daga ƙarshe ya fita daga cikin kwayar halitta.
ACE2 yana cikin yawancin kwayoyin halitta: ACE2 yana cikin kwayoyin halitta na kwayoyin halitta na alveolar type II, ƙananan ƙwayoyin cuta, ƙwayoyin arterial da venous endothelial da kuma ƙwayoyin arterial muscle a yawancin kwayoyin halitta.
An kuma gano tsarin ACE2 mRNA a cikin cerebral cortex, striatum, hypothalamus, da kuma kwakwalwar kwakwalwa.
Babban aikin ACE2 shine a matsayin mai daidaitawa a ACE.
ACE yana haifar da halayen angiotensin I ta hanyar halayen angiotensin II.
ACE2 kuma yana canza carboxyl-terminal amino acid phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) ta hanyar mai narkar da jini na angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 na iya kuma sanya wasu peptides kamar [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 kuma yana hana kwayar cutar SLC6A19 kuma yana da tasiri a cutar Hartnup.
A matsayin furotin na transmembrane, ACE2 yana aiki a matsayin ƙofa ɗaya a cikin wasu ƙwayoyin cuta na coronaviruses, kamar HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
A wani bangare kuma, haɗuwa da kwayar cutar S1 ta SARS-CoV da SARS-CoV2 a cikin enzymatic domain na ACE2 na ƙwayoyin cuta ya haifar da endocytosis da kuma sauyawar ƙwayoyin cuta biyu zuwa ƙwayoyin cuta na endosomes da ke cikin ƙwayoyin.
Wannan binciken ya hana samar da furotin S ta hanyar mai karɓar kwayar cutar TMPRSS2, wanda aka fara bincike a matsayin magani.Wannan ya haifar da tunanin cewa rage matakan ACE2 a cikin kwayoyin zai iya zama da amfani wajen magance cutar.
Koyaya, ƙungiyoyi da yawa na ƙwararru da hukumomin tsarawa sun ba da shawarar ci gaba da daidaitaccen maganin ACE inhibitor da ARB.
Binciken da aka yi na nazarin binciken da aka gudanar a ranar 11 ga Yuli, 2012, ya gano cewa "yin amfani da magungunan ACE yana da alaƙa da raguwar 34% na cutar huhu idan aka kwatanta da rigakafi".
Bugu da ƙari, "haɗarin cututtukan huhu ya ragu a cikin marasa lafiya da ke shan maganin ACE masu hanawa waɗanda ke da haɗarin kamuwa da cutar huhu, musamman a cikin waɗanda ke da cututtukan jini da cututtukan zuciya.
An kuma danganta rage shan maganin ACE da rage mutuwar masu fama da cutar huhu, ko da yake an rage yawan cutar huhu".
Recombinant human ACE2 (rhACE2) wani magani ne na zamani don magance cututtukan huhu, kuma yana taimakawa wajen rage yawan jini a cikin huhu da kuma isar da iska a cikin yara masu ciki waɗanda suka kamu da cutar ta lipopolysaccharide.
Rabin rayuwar rhACE2 a cikin mutum yana da kimanin minti 10 kuma farkon aikin shine minti 30 tare da haɓaka cikin haɗari (lokaci) a cikin awanni 24.
Yawancin bincike sun nuna cewa rhACE2 na iya zama magani mai mahimmanci ga mutanen da basu iya jurewa ga magungunan hana tsarin renin-angiotensin ba (RAS inhibitors) ko kuma a cikin cututtukan da angiotensin II ke da tasiri. An gwada rhACE2 da aka yi amfani da shi a cikin gwaji na asibiti don magance cututtukan huhu.
b'COVID-19 apps sune aikace-aikacen da aka kirkira don taimakawa gano mutane a cikin martani ga cutar coronavirus ta 2019-20, kamar yadda aka bayyana a cikin tsarin gano mutane ("abokan hulɗa") waɗanda zasu iya kasancewa tare da wanda ya kamu da cutar.
An gabatar da aikace-aikace da yawa ko kuma an ba da shawarar su, tare da taimakon gwamnati da kuma na mutum a wasu yankuna da larduna.
An gabatar da takamaiman bayani game da yadda ake bayyana aikace-aikacen haɗin kai.
Abubuwan da suka faru na dogara sun faru, musamman ma a kan hanyoyin da suka shafi gano yanayin rayuwar mutanen da ke amfani da waɗannan aikace-aikacen.
Ƙananan hanyoyin da ke nuna bayanan sirri suna amfani da siginar Bluetooth don ƙuntata kusanci da wasu wayoyi.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar a lokaci guda cewa za su gabatar da kayan aiki don tallafawa aikace-aikacen Bluetooth a cikin tsarin aiki na Android da iOS.
A China, gwamnatin kasar Sin, tare da kamfanin Alipay, sun fitar da wani aikace-aikacen da ke baiwa jama'a damar tantance ko sun kasance tare da mutanen da ke da cutar COVID-19.
Mutane suna amfani da shi a cikin birane 200 na kasar Sin. A Singapore, akwai aikace-aikacen da ake kira TraceTogether.
ITungiyar IT ta samar da aikace-aikacen, wanda ya bayyana a matsayin mai buɗewa ga duk wanda zai ba da shi ga gwamnati.A Arewacin Macedonia akwai wani aikace-aikacen da ke aiki tare da Bluetoth wanda ake kira "StopKorona!", don gano haɗarin da cutar ke haifarwa ga masu kamuwa da cutar da kuma ba da amsa mai kyau ga hukumomin kiwon lafiya.
Aikace-aikacen ya samo asali ne daga ayyukan Ma'aikatar Harkokin Kasuwanci da Fasaha da Lafiya.
A ranar 14 ga Afrilu, 2020, aikace-aikacen yana jiran karɓar Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta sanar da cewa za a samar da aikace-aikacen rigakafin cutar a cikin mako guda. An dakatar da irin wannan aikace-aikacen a Ireland, da Faransa ("StopCovid").
Australia da New Zealand suna nazarin aikace-aikacen da suka danganci TraceTogether Singapore da kuma tsarin BlueTrace. Rasha tana shirin gabatar da aikace-aikacen yin amfani da allon don yin amfani da allon don COVID-19 a Moscow, don ganowa da kuma rarraba su daga gida.
Ross Anderson, farfesa a fannin aikin tsaro a jami'ar Cambridge, ya yi la'akari da yadda matsalolin da aikace-aikacen ke fuskanta, kamar gano wanda ke da cutar amma ba gaskiya ba, zai zama mai mahimmanci idan aka yi la'akari da ƙananan al'umma.
Tare da nuna damuwa game da bayyanar da aikace-aikacen "coronavirus" masu ɓarna ko masu cutarwa, Apple ya sanya iyakoki kan yadda ƙungiyoyi za su iya ƙara aikace-aikacen da ke da alaƙa da cutar coronavirus a cikin App Store, ta hanyar hana su daga "ƙungiyoyi" ko ƙungiyoyi masu alaƙa.
Google da Amazon sun yi irin wannan bincike.
Masu kula da batun dogaro sun nuna damuwa game da yadda ake kiyaye mutane gaba daya ta hanyar aikace-aikacen coronavirus, musamman idan tsarin rigakafin da aka gabatar don hana cutar ta coronavirus ya lalace yayin da cutar ta barke.
Amnesty International da kungiyoyi sama da 100 sun yi wani bayani na daban ta hanyar yin magana kan zargin da ake yi na irin wannan cin zarafin.
Kungiyoyin sun bayyana damuwarsu game da ayyukan gwamnati:
kulawa na iya zama "mai mahimmanci, mai amfani da kuma m";
yin amfani da kayan aiki da kuma kula da su bisa ga umarnin da aka ba da izini;
aiki da bayanai sun shafi tsarin COVID-19.
Tsaron bayanan da kuma rashin rajista zai kasance kamar yadda aka adana shi kuma zai kasance kamar yadda aka bayyana a cikin bayanan;
kula da bayanan da ke nuna cewa ana iya samun damar yin amfani da su da kuma inganta su;
duk wani musayar bayanai da wani zai yi shi ne ya yi sulhu da shi.
za a samar da hanyoyin da za a iya amfani da su wajen magance matsalar da kuma samar da hanyoyin da jama'a za su iya amsawa game da matsalar;
Dole ne a horar da jama'a a cikin tsarin ta hanyar "masu kulawa da hankali", kamar su masu kula da lafiya da kungiyoyi masu lasisi. Ƙungiyar Kwamfuta ta Jamus (CCC) da Masu Ba da Labarai ba tare da iyaka (Reporter ohne Grenzen) (RSF) sun kuma ba da shawara.
Shirin Google/Apple yana nufin magance matsalar tsaro ta hanyar cire bayanin wurin da ake ciki daga umarnin da ba a amfani da shi ba.
Wasu ƙasashe suna amfani da umarnin kulawa amma ba tare da aikace-aikace ba, wanda ke faruwa ba tare da canza wani aikace-aikacen ba kuma ba tare da wani ya bi shi ba.
A Isra'ila, an amince da tsarin tsaro da oda.
Hanyoyin da ke cikin kulawar yanki na iya zama masu rikitarwa da kuma bayanan jama'a.
Duk da haka, ba duk tsarin da umarni na tsakiya suna buƙatar shiga cikin bayanan wurin zama ba; akwai wasu hanyoyin da aka tsara don adana bayanai da aka ba da izini ta hanyar umarni na tsakiya don musayar bayanai (a cikin ƙananan rukuni).
A Koriya ta Kudu, akwai tsarin da ya dace da aikace-aikacen da ke magance matsalar rashin lafiya.
Dangane da amfani da aikace-aikacen da aka bayar, hukumar ta tattara bayanan binciken ta hanyar wasu hanyoyin kamar bayanan kasancewar wayar da bayanan katin kuɗi, kuma ta haɗa su don aika saƙon saƙo ga mutanen da ke da haɗari.
Baya ga amfani da bayanan bayanan, gwamnati ta fitar da bayanan bayanan da aka bude wa jama'a, wanda ya kasance mai matukar muhimmanci ga wasu canje-canje da kuma umarnin bayanai bayan barkewar cutar MERS a kasar.
Wadannan bayanai suna bude ga jama'a ta hanyar aikace-aikace da kuma takardun shaida. Kasashe kamar Jamus sun shirya don haɗawa da tsarin kula da bayanai da kuma cibiyar sadarwa.
A ranar 6 ga Afrilu, 2020, za a sake yin bayanin.
Binciken yanki ya kasance tare da bayanan da aka adana, tare da binciken da aka yi a kalla 2013.A ranar 7 ga Afrilu, 2020, fiye da masu fasaha goma sha biyu sun yi amfani da hanyoyin adana bayanai, kamar amfani da Bluetooth Low Energy (BLE) don bincika mai amfani da wasu wayoyi.
Duk da haka, PEPP-PT shine haɗin haɗin da ke da ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'anar ma'a.
A cikin waɗannan tsarin, bayanan da za a iya samu ba za a iya samun su ba, kuma duk haɗin da aka yi ya wuce ta hanyar wannan tsari.
Privacy Group a MIT Media Lab ya yi takunkumi game da SafePaths, wani dandamali na amfani da hanyoyin adana bayanai na sirri yayin tattara bayanai da kuma amfani da bayanan wuri da kuma bayanai don hana yaduwar COVID-19.
Akwai bincike kan littafin kyauta "Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic" wanda ya fito a watan Maris na 2020.
SafeTrace yana aiki da fasaha mai kyau wanda ke ba masu amfani damar raba bayanai game da wuri da kiwon lafiya tare da wasu mutane da hukumomi, ba tare da rasa bayanan sirri ba.
A ranar 5 ga Afrilu, 2020, TCN Coalition ya fito ne daga ƙungiyoyin da suka haɗu bayan da aka yi la'akari da irin wannan tsari da kuma irin wannan yaduwar, wanda ya ba da shawarar rage ƙarancin, kuma ya tabbatar da cewa an sami damar hana yaduwar cutar ta hanyar aikace-aikacen da suka dace a duk sassan duniya.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta gabatar da tsarin BlueTrace ga jama'a ta hanyar aikace-aikacen da aka ba wa gwamnatin Singapore.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke da dandamali na Android da iOS, sun sanar da wani sabon tsarin bincike na sirri, wanda ake tsammanin zai inganta rayuwar jama'a, ta hanyar haɗa fasahar Bluetooth Low Energy da kuma bayanan bayanan sirri.
An kuma fitar da wasu hanyoyin da aka tsara a cikin wannan umarni.
A cewar Apple da Google, wannan umarni zai fito ne a cikin matakai uku:
Shirye-shiryen samar da kayan aiki na gwamnati sun bayyana aikace-aikacen hana yaduwar cutar coronavirus na gwamnati da kuma na ci gaba.
shigar da ayyukanku a cikin aikace-aikacen iOS da AndroidGoogle da Apple don samun amsoshin matsalolin shigarwa da tsaro ta hanyar rarraba su da farko ta hanyar gwajin amfani da aikace-aikacen, sannan kuma cire su kamar yadda aka saba idan cutar ta ƙare.
Binciken B'Drug (wanda aka sani da sake duba magani, sake yin amfani da shi, sake yin aiki ko kuma canza magani) shine gwajin farko na maganin da ya dace don magance wata cuta ko kuma wani nau'in cuta da aka riga aka tsara.
Duba binciken ilimin da aka yi a cikin wata hira don samar da magani mai lafiya da tasiri don magance cutar COVID-19.
Sauran hanyoyin bincike sun hada da gano kwayar cutar COVID-19 da kuma jini. SARS-CoV yana da sunadarai 66 da za a iya hada su da kwayoyi, kowannensu yana da hanyoyin hadawa da yawa.
Gano waɗannan mahaɗan zai taka muhimmiyar rawa wajen samar da maganin rigakafin cutar COVID-19.
Daga cikin sunadarai na SARS-CoV-2 masu nisa sun hada da papine-like protease, RNA-dependent RNA polymerase, helicase, S protein, da ADP ribophosphatase.
Hussein AA, et al. sun yi nazarin abubuwan da suka hada da magungunan gwaji da suka hada da gwajin gwaji na gaba, kuma sun gano wasu magungunan gwaji da magungunan gwaji don inganta yiwuwar maganin cutar SARS-CoV-2 a cikin binciken da ya gabata don a iya amfani da shi a cikin tsarin gwaji.
Chloroquine magani ne na shuka wanda aka bada shawarar don wasu cututtuka.
A ranar 18 ga watan Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine na iya kasancewa a cikin magungunan da ke cikin gwajin gwaji a asibitin Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa ana iya fara gwajin gwajin chloroquine da hydroxychloroquine a jihar New York a ranar 24 ga Maris.A ranar 28 ga Maris, FDA ta dakatar da shan hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin izinin Amfani da Gaggawa (EUA).
Hukumar kula da gwajin asibiti ta FDA ta amince da wannan magani kuma ta amince da shirin EUA a matsayin magani na gwaji ne kawai idan akwai gaggawa da magani a cikin marasa lafiya da ke asibiti amma ba za su iya samun magani a gwajin asibiti ba.
CDC ta ce "shan, bayarwa, ko kuma hana hydroxychloroquine don rigakafi ko maganin cutar SARS-CoV-2" ba shi da tasiri.
Likitoci sun ce za su ba da maganin ne idan "babu wani zaɓi".
Wani rukunin bincike na Turkiyya a Istanbul ya gabatar da wani bincike game da chloroquine da zinc, bitamin A, bitamin C da bitamin D.
Wasu daga cikin binciken sun kasance a kan binciken da aka yi a Jami'ar Duke da Jami'ar Oxford.
NYU Langone Medical School tana gudanar da gwajin lafiya da kuma amfani da maganin hydroxychloroquine a matsayin maganin rigakafi.
Gwaje-gwajen a asibitocin kasar Sin a Wuhan da Shenzhen sun ce favipiravir yana da "ingantaccen tasiri".
An samu karuwar cutar a Shenzhen da suka kai 35 a cikin kwanaki 4, kuma an samu ci gaba da cutar cikin kwanaki 11 a cikin mutane 45 da suka kamu da cutar.
A wani bincike na Wuhan na marasa lafiya 240 da ke fama da cutar huhu, rabi sun sha favipiravir kuma rabi sun sha umifenovir.
Hukumar Magunguna ta Italiya ta sanar da jama'a cewa ba a samu cikakken bayani game da tasirin maganin ba.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi magungunan a Japan saboda tana da kwarewar soja a can, don saka su a cikin takardar shaidar asibiti, kuma za a samar da magungunan don magance marasa lafiyar COVID-19.
A South China Morning Post, Shinzo Abe ya bukaci gwamnatin Trump da ta samar da maganin. Magungunan na iya zama marasa tasiri wajen magance cututtukan da suka kamu da cutar, kuma cutar ta kare.
Ba za a iya ba da shawarar yin amfani da wannan magani ga mata masu juna biyu ko waɗanda suke so su zubar da ciki ba.
Wani bincike na lopinavir/ritonavir (Kaletra), wani maganin rigakafin cutar da ke hada lopinavir da ritonavir, ya ce "babu wani sakamako da aka samu".
An samar da maganin da zai iya kama HIV ta hanyar yin amfani da shi ta hanyar hada shi da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado na son yin gyare-gyare na maganin don gano wani abu da zai iya haɗuwa da protease na SARS-CoV. Akwai shawarwari tsakanin ƙungiyar masu bincike don ƙaddamar da kayan aiki don bincika maganin da aka samar don cutar HIV/AIDS.
WHO ta maye gurbin lopinavir/ritonavir a cikin gwajin Solidarity na kasa da kasa.
Gilead Sciences ta kirkiro da kuma samar da Remdesivir a matsayin maganin cutar Ebola da cutar Marburg. Gilead Sciences ta kuma gano cewa Remdesivir yana da aikin kashe kwayar cutar a cikin in vitro akan wasu ƙwayoyin cuta kamar filo-, pneumo-, paramyxo-, da coronaviruses.
Wani dalili na maganin cutar shine jinkirin sauyawa, wanda zai iya haifar da mummunan kamuwa da cuta da kuma yaduwa.
Wasu nazarin da aka yi kafin gwaji sun nuna cewa remdesivir na iya zama mai lalacewar kwayar halitta na dogon lokaci. Akwai gwaji na asibiti da ke gudana a halin yanzu, kamar biyu da Cleveland University Hospitals ke gudanarwa; daya don mutane da ke fama da cutar kansa da kuma wani don wadanda ke fama da cutar.
Akwai gwaje-gwaje uku na asibiti na maganin bitamin C a cikin jini a cikin mutanen da ke asibiti tare da cutar COVID-19 mai tsanani; biyu placebo (China, Kanada) da kuma daya ba tare da kulawa ba (Italiya).
Jihar New York ta fara gwajin maganin maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) tana shirin gudanar da gwajin asibiti na Teijin's Alvesco (ciclesonide), wani maganin rigakafin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Wani nau'in enzyme mai canza angiotensin 2, gwajin Cure II wanda aka yi a kan kamuwa da cutar tare da marasa lafiya 200 da aka zaɓa daga cikin waɗanda suka kamu da cutar, yana cikin asibitoci a Denmark, Jamus, da Austria don fahimtar tasirin maganin.
Masu bincike a Cibiyar Kula da Zuciya ta Montreal a Kanada suna nazarin tasirin colchicine don rage haɗarin kamuwa da cutar huhu a cikin marasa lafiya da ke da alamun cutar COVID-19.
Binciken, wanda ake kira COLCORONA, ya dauki mutane 6000 masu shekaru sama da haihuwa wadanda suka kamu da cutar COVID-19 kuma suna da alamun da ba sa bukatar asibiti.
Amma mata masu juna biyu, da mata masu juna biyu, da mata marasa haihuwa, ba za su shiga ba.
An gwada maganin rigakafi da yawa a Italiya.
Heparin mai ƙarancin kwayar halitta yana da kyau a cikin maganin cututtuka, wanda ya sa Hukumar Kula da Lafiya ta Italiya ta ba da shawarar yin amfani da shi.
Wani binciken da aka yi a cikin marasa lafiya 300 wanda ke bincika tasirin enoxaparin sodium a cikin rigakafi da tsarin kulawa da ciki an sanar da shi a Italiya a ranar 14 ga Afrilu.
Yayin da SARS-CoV-2 kwayar cuta ce, akwai damar da za a iya amfani da ita wajen gwada maganin cutar da ke kashe kwayar cutar da ta riga ta haifar da cututtuka kamar su MERS, SARS, da kuma cutar West Nile.
Ribavirin: ribavirin da aka ba da shawarar don maganin COVID-19 bisa ga takaddun shaida na 7 na kasar Sin
Umifenovir: an bada shawarar umifenovir don maganin COVID-19 bisa ga labarin binciken 7 na kasar Sin
Wasu daga cikin magungunan rigakafi da aka ambata za a iya la'akari da su a matsayin maganin COVID-19:
Tocilizumab (Anti-IL-6 receptor): An amince da shi a kasar Sin.
Hakanan akwai gwaji a Italiya da China. a cikin Tocilizumab#COVID-19.
Mataki na B na COVID-19 ya kasance a matsayin rigakafin da aka amince da shi na cutar coronavirus 2019 (COVID-19).
Kodayake babu wani rigakafin da ya kammala gwajin asibiti, akwai wasu hanyoyin da ake bi don samar da irin wannan rigakafin.
A watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce tana tsammanin cewa maganin rigakafin SARS-CoV-2, kwayar cutar da ke haifar da cutar, zai kasance kafin shekaru 18.
Kayan gwajin guda shida sun dogara ne akan darussan zaman lafiya na yakin basasa na Afrilu.
COVID-19 ya bayyana a watan Disamba na 2020.
Cutar ta barke a duniya a shekarar 2020, wanda ya janyo kudaden shiga da kuma masu bincike kan samar da maganin rigakafi.
Ƙungiyoyi da dama suna amfani da kwayoyin halitta don samar da maganin rigakafin cutar SARS-CoV-2.
A watan Afrilu, kuskuren tsarin CEPI na samar da allurar rigakafi shine saurin, tsari, amfani da al'umma mai yawa, da kuma samun damar yin amfani da shi.
A watan Afrilu, masana na CEPI sun sanar da cewa akwai dabarun da aka tsara guda 10 da ke cikin bincike da kuma ci gaba a farkon 2020 don samar da ingantaccen rigakafin COVID-19.
Muhimman darussan da suka shafi zaman lafiya na I sun hada da:
nucleic acid (DNA da RNA) (mai ba da labari na farko da kuma samfurin gwaji: Moderna, mRNA-1273)
cutar (mai ba da labarin I da kuma maganin gwaji: CanSino Biologics, adenovirus type 5 vector)
Kamar yadda aka sanar da CEPI a watan Afrilu, alluran rigakafin gwaji guda 115 suna kan shiri, kuma 78 suna aiki a matsayin ci gaba (79, a cewar Cibiyar Milken), kuma an sanar da wasu 37, amma tare da bayanan jama'a (wanda ya shiga cikin jadawalin ko kuma an zaɓi shi).
Gwajin na I-II ya wuce matakin farko na gwajin lafiya da rigakafi, ya zama mai guba, mai hanawa da placebo, kuma a mafi yawan lokuta, lokacin da aka gano cutar da kyau.
Gwajin na III ya shafi jama'a da yawa, da kuma kungiyoyin kulawa, da kuma nazarin tasirin allurar rigakafi don hana cutar, da kuma kula da haɗarin da ke tattare da ita.
Daga cikin alluran rigakafi 79 da aka shirya fitarwa (wanda aka tabbatar a farkon Afrilu 2020), 74 za su shiga gwajin ɗan adam (a halin yanzu a cikin binciken "kafin asibiti").
A ranar 24 ga Janairu, 2020 a Australia, Jami'ar Queensland ta sanar da cewa tana gudanar da binciken kwayoyin da za su iya samar da rigakafin da zai iya canza furotin na kwayar cutar don samun kwayar cutar.
A ranar 24 ga Janairu, 2020 a Kanada, Cibiyar Alurar rigakafin kasa da kasa (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da cewa an fara aikin yin allurar rigakafin, wanda ke da nufin isar da gwajin ɗan adam a 2021.
An sanar da ci gaban allurar rigakafin a Cibiyar Nazarin Cututtuka da Kula da Cututtuka ta kasar Sin a ranar 26 ga Janairu, 2020, da kuma Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanin Janssen Pharmaceutical Companies, wanda Hanneke Schuitemaker ke jagorantar, ya ce ya fara aiki kan allurar rigakafin.
Janssen yana aiki a kan maganin maganin baki tare da dan uwansa, Vaxart.
A ranar 18 ga watan Maris, Emmergent BioSolution ta sanar da hada kai da Vaxart don samar da maganin.
A ranar 8 ga Fabrairu, 2020, cibiyar bincike ta OncoGen a Romania ta fitar da wani labari game da yadda za a samar da rigakafi da kuma irin wannan fasaha ta maganin cutar neoantigen.
A ranar 25 ga watan Maris ne shugaban kungiyar binciken ya sanar da cewa an kammala gwajin rigakafin kuma an fara gwajin.
A ranar 27 ga Fabrairu, 2020, wani kamfanin Generex, NuGenerex Immuno-Oncology, ya sanar da cewa suna kan aikin binciken rigakafi don samar da Li-Key peptide vaccine don COVID-19.
Suna son samar da rigakafin gwaji wanda zai iya yin nazarin mutane "a cikin kwanaki 90".
A ranar 5 ga watan Maris na shekarar 2020, Jami'ar Washington da ke St. Louis ta sanar da cewa tana kan aikin samar da maganin rigakafin.
A ranar Talata 5 ga watan Maris, Shugaban Cibiyar Bincike ta Sojojin Amurka a Fort Detrick da Cibiyar Bincike ta Sojoji ta Walter Reed a Silver Spring, duka biyu a Yammacin Maryland, sun sanar da cewa suna aiki kan samar da allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ya sanar da haɗin gwiwa tare da Novavax Inc.
don samar da maganin rigakafi.
Ofishin ya sanar da cewa an tsara jadawalin gwajin rigakafin rigakafin da gwajin nau'in I a asibiti a watan Yuli na 2020.
A ranar 12 ga Maris, 2020, Hukumar Lafiya ta Indiya ta sanar da cewa suna kan aiki kan alluran rigakafi 11, kuma ko da kuwa zai ɗauki shekaru biyu da rabi ko biyu kafin a samar da rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere-kere na kere-kere a Quebec City, Quebec, ya sanar da aikin samar da wasu kayayyakin maganin coronavirus da Cibiyar Nazarin Lafiya ta Kanada ta samar da tallafi.
Ana gudanar da gwajin gwaji a cikin dakin gwaje-gwaje, kuma ana shirin gudanar da gwajin mutum a watan Mayu ko Oktoba 2020.
A farkon wannan makon, The Guardian ta ruwaito cewa Shugaban Amurka Donald Trump ya ba CureVac "babban tallafi don samar da allurar COVID-19", wanda gwamnatin Jamus ta amince da shi.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar mRNA.
Tsarin gwajin BNT162 mRNA, a halin yanzu yana cikin gwajin rigakafin magani tare da gwajin da aka shirya don fitowa a farkon Afrilu 2020.
A Italiya a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfanin kere-kere na Italiya ya sanar da cewa za su kammala gwajin rigakafin kafin watan Afrilu na 2020 kuma za a fara gwajin rigakafin na karshe kafin karshen wannan shekarar.
A Faransa a ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) ta sanar da bayar da dala miliyan 4.9 don gudanar da binciken rigakafin COVID-19 tare da kungiyoyi kamar Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ke hada kan kudaden CEPI don samar da allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran cibiyoyin da CEPI ke aiki tare don samar da allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an gwamnatin Rasha sun sanar da cewa masana sun fara gwajin dabbobi da allurar rigakafi guda shida.
Masu binciken Kwalejin Imperial College London sun sanar a ranar 20 ga Maris 2020 cewa suna kan shirin samar da rigakafin NRA mai saurin yaduwa don COVID-19.
Ana iya amfani da allurar rigakafin a cikin kwanaki 14 daga lokacin da aka karɓi kayan aikin a China.
A karshen watan Maris, gwamnatin Kanada ta sanar da bayar da dala miliyan 275 a matsayin tallafin bincike na 96 don hanyoyin kiwon lafiya na COVID-19, da kuma alluran rigakafi da yawa a cibiyoyi da jami'o'in Kanada kamar su Medicago da kuma Jami'ar Saskatchewan.
A halin yanzu, gwamnatin Kanada ta sanar da kashe dala miliyan C$192 don samar da allurar rigakafin COVID-19, tare da shirye-shiryen gina "garin rigakafi" don sabbin alluran rigakafi da yawa waɗanda zasu iya zama masu tasiri idan akwai wani sabon kamuwa da kwayar cutar coronavirus.
A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun sanar da cewa za su gwada PittCoVacc, allurar rigakafin COVID-19 a cikin yara, ta hanyar bayyana cewa "MNA ta samar da rukunin SARS-CoV-2 S1 na rigakafin rigakafin da ke haifar da kwayar cutar mai ƙarfi [a cikin yara] wanda ya fara makonni 2 bayan rigakafin".
A Kanada a ranar 16 ga Afrilu, 2020, Jami'ar Waterloo School of Pharmacy ta sanar da gano wani kwayar cutar DNA mai yiwuwa da ke aiki a matsayin maganin cutar sankarar bargo.
A cikin aiki tare da bacteriophages, DNA na iya shiga cikin kwayoyin halittar mutum don samar da kwayoyin da ba su da cutarwa, wanda zai iya haifar da tsarin garkuwar jiki don samar da rigakafi ga cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Amurka, masana'antu, da jami'o'i sun hada kai don shiga cikin umarni na IBM, wanda ya hada da tsarin aiki na kamfanin Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu hanyoyi suna da wasu haɗari, kuma ana kiran su haɗari masu canji.
A cewarsa, za su iya samun riba a nan gaba idan cutar ta kamu da ita.
Wani gwaji a Australia yana neman shigar da ma'aikatan kiwon lafiya 4,170.
Hakanan ana iya samun cewa alluran rigakafin da aka fitar ba su da lafiya ko kuma ba su da tasiri.
Binciken farko na gudanar da gwajin rigakafin cutar ta hanyar gano nau'in COVID-19 mai dacewa da dabbobi kamar ACE2-transgenic na'urori, wasu nau'ikan gwaje-gwaje, da kuma wadanda suka shiga cikin asalin ɗan adam, sun nuna buƙatar matakan kiyaye lafiyar 3 don magance ƙwayoyin cuta masu cutarwa, da kuma kare lafiyar duniya don tabbatar da ingantattun hanyoyin lafiya.
An gwada kwayoyin cutar SARS da MERS a cikin wasu gwaje-gwaje.
Ya zuwa 2020, babu magani ko rigakafin cutar SARS da aka tabbatar da lafiya da kuma inganci ga mutane.
A cewar takardun bincike na 2005 da 2006, ganowa da kuma samar da sabbin hanyoyin maganin cutar SARS shine babban abin da gwamnatoci da kungiyoyin kiwon lafiyar jama'a ke tunani a kasar.
A lokacin da cutar MERS ta bulla, mutane sun yi tunanin cewa binciken SARS zai iya zama wata hanya ta samar da maganin cutar MERS-CoV.
A ranar 20 ga Maris, 2020, akwai nau'ikan allurar rigakafin MERS (wanda ya dogara da DNA) wanda ya kammala gwajin gwaji na farko, da kuma wasu guda uku, wadanda ke da kwayar cutar adenovirus, (ChAdOx1-MERS, BVRS-GamVac), da kuma MVA-vectored (MVA-MERS-S).
Binciken da aka yi a kafofin sada zumunta ya samar da rahotanni masu gamsarwa game da yadda za a iya gano kwayar cutar bayan COVID-19 kuma an kammala aikin rigakafin.
Bayanan da aka lissafa a kan al'umma sun koma ga bayanan da suka kasance a baya don nazarin kwayoyin halitta don asalin wasu coronavirus kamar SARS coronavirus.
Cutar kwayar cutar korona ta 2019 (COVID-19) cuta ce mai saurin yaduwa da kuma cutar huhu da ke haifar da kwayar cutar korona ta 2 (SARS-CoV-2).
Abubuwan da suka fi faruwa sun hada da ciwon jiki, tashin hankali, da kuma numfashi kamar yadda ake kira ciwon daji.
Sauran alamun na iya zama rauni, ciwo, kumburi, ciwon baya da kuma ciwo, rashin jin daɗi, ciwon ciki.
Lokaci daga kamuwa da cutar zuwa bayyanar cututtuka shine kimanin kwanaki shida amma zai iya wucewa daga kwana biyu zuwa goma sha huɗu.
Yawancin marasa lafiya suna da alamun rashin lafiya, amma wasu na iya zuwa pneumonia da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan da cututtukan cututtukan cututtukan da cututtukan da cututtukan da cututtukan da cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
A ranar 17 ga Afrilu, 2020, an samu rahoton kamuwa da cutar sama da mutane miliyan 2.24 a kasashe da yankuna 210, kuma sama da mutane 153,000 suka mutu.
An yi wa mutane sama da 568,000 allurar rigakafi. An fara yada cutar ta hanyar hulɗa da mutane, galibi ta hanyar raunuka da aka samu ta hanyar yin iyo, yin fitsari, ko kuma shan taba.
Sa'ad da aka yi ta fure a lokacin da ake yin shuka, ana yayyafa su a ƙasa ko a kan tebur don kada iska ta shawo kan mutane.
Mutane na iya kamuwa da cutar ta hanyar taɓawa da naman alade da ke kamuwa da cutar sannan kuma taɓawa da idanunsu, hanci ko bakin su.
Cutar za ta iya yaduwa a cikin masana'antu a cikin sa'o'i 72.
Cutar ta fi yawa a cikin kwanaki uku na farko na kamuwa da cutar, kodayake ana iya samun yaduwar cutar kafin bayyanar cututtuka da kuma bayan kamuwa da cutar. Hanyar da aka fi sani da ita ita ce nazarin polymerase chain reaction (rRT-PCR) daga baya ta hanci ko hanci.
Ana ba da shawarar yin amfani da abin rufe fuska ga mutanen da ake tsammanin suna da kwayar cutar da masu kula da su.
Samun takunkumin fuska a cikin jama'a ya bambanta, tare da wasu hukumomi da ke ba da izinin yin hakan, wasu kuma suna ba da shawarar yin hakan, wasu kuma ba sa yin hakan.
A halin yanzu, babu wani rigakafi ko magani na cutar COVID-19.
An samu rahoton yaduwar cutar a cikin al'umma a kusan dukkan kasashen da ke cikin kungiyar WHO.
Mutanen da suka kamu da kwayar cutar na iya samun alamun kamuwa da cutar ko kuma nuna alamun cutar kamar su kumburi, tari, rashin ƙarfi, da kuma numfashi kamar sanyi.
Abubuwan da ke faruwa a farkon bayyanar sun hada da wahalar numfashi, ciwo ko rashin jin daɗi na dogon lokaci, tashin hankali, wahalar yin hanci da ciwo, canza fuska da hanci; idan waɗannan alamun sun faru, ya kamata a nemi shawarar likita.
A wasu lokuta, cututtukan numfashi kamar su ciwon hanta, ciwon hanta ko ciwon hanta da kuma tashin hankali na iya faruwa.
Abubuwan da ke faruwa a cikin ciki ko na ciki kamar su ciwon ciki, ciki da kuma na ciki suna da bambancin yanayin.
Wasu marasa lafiya a kasar Sin sun fara nuna rashin jin daɗi da kuma rashin jin daɗi.
A wasu, cutar na iya zama ciwon huhu, matsalar rashin lafiyar ciki da kuma rashin lafiya.
Wannan ana kiranta lokacin imani.
Lokacin da aka yi la'akari da COVID-19 shine kwanaki shida zuwa shida amma zai iya zama tsakanin kwanaki biyu zuwa 14.
Kashi 97.5% na mutanen da ke nuna alamun cutar za su yi hakan a cikin kwanaki 11.5 na cutar. Rahotanni sun nuna cewa ba duk wanda ke da cutar ba ne ke nuna alamun cutar.
Ba a san irin rawar da irin waɗannan masu ba da izini a cikin yaduwar cutar ba; duk da haka, hujjojin farko sun nuna cewa suna iya zama masu tasiri a cikin yaduwar cutar.
Tarihin mutanen da ke da cutar amma ba su nuna alamun cutar ba an san su kuma ana ci gaba da nazarin su, saboda Cibiyar Kula da Cututtuka da Cututtuka (KCDC) ta ce kashi 20 cikin 100 za su nuna alamun cutar a lokacin rayuwarsu a asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada wadanda ke nuna alamun cutar a cikin adadin masu cutar a ranar 1 ga watan Afrilu; daga cikin mutane 166 da suka kamu da cutar a ranar, 130 (78%) ba su nuna alamun cutar ba a lokacin da aka yi bincike.
Kowane ƙaho da yake da ƙaho, yana iya yin ƙyalli.
Magana da ƙarfi yana da kyau fiye da magana da ƙarfi.
Wani bincike a Singapore ya gano cewa tsuntsayen da ke cikin rana suna iya yin addu'o'i kuma suna iya kaiwa mita 4.5 (ƙafa).
Kodayake kwayar cutar tana yaduwa ta hanyar iska, National Academy of Science ta nuna cewa yaduwar iska na iya faruwa, kuma masu karɓar iska da ke tsaye a ƙofar ƙofar suna kama da magungunan da ke dauke da kwayar cutar RNA.
Sauran hanyoyin kiwon lafiya kamar su shigar da abu ta hanyar hanci da kuma numfashi na zuciya (CPR) na iya nuna alamun numfashi wanda zai iya fitowa daga numfashi kuma ya zama mai iska.
Lokacin da akwai damuwa game da yiwuwar watsawa ta hanyar hayaniya, ana tsammanin haɗarin ya ragu; lokacin da za a iya watsawa kafin bayyanar cututtuka, haɗarin ya ragu.
Cibiyar Kula da Cututtuka da Cututtuka (ECDC) ta ce ko da yake ba a san yadda cutar za ta iya yaduwa ba, mutum ɗaya na iya cutar da mutane biyu ko uku.
An gano cewa cutar za ta iya kamuwa da ita a cikin kwana daya a kan takarda, saboda a cikin kwana uku a kan roba (polypropylene) da kuma takarda mai laushi (AISI 304), kuma a cikin ƙarfe a cikin kashi 99% na tagulla.
Duk da haka, wannan yana canzawa tare da sanyi da zafi.
Sabulu da ruwa suna da amfani idan aka ɗauka da hannu; kayan sabulu suna rufe ɓangarorin da ke da rauni, cire su, da kuma sanya su a jikin jiki da sauran wurare.
Sauran hanyoyin kamar benzalkonium chloride da chlorhexidine gluconate (mai tsabtace mai tsabta), ba su da tasiri sosai.A wani binciken da aka yi a Hong Kong, ana iya yin amfani da maganin cutar har tsawon kwanaki biyu bayan an fara asibiti.
Daga cikin mutum huɗu, na shida, gwajin farko ya nuna yawan kwayar cutar, kuma kowane mutum shida ya nuna yawan kwayar cutar a rana ta biyu na gwajin.
Coronavirus 2 (SARS-CoV-2) wanda ke haifar da cutar sankara, sabon coronavirus ne mai saurin kamuwa da cutar sankara, wanda aka fara ganowa a cikin mutane uku da ke fama da cutar sankara da ta shafi cutar sankara a Wuhan.
Alamar cutar SARS-CoV mai saurin kamuwa da cuta kamar ta coronavirus.
A waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, wanda ke kawar da cutar. SARS-CoV-2 ya yi kama da SARS-CoV na farko.
Cutar kumburi ta kasance mai matukar tasiri ga COVID-19 saboda kwayar cutar tana shiga cikin ƙwayoyin mai karɓar ta hanyar kwayar angiotensin-converting enzyme 2 (ACE2), wanda ya fi yawa a cikin nau'in II na alveolar na ƙwayar kumburi.
Kwayar cutar tana ɗaukar wani nau'in glycoprotein da ake kira "mai aiki" (peplomer) don haɗuwa da ACE2 kuma ya shiga cikin kwayar mai karɓa.
An gano ƙananan cututtukan zuciya a kashi 12% na waɗanda suka kamu da cutar da kuma waɗanda aka kwantar a asibiti a Wuhan, China, kuma sun kasance mafi yawan lokuta.
An ba da rahoton alamun cututtukan cututtukan zuciya, saboda amsawar da za a iya yi game da maganin rigakafi a yayin ci gaba da cutar, amma kuma aikin myocardium na iya shafar mai karɓar ACE2 a cikin zuciya.
ACE2 mai karɓa yana nunawa a cikin kwakwalwa kuma yana da muhimmanci a cikin aikin kwakwalwa.
An gano cewa akwai wasu cututtukan jini (31%) da kuma wani abu mai suna thromboembolism (25%) da aka gano a cikin marasa lafiya na ICU da ke dauke da cutar COVID-19 kuma ana iya yin watsi da su.Binciken jikin marasa lafiya na COVID-19 da suka mutu ya nuna cutar numfashi (DAD), kuma ruwan jini mai dauke da cutar ya ragu a cikin huhu.
Kodayake SARS-COV-2 yana da tropism na ACE2-bayyana epithelial ƙwayoyin cuta na huhu, marasa lafiya da ke fama da COVID-19 suna da alamun wucewa ta wannan cutar.
Misali, kwayar cutar ta GM-CSF tana lalata kwayoyin T-cell kamar yadda yake daidai da shigar IL-6 mai kumburi wanda ke haifar da monocytes da kuma alamun kumburi mai cutarwa a cikin masu cutar COVID-19.
An kuma bayar da rahoton rashin lafiyar lymphocytes a cikin mutuwar.
Hukumar Lafiya ta Duniya ta bayyana hanyoyin da za a iya gano cutar.
Hanyar da aka saba amfani da ita ita ce ainihin lokacin da aka sake yin amfani da polymerase chain reaction (rRT-PCR).
Ana yin wannan gwajin ne ta hanyar shan kwayar cutar numfashi ta hanyar hanci ko kuma ta baki; duk da haka, ana iya shan kwayar cutar hanci ko hanci.
Sau da yawa ana samun sakamako a cikin 'yan sa'o'i ko kwana biyu.
Ana iya yin gwajin jini, amma ana buƙatar ɗaukar allurai biyu da aka ɗauka a mako biyu tare da bayyanar bayyanar bayyanar.
Masu binciken kasar Sin sun gano yadda za a iya gano asalin wani kwayar cutar coronavirus kuma sun nuna cewa tushen kwayar cutar da aka gano a dakunan gwaje-gwaje a duniya na iya haifar da gwajin polymerase chain reaction (PCR) don gano cutar.
Ya zuwa watan Afrilu 2020, gwajin rigakafi (wanda zai iya gano cutar da kuma yadda mutum ya kamu da cutar) yana kan gaba, amma ba a amfani da shi ga kowa ba.
Binciken al'adun kasar Sin da bincike sun nuna cewa yawan masu cin hanci da rashawa ya kai kashi 60 zuwa 70 cikin dari.
FDA a Amurka ta amince da gwajin farko a cikin asibiti a ranar 21 ga Maris 2020 don amfani a ƙarshen watan. Tsarin gwajin da aka shirya ta Asibitin Zhongnan na Jami'ar Wuhan ya ba da shawarar hanyoyin gano cutar ta hanyar alamun cutar da kuma hadarin cutar.
An gano rashin daidaito na filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen.
Subpleural dominance, crazy paving (ƙaddamar da lobular septal tare da canji a cikin alveoli), da kuma saurin iya faruwa idan cutar ta ci gaba.
Babu cikakken bayani game da tasirin kwayar cutar da kuma yadda COVID-19 ke yaduwa cikin jiki.
Bayanan farko na bayyanar cututtuka a cikin gwajin mutuwa sune:
Makroscopy: pleurisy, pericarditis, ƙuntatawar numfashi da kuma ƙaruwa
Cutar cutar huhu ta hanyar kwayar cuta ta haifar da matsaloli guda hudu:
cututtukan huhu: ciwon huhu, cutar pneumocyte, ciwon pneumocytes, cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan da cututtukan da da da da da da da da da da da da da da da da da da da ke da ke da ke da ke da ke da ke da ke da ke da ke da da da da da da da da da da da da da da da da da da da da da da da da da da da da
cutar sankarar bargo: lalacewar alveolar diffuse (DAD) da kuma yaduwar alveolar exudates.
DAD shine sanadin cututtukan cututtukan numfashi (ARDS) da kuma matsanancin hypoxemia.
cutar huhu: haɗuwa da ƙwayoyin cuta a cikin alveolar cavities da kuma pulmonary interstitial fibrosis
Ruwa: ƙwayar cuta mai ƙwayar cuta (DIC); halayen leukoerythroblastic
Matakan rigakafi don rage yawan kamuwa da cutar sun hada da zama a gida, guje wa hulɗa da jama'a, wanke hannuwanka da sabulu da ruwa a kai a kai na akalla sakan 20, tsabtace numfashi da kuma guje wa taɓa idanu, hanci ko baki da hannaye marasa tsabta.
CDC ta ba da shawarar rufe baki da hanci lokacin da kake yin hancin ko tari da kuma a cikin takunkumin hannu lokacin da ba tare da sutura ba.
Ana bada shawarar wanke hannu bayan wanka ko wanka.
CDC ta ba da shawarar sanya abin rufe fuska a wuraren taruwa, don rage haɗuwa da mutanen da ke nuna alamun cutar. Tsarin taruwa da jama'a yana nufin rage haɗuwa da mutanen da ke da cutar a wuraren taruwa ta hanyar rufe makarantu da ofisoshi, rage zirga-zirga da kuma hana jama'a yin amfani da hanyoyin sadarwa.
Hanyoyin haihuwar sun hada da kasancewa aƙalla ƙafa 6 (1.8 m) tare da wani.
Babu wani magani da aka sani da aka riga aka tsara don hana COVID-19. Tunda ba za a iya samun allurar rigakafi ba kafin 2021 aƙalla, hanyar da za a iya sarrafa COVID-19 ita ce rage yawan kamuwa da cutar, wanda aka sani da "tsallakewar yaduwar cutar".
CDC ta kuma ba da shawarar cewa mutane su riƙa wanke hannayensu da sabulu da ruwa na akalla sakan 20, musamman bayan yin tafiya ko kuma tare da tufafi, kafin shan nono da kuma bayan shan iska, taushi ko taushi.
Ya kuma bada shawarar yin amfani da kayan wanke hannu da ke dauke da akalla kashi 60 cikin dari na barasa, amma sai dai idan sabulu da ruwa ba su da su. A wuraren da babu kayan wanke hannu na kasuwanci, WHO ta ba da shawarar yin hakan da kanka.
A cikin waɗannan hanyoyin, maganin kashe ƙwayoyin cuta ya faru ne ta hanyar ethanol ko isopropanol.
Hydrogen peroxide ya isa ya kawar da kwayoyin cuta a cikin giya; zai zama "wani abu mai amfani don tsabtace hannu".
Glycerol yana da mahimmanci a matsayin kayan aiki.
Ana ba wa mutane kulawa ta rigakafi, wanda zai iya haɗawa da maganin rigakafi, taimakon iska, da kuma taimakon sauran kayan aikin jiki.
CDC ta ba da shawarar cewa mutanen da ke da tabbacin cewa suna da cutar su sanya abin rufe fuska.
Extracorporeal membrane oxygenation (ECMO) ya yi tasiri sosai wajen magance cutar numfashi, amma amfaninta na kan gwaji ne a yanzu.
An bada shawarar yin aikin tsabtace jiki da rayuwa mai kyau da abinci mai gina jiki don inganta rigakafi.
Gwajin tallafi na iya zama mai tasiri tare da rashin ingantaccen bincike a farkon cutar. WHO da Hukumar Lafiya ta China sun ba da shawarar rashin kulawa ga mutanen da ke asibiti da ke dauke da COVID-19.
Masu aiki da gaggawa ko masu kula da allurar rigakafi a Amurka sun gabatar da ƙuri'u ga ƙungiyoyi da yawa don taimakon marasa amfani, IBCC.
A watan Afrilu 2020, akwai magungunan COVID-19 guda huɗu.
Dangane da bayanan, likitoci sun ba da shawarar paracetamol (acetaminophen) ga marasa lafiya fiye da ibuprofen.
Yi aiki tare da taka tsantsan don rage haɗarin haɗarin haɗari, musamman a cikin yanayin lafiyar jiki yayin yin ayyukan da zasu iya haifar da numfashi, kamar shigar da kayan aiki a cikin bakinka ko numfashi tare da hannu.
Ga ma'aikatan kiwon lafiya da ke kula da lafiyar mutum da COVID-19, CDC ta ba da shawarar sanya mutum a cikin dakin keɓewar cutar ta iska (AIIR) don ƙarin aiki da kulawa. CDC ta gabatar da matakan kariya na mutum (PPE) a lokacin annobar.
Abubuwan da aka ba da shawarar su sa: kayan aikin PPE, kayan shafawa ko abin rufe fuska, kayan kariya na ido, da kayan rufe hannu. Idan akwai, kayan numfashi (a kan abin rufe fuska) sun fi dacewa.
An ba da umarnin yin amfani da N95 don amfani a masana'antar kayan aiki amma FDA ta yanke shawarar sanya waɗannan masks a cikin Dokar Amfani da Gaggawa (EUA).
Ayyukan su shine suyi kariya ga abubuwa masu iska kamar su cools amma suna da amfani saboda tsoratar da aka sani ba zai iya ba da amsa mai kyau ba.
Idan ba a sami masks ba, CDC ta ba da shawarar sanya kayan kariya na fuska ko, a matsayin zaɓi na ƙarshe, masks da aka yi a gida.
Masu cutar COVID-19 galibi suna yin iska ta hanyar iska ko kuma wani tsari, NS
Irin wannan taimakon na numfashi ga mutanen da ke fama da cutar COVID-19 da kuma matsalar numfashi ya dogara ne da binciken da aka yi a asibiti, tare da nuna cewa zai iya hana shigar da kayan numfashi a cikin hanci da kuma hanci da kuma matsalolin numfashi.
Ko duka biyun suna da tasiri ga duk waɗanda ke da cutar ba a san su ba.
Wasu likitoci sun daina yin amfani da iska mai iska da iska mai iska idan akwai saboda wannan hanyar tana rage yaduwar abubuwan da iska ke iya ɗauka idan aka kwatanta da ƙwayoyin cuta masu guba.
Kasashe masu tasowa da wadataccen tattalin arziki ba su da gadajen jinya na kowa da kowa, wanda zai iya zama mai wahala ga kowa da kowa idan aka yi la'akari da yawan adadin COVID-19 da ke buƙatar asibiti.
Wani bincike a kasar Sin ya nuna cewa kashi 5% na marasa lafiya sun shiga kungiyoyin kiwon lafiya, kashi 2.3% sun bukaci samun iska a cikin gida, kuma kashi 1.4% sun mutu.
A China, kusan kashi 30% na waɗanda ke asibiti tare da COVID-19 ana shigar da su ICU.
Canzawa ta hanyar umarnin iska mai guba ya faru ne a lokacin da cutar ta COVID-19 ta fara kamuwa da cutar numfashi (ARDS) tare da iska mai guba.
Tsarin iska mai iska mai iska mai iska da kuma PEEP mai kyau zai iya taimakawa wajen rage yawan iska yayin da rage hadarin haɗuwa da numfashi da pneumothorax don hana iska.
Ana iya samun PEEP a cikin tsarin numfashi na farko.
Bincike kan yiwuwar maganin ya fara ne a watan Janairun 2020 kuma maganin rigakafin cutar ya dogara ne akan gwajin asibiti.
Remdesivir ya kasance mafi inganci.
Kodayake ana iya samun sabbin magunguna a 2021 kafin a fitar da su, yawancin magunguna suna kan gwaji kuma an yarda da su don ƙarin aiki ko kuma an kammala gwajin farko.
Ana iya gwada maganin rigakafin cutar a cikin mutane da ke fama da cutar.
WHO ta shawarci masu gwajin su kasance cikin gwajin inganci da amincin magunguna. FDA ta ba da izinin lokaci da kuma magani a kan sinadarin jini a matsayin magani na gwaji a cikin marasa lafiya masu fama da cutar.
Za a gudanar da gwaje-gwaje na asibiti don tabbatar da cewa akwai yiwuwar cutar.
A watan Fabrairun 2020, kasar Sin ta fitar da wani manhaja da ke hana yaduwar cutar.
Masu aiki da masu shayarwa za su koyi yadda za su shiga cikin alamun su.
Wannan aikace-aikacen na iya yin amfani da "ƙananan hoto" ta hanyar amfani da bayanan tsaro da kuma haɗarin kamuwa da cuta.
Kowane mai aiki da makami zai iya tabbatar da cewa akwai wasu mutane uku da suka mallaki shi.
Idan an gano wani haɗari, aikace-aikacen ba kawai yana ba da shawarar ka ware kanka ba, amma kuma yana sanar da ma'aikatan kiwon lafiya na gida. Bayanai masu yawa na binciken bayanai, tsarin sa ido, bin diddigin wuri da kuma bayanan umarni suna da amfani don gano mutanen da ke da cutar da kuma mutanen da suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da umarni ga kungiyoyin lafiya da su bi diddigin alamun wayar salula na mutane da ke dauke da cutar coronavirus.
An tsara wannan tsari ne don kiyaye keɓewa da kuma kare waɗanda ke iya hulɗa da waɗanda ke da cutar.
Har ila yau, a watan Maris na 2020, Deutsche Telekon ta raba bayanan da suka nuna cewa cibiyoyin sadarwa na sadarwa suna aiki tare da cibiyar Robert Koch ta gwamnatin Jamus don gudanar da bincike kan yaduwar cutar.
Rasha ta gabatar da wani shiri na tsare-tsaren da za a yi don tsare mutanen da ke son su zauna a kasar.
Ministan kiwon lafiya na Italiya Giulio Gallera ya ce jami'an wayar salula sun sanar da shi cewa "kashi 40% na mutane suna ci gaba da yin kuka".
Gwamnatin Jamus ta gudanar da binciken ne ta hanyar yin amfani da bayanan da aka samu a cikin daren jiya da suka hada da mutane dubu 42 da suka halarci taron.
A wani bangare kuma, shugaban kasar Estonia Kersti Kaljulaid ya kira mutane da dama domin gudanar da taron jama'a a wani muhimmin taron da ya shafi yaduwar cutar coronavirus.
Mutane na iya fuskantar matsalar rashin lafiya saboda keɓewa, ƙuntatawa na tafiya, haɗarin magani da kuma tsoron kamuwa da cutar.
BBC ta ruwaito Rory O'Connor tana cewa, "Rashin zaman lafiya, zaman kadaici, tunanin kiwon lafiya, rashin lafiya da kuma rage yawan dabbobi na iya zama dalilin da ya sa ake hana mutane hakkoki da zaman lafiya".
Cutar na iya ci gaba da tafiya tare da ƙananan ko ƙananan cututtuka, wanda ya dace da cututtukan cututtukan huhu kamar su mura.
Yara masu cutar za su iya cin abinci na tsawon makonni biyu, kuma waɗanda ke da cututtuka masu tsanani ko kuma masu tsanani za su iya ɗaukar makonni uku zuwa shida a cikin abinci.
Mata masu juna biyu na iya zama masu haɗarin kamuwa da COVID-19 dangane da alamun cutar coronavirus, kamar SARS da MERS, amma akwai ƙarancin bayanai game da COVID-19. A cikin wasu mutane, COVID-19 na iya shafar huhu kuma yana haifar da ciwon huhu.
A cikin waɗanda ke fama da cutar, COVID-19 na iya haifar da cututtukan huhu na yau da kullun (ARDS) wanda ke haifar da matsalar numfashi, kumburi ko kuma kamuwa da wasu cututtukan jiki.
Abubuwan da ke tattare da COVID-19 sun haɗa da rauni, rashin jin daɗi ko ciwon hanci, kumburi da kumburi.
An gano cutar jini mai saurin raguwa, tare da raguwar prothrombin, a kashi 6% na waɗanda aka kwantar da su tare da COVID-19, da kuma kashi 4% na marasa lafiya masu aiki a cikin rukuni.
Kusan kashi 20-30% na mutanen da ke da COVID-19 suna nuna alamun ƙwayoyin cuta (transaminases) a cikin jiki.
A cikin wannan labarin, matsakaicin lokacin da aka fara bayyanar cututtuka a waje shine kimanin kwanaki 10, tare da kwanaki shida a asibiti.
A halin yanzu, marasa lafiya da aka aika zuwa ICU suna da kwanaki shida da biyu tsakanin asibiti da mutuwa.
A cikin binciken farko na marasa lafiya, matsakaicin lokaci daga farkon bayyanar cututtuka zuwa mutuwa shine kimanin kwanaki 14, tare da kwanaki daga shida zuwa 41.
A cewar wani binciken da Hukumar Lafiya ta Kasa (NHC) ta kasar Sin ta yi, maza suna da kashi 2.8% na mace-mace kuma mata suna da kashi 1.7%.
Binciken da aka yi a kan kwayar cutar a cikin kwayar cutar ta mutu ya nuna lalacewar alveolar da kuma fibromyxoid na kwayar halitta a cikin kwayar cutar.
An gano kwayar cutar a cikin ƙwayoyin cuta a cikin pneumocytes.
Hoton da aka yi a baya ya nuna cewa cutar ta ARDS ce.
A cikin kashi 11.8% na mutuwar da Hukumar Lafiya ta kasar Sin ta ruwaito, an ba da rahoton ciwon zuciya tare da matakan tropinin ko kuma ciwon zuciya.
A cewar bayanan Maris na Amurka, kashi 89% na wadanda suka shiga asibiti suna da wasu matsaloli.
Yawan mutuwar bala'i ya bambanta saboda bambancin da ke tsakanin waɗannan takardun, amma kuma saboda matsalolin da ke faruwa a cikin hanya.
Yawan marasa lafiya da ke fama da cutar na iya kara yawan mutuwar.
Koyaya, gaskiyar cewa mutuwar ta kasance sakamakon kamuwa da cutar ta hanyar cutar ta farko na iya nuna cewa adadin mutuwar yanzu ya ragu.
Masu yin rigakafi suna da sau 1.4 na rashin lafiyar COVID-19 kuma kusan sau 2.4 na buƙatar ƙarin kulawa ko magani idan aka kwatanta da waɗanda ba su da rigakafi. Akwai damuwa game da abin da cutar za ta iya haifar da bayan magani.
Hukumar Asibitocin Hong Kong ta gano raguwar kashi 20% da 30% na karfin numfashi a cikin wadanda suka kamu da cutar, tare da gwajin numfashi da ke nuna cutar.
Wannan na iya haifar da rashin lafiyar jiki bayan cin abinci.
A watan Maris na shekarar 2020, mutane sun san ko cutar ta riga ta ba da kariya ga mutanen da aka warkar.
Fadal na iya zama mai yiwuwa, dangane da yanayin wasu coronavirus, amma ana bin marasa lafiya da suka kamu da COVID-19 da gwajin cutar.
Irin waɗannan magunguna suna ɗauka a matsayin wani nau'i na cututtuka wanda ba ya haifar da sabon kamuwa da cuta.
An yi imanin cewa kwayar cutar ta samo asali ne daga dabbobi, ta hanyar cutar da ta riga ta ƙare.
Ba mu san yadda aka bayyana ba, amma a watan Disamba na 2019 cutar ta riga ta kai ga yawancin mutane, ba a nan ba.
Binciken farko na mutane 41 da aka gano suna da cutar COVID-19, wanda ya fito a cikin Janairu 2020 a cikin Lancet, ya nuna lokacin da alamun cutar suka fi bayyana a ranar 1 ga Disamba, 2019.
Binciken WHO ya nuna farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Yawancin hanyoyin suna da tasiri sosai saboda yawan mutuwar.
Wadannan ƙididdigar sun bambanta da wuri da lokaci kuma suna rinjayar bincike, darajar tsarin kiwon lafiya, zaɓin magani, lokaci daga farkon bayyanar cutar da kuma yanayin zamantakewa kamar shekaru, bincike da kuma lafiyar jiki.
A karshen shekarar 2019, WHO ta ba da lambar cutar ta ICD-10 U07.1 don mutuwar sakamakon gano cutar SARS-CoV-2 a cikin dakin gwaje-gwaje da kuma U07.1 don mutuwar asibiti ko ta hanyar kamuwa da cutar COVID-19 ba tare da SARS-CoV-2 da ke shiga asibiti ba.
Dangane da bayanan Jami'ar Johns Hopkins, yawan masu kamuwa da cutar ya kai 6.9% (153,822/2,240,191) tun daga ranar 17 ga Afrilu 2020.
Yawan ya bambanta da yanki. Sauran hanyoyin sun hada da yawan mutuwar (CFR), wanda ke nuna yawan mutanen da suka kamu da cutar da suka mutu, da kuma yawan kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da suka mutu (wanda aka gano da kuma wanda aka gano) daga wata cuta.
Wadannan bincike sun hada da lokacin da ake bin al'umma don cutar ta hanyar maganin cutar.
Ko da yake ba kowa ba ne zai iya samar da kwayoyin cutar, kasancewarsu na iya ba da bayani game da yadda mutane da yawa suka kamu da cutar.
A tsakiyar annobar a Italiya, Castiglione d'Adda, wani karamin gari mai yawan mutane 4600, da kashi 80 (1.7%) sun mutu.
A Gangelt, cutar ta bazu ta hanyar bukukuwan Carnival, ta shafi al'ummar masu yawon bude ido, tare da karancin adadin mutuwar, kuma ba duk wanda ya mutu daga COVID-19 ya shiga wannan rukunin ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus ya fi kyau.
A Netherlands, kusan kashi 3% na iya samun rigakafi, wanda ke nuna cewa sun ba da gudummawar jini.
69 (0.004% na yawan jama'a) an tabbatar da mutuwarsu saboda COVID-19.
Matsayin kamuwa da cutar da kuma yawan mutuwar sun bambanta tsakanin maza da mata.
Yawan mutuwar ya fi muhimmanci ga maza a cikin binciken da aka yi a China da Italiya.
Mafi yawan cutar a cikin maza yana da shekaru 50, tare da bambanci tsakanin maza da mata a cikin shekaru 90.
A China, yawan mace-mace ya kai 2.8 cikin dari da 1.7 cikin dari.
Abubuwan da ke haifar da bambancin tsakanin maza da mata ba su da kyau, amma kwayoyin halitta da halayyar hali na iya zama wannan.
Bambance-bambance na rigakafi tsakanin maza da mata, raguwar yawan kamuwa da cutar a cikin mata da maza da kuma karfafawa daga likitan mata na iya haifar da ƙarin mutuwar maza.
A Turai, kashi 57% na masu kamuwa da cutar maza ne kuma kashi 72% na waɗanda suka mutu daga COVID-19 maza ne.
A watan Afrilu 2020, gwamnatin Amurka ta yi watsi da bayanan da suka shafi cutar COVID-19.
Bincike ya nuna cewa cututtukan kwayar cuta kamar Ebola, HIV, zazzabin cizon sauro da SARS suna shafar maza da mata daban.
Yawancin ma'aikatan kiwon lafiya, likitoci, mata, da sauransu suna da sa'a sosai don kasancewa cikin yanayin cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu 2020 cewa sunan cutar zai zama "COVID-19".
Daraktan WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin Corona, VI kuma kwayar cutar, D don annoba, da 19 don lokacin bayyanar cutar: 31 Disamba 2019.
Wannan sunan yana iya zaɓar don haɗuwa da sunan wani yanki (kamar Sin), asalin dabba ko rukuni.
WHO ta kuma kara sanya "kwayar COVID-19" da "kwayar da ke haifar da COVID-19" a cikin jerin labaran jama'a.
An kira cutar da kwayar cutar "coronavirus".
A farkon bayyanar cutar a Wuhan, China, an kira kwayar cutar da cutar "coronavirus" da "Wuhan coronavirus".
A watan Janairun 2020, WHO ta sanya sunayen cututtukan huhu na 2019-nCov da 2019-nCoV a matsayin sunayen pre-virus da kuma cutar a matsayin kuskuren rigakafi na 2015 saboda sunayen yankin da cutar ta shafa.
An fitar da ainihin sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda ƙuntatawa a cikin samar da kayayyaki, masana'antun kayayyaki suna samar da kayayyakin kiwon lafiya kamar su kayan aikin kashe kumburi da kuma na'urorin numfashi.
A wani misali, lokacin da wani asibiti a Italiya ya yi amfani da kayan aikin maganin numfashi na gaggawa, mai ba da magani bai iya bayyana shi a cikin lokacin da ake yin maganin ba, wani mai ba da magani a wani yanki wanda ba a san shi ba ya bincika kayan aikin kuma ya fitar da 100 a daren.
Bayan barkewar cutar COVID-19, bayanai, bayanai da kuma bayanan da aka bayar sun dogara ne da bayanai na duniya don ganowa, ci gaba, rigakafi, magani da alamun cutar.
Mutane suna iya yada kwayar cutar a wasu dabbobi.
Binciken zai gano sakamakon gwajin kwayar cutar a cikin ƙwayoyin cuta, ƙwayoyin cuta, da ƙwayoyin cuta.
Babu magani ko rigakafin da zai iya magance cutar.
Bincike na duniya kan alluran rigakafi da magunguna na COVID-19 yana fuskantar ci gaba ta hanyar ƙungiyoyi, ƙungiyoyin ilimi da masu bincike na musamman.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da "SOLIDARITY Trial" don tantance hadarin maganin hadewar magunguna hudu da ke nuna yawan amfani.
Babu rigakafin da ake da shi, amma kungiyoyi da dama suna aiki a kan rigakafin gwaji.
Aikin SARS-Cov na kamuwa da cutar ya zama mai amfani ga SARS-CoV BE saboda cOv-2 duka biyu suna aiki tare da ACE2 don shiga cikin jikin mutum.
Akwai hanyoyin rigakafi da ake gwadawa a halin yanzu.
Da farko, masu bincike sun so su bayyana rigakafin cutar gaba daya.
Yin aiki tare da wannan nau'in kwayar cutar, ko dai mai aiki ko mai mutuwa, yana nufin haifar da amsawar rigakafi a jikin mutum ga sabon kamuwa da COVID-19.
Tsarin na biyu, rukuni na rigakafi, yana nufin samar da rigakafi wanda zai rage rigakafin jiki ga wasu nau'ikan ƙwayoyin cuta.
A cikin yanayin SARS-CoV-2, irin wannan binciken ya shafi furotin S-spike wanda ke taimakawa kwayar cutar ta shiga cikin kwayar halitta wanda ke amsa ACE2.
Hanyar ta uku ita ce ta kwayar cuta ta nucleic acid (DNA ko RNA, sabuwar hanyar da za a iya bayyana kwayar cutar).
Dole ne a bincika gwajin gwaji a tsakanin ɗayan waɗannan hanyoyin don aminci da fa'ida.A ranar 16 ga Maris, 2020, an fara gwajin farko na allurar rigakafi tare da masu gwaji huɗu zuwa huɗu.
Baital yana dauke da kwayar cutar da ba ta da hatsari wacce ta kai ga kwayar cutar da ke haifar da cutar. An ba da shawarar mai yin kwayar cutar a matsayin maganin da zai iya magance SARS-CoV-2, amma wasu masu bincike sun ƙi.
Akwai gwaje-gwaje fiye da 300 na asibiti a cikin bincike tun daga watan Afrilu 2020.
An yi gwaje-gwaje guda shida da suka bincika magungunan da aka yi amfani da su a cikin maganin cututtuka, da kuma gwaje-gwaje huɗu na hydroxychloroquine ko chloroquine.
Magungunan rigakafin cutar sun kasance babban abin bincike a China, tare da gwajin Phase III na remdesivir a cikin ƙasashe da yawa don gwaji a ƙarshen Afrilu.
An fara amfani da allurar rigakafin COVID-19 da aka riga aka yi a cikin watan Afrilu na 2020.
Akwai tsammanin samun sakamako na cutar ta hanyar remdesivir, a watan Maris na 2020.
An samu nasara a gwajin asibiti a cikin marasa lafiya da ke shan remdesivir a hankali.
Gwaje-gwajen gwaji na III da aka gudanar a Amurka, China da Italiya. Chloroquine, wanda a baya ya kasance mai amfani wajen maganin zazzabin cizon sauro, an gwada shi a China a watan Fabrairun 2020, tare da sakamakon farko.
Duk da haka, akwai wasu dalilai da suka sa ya kamata a bincika wannan bincike.
Ma'aikatar Lafiya ta Koriya da China sun ba da shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kwayar cuta ta Wuhan, tana ganin shan magungunan gram ɗaya a rana, yana da haɗari sosai kuma yana iya zama mai haɗari.
A ranar 28 ga Maris, 2020, FDA ta ba da umarnin gaggawa game da amfani da hydroxychloroquine da chloroquine ba tare da izini ba ga likitocin da ke kula da mutane da ke fama da COVID-19.
Bayanai na farko sun nuna cewa ana iya samun ribavirin a cikin allurar rigakafin SARS-CoV-2 a cikin in vitro.
An ba da shawarar Nitazoxanide don nazarin in vivo bayan an gano ƙarancin ƙwayar cutar SARS-CoV-2 da aka gano. Nazarin ya nuna cewa gano farkon kwayar protein ta hanyar transmembrane protease serine 2 (TMPRSS2) yana da mahimmanci ga SARS-CoV-2 ta hanyar aiki tare da mai karɓar ACE2.
Nazarin da aka yi kan chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba yana da wasu matsaloli waɗanda ke hana al'ummarmu maganin su karɓa ba tare da ƙarin nazarin ba. Oseltamivir ya kamu da SARS-CoV-2 in vitro kuma yana da tasiri mai mahimmanci a cikin maganin COVID-19.
Rashin ƙwayoyin cytokine na iya zama sanadin wasu cututtukan COVID-19.
Akwai tabbacin cewa hydroxychloroquine na iya samun damar rage yawan kwayar cytokine. An sanya Tocilizumab a cikin tsarin gwaji ta Hukumar Lafiya ta China bayan kammala wani karamin bincike.
An yi gwajin matakin 2 na rashin zaɓe a Italiya don gano cutar a cikin mutane da ke da cutar.
A hade tare da gwajin kwayar cutar ta jini don gano yawan kwayar cytokine, aikinsa shine hana irin wannan yaduwar, wanda ke iya zama sanadin mutuwa ga wasu masu cutar.
An amince da maganin maganin interleukin-6 antagonist ta FDA a kan wani binciken da aka yi don maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin COVIDACA.
A yau, ko kuma a wannan yanayin, an tabbatar da cewa tocilizumab yana da mahimmanci don magance CRS.
Canza kwayar cutar ta rigakafi da aka gano ta jikin mutane da ke shan magani don COVID-19 zuwa ga mutanen da ke buƙatarsa ya dogara da gwaji a matsayin hanyar rigakafi ba tare da sani ba.
Wannan maganin ya dace da SARS amma yana da tasiri.
Kashe kwayar cutar a matsayin hanyar aiki ta hanyar maganin rigakafi wanda zai iya haifar da rigakafin SARS-CoV-2.
Sauran abubuwan, kamar su cytotoxity na salula da/ko cin abinci, na iya zama.
Irin wannan maganin maganin rigakafi na rigakafi, misali, ta hanyar rigakafi na jiki guda ɗaya, yana ci gaba.
Samun maganin jini daga mai magani, wanda shine ruwan jini da aka karɓa daga marasa lafiya masu kamuwa da cutar da ke da rigakafin kwayar cutar, na iya ƙara yawan amsawa ta hanyar maganin.
Cutar kwayar cutar coronavirus, wani nau'in cututtuka da ke tattare da ita
Li Wenliang, likita a asibitin Wuhan Central, wanda ya kamu da cutar COVID-19 kuma ya mutu bayan da ya yi kira ga jama'a da su kara fargabar cutar.
